0000866439 false 0000866439 2021-01-01
2021-09-30 0000866439 2021-01-01 2021-12-31 0000866439 2020-01-01
2020-12-31 0000866439 2021-12-31 0000866439 2020-12-31 0000866439
DPLS:ClassDVotingPreferredStockMember 2021-12-31 0000866439
DPLS:ClassDVotingPreferredStockMember 2020-12-31 0000866439
us-gaap:PreferredStockMember 2019-12-31 0000866439
us-gaap:CommonStockMember 2019-12-31 0000866439
us-gaap:TreasuryStockMember 2019-12-31 0000866439
us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000866439
DPLS:NoncontrollingInterestInsubsidiaryMember 2019-12-31 0000866439
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31
0000866439 us-gaap:RetainedEarningsMember 2019-12-31 0000866439
2019-12-31 0000866439 us-gaap:PreferredStockMember 2020-12-31
0000866439 us-gaap:CommonStockMember 2020-12-31 0000866439
us-gaap:TreasuryStockMember 2020-12-31 0000866439
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000866439
DPLS:NoncontrollingInterestInsubsidiaryMember 2020-12-31 0000866439
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31
0000866439 us-gaap:RetainedEarningsMember 2020-12-31 0000866439
us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0000866439
us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000866439
us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000866439
us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31
0000866439 DPLS:NoncontrollingInterestInsubsidiaryMember 2020-01-01
2020-12-31 0000866439
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01
2020-12-31 0000866439 us-gaap:RetainedEarningsMember 2020-01-01
2020-12-31 0000866439 us-gaap:PreferredStockMember 2021-01-01
2021-12-31 0000866439 us-gaap:CommonStockMember 2021-01-01
2021-12-31 0000866439 us-gaap:TreasuryStockMember 2021-01-01
2021-12-31 0000866439 us-gaap:AdditionalPaidInCapitalMember
2021-01-01 2021-12-31 0000866439
DPLS:NoncontrollingInterestInsubsidiaryMember 2021-01-01 2021-12-31
0000866439 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-01-01 2021-12-31 0000866439 us-gaap:RetainedEarningsMember
2021-01-01 2021-12-31 0000866439 us-gaap:PreferredStockMember
2021-12-31 0000866439 us-gaap:CommonStockMember 2021-12-31
0000866439 us-gaap:TreasuryStockMember 2021-12-31 0000866439
us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000866439
DPLS:NoncontrollingInterestInsubsidiaryMember 2021-12-31 0000866439
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31
0000866439 us-gaap:RetainedEarningsMember 2021-12-31 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember
DPLS:RemoteIntelligenceMember 2021-08-29 2021-08-30 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember
DPLS:WildlifeSpecialistsMember 2021-08-29 2021-08-30 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember
DPLS:RemoteIntelligenceMember 2021-08-30 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember
DPLS:WildlifeSpecialistsMember 2021-08-30 0000866439
DPLS:TJMElectronicsWestMember 2021-09-07 2021-09-08 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember
DPLS:TerraDataUnmannedMember 2021-10-02 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember
DPLS:TerraDataUnmannedMember 2021-10-01 2021-10-02 0000866439
currency:GBP 2021-12-31 0000866439 currency:GBP
DPLS:OptilianAcquisitionMember 2021-12-31 0000866439 currency:CAD
2021-12-31 0000866439 currency:CAD 2020-12-31 0000866439
us-gaap:PatentsMember DPLS:DPTITechnologyMember 2021-12-31
0000866439 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31
0000866439 us-gaap:PropertyPlantAndEquipmentMember
srt:MinimumMember 2021-01-01 2021-12-31 0000866439
us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2021-01-01
2021-12-31 0000866439 us-gaap:LeaseholdImprovementsMember
2021-01-01 2021-12-31 0000866439 DPLS:MotorVehiclesMember
2021-01-01 2021-12-31 0000866439
us-gaap:ConvertiblePreferredStockMember 2021-01-01 2021-12-31
0000866439 us-gaap:ConvertiblePreferredStockMember 2020-01-01
2020-12-31 0000866439 us-gaap:StockOptionMember 2021-01-01
2021-12-31 0000866439 us-gaap:StockOptionMember 2020-01-01
2020-12-31 0000866439 us-gaap:WarrantMember 2021-01-01 2021-12-31
0000866439 us-gaap:WarrantMember 2020-01-01 2020-12-31 0000866439
DPLS:OptilanHoldcoMember 2021-01-01 2021-09-30 0000866439
DPLS:WildlifeSpecialistsMember 2021-01-01 2021-09-30 0000866439
DPLS:RemoteIntelligenceMember 2021-01-01 2021-09-30 0000866439
DPLS:TJMElectronicsWestMember 2021-01-01 2021-09-30 0000866439
DPLS:TerraDataUnmannedMember 2021-01-01 2021-09-30 0000866439
DPLS:OptilanHoldco3LimitedMember 2021-12-31 0000866439
DPLS:WildlifeSpecialistsMember 2021-12-31 0000866439
DPLS:RemoteIntelligenceMember 2021-12-31 0000866439
DPLS:TJMElectronicsWestMember 2021-12-31 0000866439
DPLS:TerraDataUnmannedMember 2021-12-31 0000866439
us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31
0000866439 us-gaap:TransferredAtPointInTimeMember 2020-01-01
2020-12-31 0000866439 us-gaap:TransferredOverTimeMember 2021-01-01
2021-12-31 0000866439 us-gaap:TransferredOverTimeMember 2020-01-01
2020-12-31 0000866439 us-gaap:ProductMember 2021-01-01 2021-12-31
0000866439 us-gaap:ProductMember 2020-01-01 2020-12-31 0000866439
us-gaap:ServiceMember 2021-01-01 2021-12-31 0000866439
us-gaap:ServiceMember 2020-01-01 2020-12-31 0000866439
srt:NorthAmericaMember 2021-01-01 2021-12-31 0000866439
srt:NorthAmericaMember 2020-01-01 2020-12-31 0000866439
DPLS:InternationalMember 2021-01-01 2021-12-31 0000866439
DPLS:InternationalMember 2020-01-01 2020-12-31 0000866439
DPLS:ConvertibleDebt1Member 2021-12-31 0000866439
DPLS:ConvertibleDebt1Member 2021-01-01 2021-12-31 0000866439
DPLS:ConvertibleDebt2Member 2021-12-31 0000866439
DPLS:ConvertibleDebt2Member 2021-01-01 2021-12-31 0000866439
DPLS:ConvertibleDebt3Member 2021-12-31 0000866439
DPLS:ConvertibleDebt3Member 2021-01-01 2021-12-31 0000866439
DPLS:ConvertibleDebt4Member 2021-12-31 0000866439
DPLS:ConvertibleDebt4Member 2021-01-01 2021-12-31 0000866439
DPLS:DerivativeLiabilitiesMember 2021-12-31 0000866439
DPLS:GenevaRoth2Member 2020-10-07 0000866439 DPLS:GenevaRoth2Member
2021-10-07 0000866439 DPLS:GenevaRoth2Member 2020-10-06 2020-10-07
0000866439 DPLS:GenevaRoth2Member 2021-04-14 2021-04-16 0000866439
DPLS:GenevaRoth3Member 2021-01-04 0000866439 DPLS:GenevaRoth3Member
2021-01-03 2021-01-04 0000866439 DPLS:GenevaRoth3Member 2021-07-11
2021-07-12 0000866439 DPLS:GenevaRoth4Member 2021-02-03 0000866439
DPLS:GenevaRoth4Member 2021-02-01 2021-02-03 0000866439
DPLS:GenevaRoth4Member 2021-07-13 2021-07-14 0000866439
DPLS:GenevaRoth5Member 2021-02-18 0000866439 DPLS:GenevaRoth5Member
2021-02-17 2021-02-18 0000866439 DPLS:GenevaRoth5Member 2021-07-13
2021-07-14 0000866439 DPLS:GenevaRoth6Member 2021-04-05 0000866439
DPLS:GenevaRoth2Member 2021-04-01 2021-04-05 0000866439 2021-04-26
0000866439 2021-04-01 2021-04-26 0000866439 2021-05-19 0000866439
2021-06-03 0000866439 2021-06-01 2021-06-03 0000866439 2021-07-14
0000866439 2021-07-01 2021-07-14 0000866439 2021-01-01 2021-01-12
0000866439 2021-05-01 2021-05-27 0000866439 2021-08-01 2021-08-31
0000866439 2021-10-01 2021-10-20 0000866439
us-gaap:AccountsPayableMember 2021-12-31 0000866439
us-gaap:AccountsPayableMember 2020-12-31 0000866439
us-gaap:AccruedLiabilitiesMember 2021-12-31 0000866439
us-gaap:AccruedLiabilitiesMember 2020-12-31 0000866439
DPLS:FederalAndStateMember 2021-12-31 0000866439
DPLS:UnitedKingdom1Member 2021-12-31 0000866439 DPLS:Canada1Member
2021-12-31 0000866439 2021-01-13 2021-01-14 0000866439 2021-01-24
2021-01-25 0000866439 2021-01-30 2021-02-02 0000866439 2021-02-10
2021-02-11 0000866439 2021-02-17 2021-02-18 0000866439 2021-04-14
2021-04-16 0000866439 2021-04-29 2021-04-30 0000866439 2021-06-01
2021-06-04 0000866439 2021-07-01 2021-07-12 0000866439 2021-07-13
2021-07-14 0000866439 2021-07-18 2021-07-19 0000866439 2021-08-24
2021-08-25 0000866439 2021-08-29 2021-08-31 0000866439 2021-09-21
2021-09-22 0000866439
DPLS:MembershipInterestPurchaseAgreementsMember 2021-09-29
2021-09-30 0000866439 2021-09-01 2021-09-30 0000866439 2021-09-29
2021-10-02 0000866439 2021-10-01 2021-10-15 0000866439 2021-10-01
2021-10-22 0000866439 2021-10-01 2021-10-25 0000866439 2021-11-01
2021-11-17 0000866439 srt:ChiefExecutiveOfficerMember 2021-01-01
2021-12-31 0000866439 srt:ChiefExecutiveOfficerMember 2020-01-01
2020-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
xbrli:pure
Table of Contents
As filed with the Securities and Exchange Commission on April
20, 2022
Registration No. 333-261453
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1
TO
FORM
S-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
DARKPULSE, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
7372 |
|
87-0472109 |
(State or Other Jurisdiction
of Incorporation)
|
|
(Primary Standard
Classification Code)
|
|
(IRS Employer
Identification No.)
|
1345 Ave of the Americas, 2nd Floor
New York,
NY
10105
(800)
436-1436
(Address, including zip code, and telephone number, including area
code of registrant’s principal executive offices)
The Corporation Trust Company
Corporation Trust Center
1209 Orange St.
Wilmington, DE 19801
(302)
658-7581
(Name, address, including zip code, and telephone number, including
area code, of agent for service)
Copies to:
Brian Higley, Esq.
Business Legal Advisors, LLC
14888 Auburn Sky Drive
Draper, UT 84020
(801)
634-1984
Approximate date of commencement of proposed sale to the
public:
As soon as practicable after the effective date of this
Registration Statement.
Approximate date of commencement of proposed sale to the public: As
soon as practicable and from time to time after this Registration
Statement is declared effective.
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933 check the following box. ☒
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule
462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company” and “emerging growth company” in Rule
12b-2 of the Exchange Act. (Check one):
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated filer |
☒ |
Smaller reporting
company |
☒ |
|
|
Emerging growth
company |
☐ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
The registrant hereby amends this Registration Statement on such
date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically
states that this Registration Statement shall thereafter become
effective in accordance with Section 8(A) of the Securities Act or
until the Registration Statement shall become effective on such
date as the Commission, acting pursuant to said Section 8(A), may
determine.
EXPLANATORY NOTE
On December 1, 2021, DarkPulse, Inc., a Delaware corporation (the
“Company”), filed a registration statement with the
Securities and Exchange Commission (the “SEC”) on Form S-1
(File No. 333-261453), as amended (the “Registration
Statement”), covering the sales of up to 300,000,000 shares of
the Company’s common stock, par value $0.001 (the “Common
Stock”). The Registration Statement was originally declared
effective by the SEC on December 10, 2021.
This Post-Effective Amendment No. 1 is being filed in order to
include information from the Company’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2021 that was filed with the
SEC on April 15, 2022 and to make certain corresponding changes in
the Registration Statement.
No additional securities are being registered under this
Post-Effective Amendment. All applicable registration and filing
fees were paid at the time of the original filing of the
Registration Statement.
The information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these securities
and it is not soliciting offers to buy these securities in any
jurisdiction where the offer or sale is not permitted.
PRELIMINARY
PROSPECTUS |
SUBJECT TO
COMPLETION |
DATED APRIL 20,
2022 |

300,000,000 Shares of Common Stock
This prospectus relates to the offer and resale of up to:
300,000,000 shares of our common stock, par value $0.0001 per share
(the “Shares”), that may be purchased by GHS Investments
LLC, a Nevada limited liability company (“GHS”), pursuant to
the Equity Financing Agreement dated November 9, 2021 between the
Company and GHS (the “EFA”). GHS is also referred to herein
as the “Selling Security Holder.”
We will not receive any of the proceeds from the sales of the
Shares by the Selling Security Holder.
The Selling Security Holder identified in this prospectus may offer
the shares of Common Stock from time to time through public or
private transactions at prevailing market prices or at privately
negotiated prices. The Selling Security Holder can offer all, some
or none of its shares of Common Stock, thus we have no way of
determining the number of shares of Common Stock it will hold after
this offering. See “Plan of
Distribution.”
The Selling Security Holder is an “underwriter” within the meaning
of Section 2(a)(11) of the Securities Act.
Our Common Stock is currently quoted on the OTC Markets under the
symbol “DPLS.” On April 14, 2022, the last reported sale price of
our Common Stock on the OTC Markets was $0.048.
Investing in our Common Stock involves a high degree of risk.
You should review carefully the risks and uncertainties described
under the heading “Risk
Factors” beginning on page 5 of this prospectus, and under
similar headings in any amendments or supplements to this
prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal
offense.
The date of this prospectus is April 20, 2022
TABLE OF
CONTENTS
You should rely only on the information contained in this
prospectus. We have not authorized anyone to provide you with
information different from that which is contained in this
prospectus. This prospectus may be used only where it is legal to
sell these securities. The information in this prospectus may only
be accurate on the date of this prospectus, regardless of the time
of delivery of this prospectus or of any sale of securities.
ABOUT THIS
PROSPECTUS
The registration statement of which this prospectus forms a part
that we have filed with the U.S. Securities and Exchange Commission
(the “SEC”) and includes exhibits that provide more detail
of the matters discussed in this prospectus. You should read this
prospectus and the related exhibits filed with the SEC, together
with the additional information described under the heading
“Where You Can Find More
Information” before making your investment decision.
You should rely only on the information provided in this prospectus
or in any prospectus supplement or any free writing prospectuses or
amendments thereto. Neither we, nor the Selling Security Holder,
have authorized anyone else to provide you with different
information. If anyone provides you with different or inconsistent
information, you should not rely on it. You should assume that the
information in this prospectus is accurate only as of the date
hereof. Our business, financial condition, results of operations
and prospects may have changed since that date.
Neither we, nor the Selling Security Holder, are offering to sell
or seeking offers to purchase these securities in any jurisdiction
where the offer or sale is not permitted. Neither we, nor the
Selling Security Holder, have done anything that would permit this
offering or possession or distribution of this prospectus in any
jurisdiction where action for that purpose is required, other than
in the United States. Persons outside the United States who come
into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of the
securities as to distribution of the prospectus outside of the
United States.
Information contained in, and that can be accessed through, our web
site, www.darkpulse.com, does not constitute part of this
prospectus.
This prospectus includes market and industry data that has been
obtained from third party sources, including industry publications,
as well as industry data prepared by our management on the basis of
its knowledge of and experience in the industries in which we
operate (including our management’s estimates and assumptions
relating to such industries based on that knowledge). Management’s
knowledge of such industries has been developed through its
experience and participation in these industries. While our
management believes the third-party sources referred to in this
prospectus are reliable, neither we nor our management have
independently verified any of the data from such sources referred
to in this prospectus or ascertained the underlying economic
assumptions relied upon by such sources. Internally prepared and
third-party market forecasts in particular are estimates only and
may be inaccurate, especially over long periods of time. In
addition, the underwriters have not independently verified any of
the industry data prepared by management or ascertained the
underlying estimates and assumptions relied upon by management.
Furthermore, references in this prospectus to any publications,
reports, surveys or articles prepared by third parties should not
be construed as depicting the complete findings of the entire
publication, report, survey or article. The information in any such
publication, report, survey or article is not incorporated by
reference in this prospectus.
PROSPECTUS
SUMMARY
This summary highlights information contained elsewhere in this
prospectus; it does not contain all the information you should
consider before investing in our Common Stock. You should read the
entire prospectus before making an investment decision. Throughout
this prospectus, the terms the “Company”, “DarkPulse”, “we,” “us,”
“our,” and “our company” refer to DarkPulse, Inc., a Delaware
corporation.
Company Overview
DarkPulse, Inc. (“DarkPulse” or the "Company") is a
technology-security company incorporated in 1989 as Klever
Marketing, Inc ("Klever"). One of our principal wholly-owned
subsidiaries, DarkPulse Technologies Inc. ("DPTI"),
originally started as a technology spinout from the University of
New Brunswick, Fredericton, Canada. DPI is comprised of multiple
security platforms: Patented BOTDA Fiber Optic sensor systems and
Satellite Communications services.
In December 2010, DPTI entered into an Assignment Agreement with
the University of New Brunswick, Canada (the “University”),
pursuant to which the University sold, transferred, and assigned to
us certain patents related to the University’s BOTDA dark-pulse
technology (the "Patents") in exchange for the issuance of a
debenture to the University in the amount of C$1,500,000 (Canadian
dollars). In April 2017, DPTI issued a replacement debenture
to the University in the amount of US$1,491,923 (the
“Debenture”). The Patents and the Debenture were
initially recorded in our accounts at $1,491,923, based upon the
exchange rate between the U.S. dollar and the Canadian dollar on
December 16, 2010, the date of the original debenture. In addition
to the repayment of principal and interest, the Debenture requires
DPTI to pay the University a 2% royalty on sales of any and all
products or services which incorporate the Patents for a period of
five years commencing on April 24, 2018, as well as to reimburse
the University for its patent-related costs.
On April 27, 2018, Klever entered into an Agreement and Plan of
Merger (the “Merger Agreement” or the “Merger”)
involving Klever as the surviving parent corporation and acquiring
DPTI as its wholly-owned subsidiary. On July 18, 2018, the parties
closed the Merger Agreement, as amended on July 7, 2018, and the
name of the Company was subsequently changed to “DarkPulse, Inc.”
With the change of control of the Company, the Merger was accounted
for as a recapitalization in a manner similar to a reverse
acquisition.
On July 20, 2018, we filed a Certificate of Amendment to our
Certificate of Incorporation with the State of Delaware, changing
the name of the Company to “DarkPulse, Inc.” We filed a corporate
action notification with the Financial Industry Regulatory
Authority (“FINRA”), and our ticker symbol was changed to
“DPLS.”
Our security and monitoring systems will be delivered in
applications for critical infrastructure/ key resources such as but
not limited to border security, pipelines, the oil and gas industry
and mine safety. Current uses of fiber optic distributed sensor
technology have been limited to quasi-static, long-term structural
health monitoring due to the time required to obtain the data and
its poor precision. Our patented BOTDA dark-pulse sensor technology
allows for the monitoring of highly dynamic environments due to its
greater resolution and accuracy.
The Company has recently completed several acquisitions.
Our Business
We offer a full suite of engineering, installation and security
management solutions to industries and governments. Coupled with
our patented Brillouin
optical time domain analyzer (“BOTDA”) dark-pulse
technology (the “DarkPulse Technology”), we provide our
customers a comprehensive data stream of critical metrics for
assessing the health and security of their infrastructure. Our
comprehensive system provides for rapid, precise analysis and
responsive activities predetermined by the end-user
customer. These responses include the use of “smart” AI
platformed cameras, facial recognition technologies and multiple
drone platforms. Our User Interface (UI) is cloud based which
offers end-users access to their systems on any device located
anywhere in the world. Additional programming of the UI is being
completed within a game engine that will also offer access via
Virtual Reality headsets, allowing end-users to virtually
inspection their assets.
Historically, distributed sensor systems have been too costly, slow
and limited in their capabilities to attain widespread use. In
addition, Brillouin-based sensors have been plagued with
temperature and strain cross-sensitivity, i.e. the inability to
distinguish between temperature and strain change along the same
fiber. The loss of spatial resolution with an increase in fiber
length has also limited the use of distributed sensor systems. Due
to these shortcomings, existing technologies are unable to succeed
within today’s dynamic environments, and needs for more advanced
sensor technologies have remained unsatisfied.
By contrast to existing technologies, the DarkPulse Technology is a
distributed-fiber sensing system, based on
dark-pulse Brillouin scattering, which reports in
real-time on conditions such as temperature, stress, strain
corrosion and structural health monitoring of Critical
Infrastructure/Key Resources including Bridges, Buildings, Roadways
pipelines and mining installations.
DarkPulse Technology’s differentiators from and advantages over
existing technologies:
|
· |
Real-time Reporting: Higher data acquisition
speeds allowing for structural monitoring of dynamic
systems |
|
|
|
|
· |
Cost
to Customer: Significantly lower acquisition and operating
costs |
|
|
|
|
· |
Precision: A greater magnitude of precision and
spatial resolution than other systems currently
available |
|
|
|
|
· |
Applications: Wider range of capabilities than
other systems currently available |
|
|
|
|
· |
Power
consumption: Lower power consumption than existing systems allowing
for off-grid installations |
|
|
|
|
· |
Integration: Capable of integrating with existing
systems |
|
|
|
|
· |
Central station monitoring/cloud-based
GUI |
We believe that these key advantages should allow us not only to
enter existing markets, but more importantly, to open new market
opportunities with new applications. We intend to leverage new
applications to target clients that have been unable to make use of
distributed fiber optic technology to date.
Available Information
All reports of the Company filed with the SEC are available free of
charge through the SEC’s website at www.sec.gov. In
addition, the public may read and copy materials filed by the
Company at the SEC’s Public Reference Room located at 100 F Street,
N.E., Washington, D.C. 20549. The public may also obtain additional
information on the operation of the Public Reference Room by
calling the Commission at 1-800-SEC-0330.
Where You Can Find Us
The Company’s executive offices are located at 1345 Ave of the
Americas, 2nd Floor, New York, NY 10105, and our
telephone number is (800) 436-1436. Our website address is
www.darkpulse.com. Information contained on our website does
not form part of this prospectus and is intended for informational
purposes only.
THE
OFFERING
Common
Stock outstanding before the offering |
|
5,379,471,416
shares of Common Stock. |
|
|
|
Common Stock to be outstanding
after giving effect to the issuance of 300,000,000 shares of Common
Stock, 169,649,518 of which have been sold with 130,350,482
remaining to be issued |
|
5,584,394,889
shares of Common Stock. |
|
|
|
Use of
Proceeds |
|
We
will not receive any of the proceeds from any sale of the shares of
Common Stock by the Selling Security Holder. We will receive
proceeds from the purchase of the Common Stock under the EFA from
the Selling Security Holder. See “Use of Proceeds.” |
|
|
|
Risk Factors |
|
The
Common Stock offered hereby involves a high degree of risk and
should not be purchased by investors who cannot afford the loss of
their entire investment. See “Risk Factors” beginning on page
5. |
|
|
|
Trading Symbol |
|
The
Company’s Common Stock is quoted on the OTC Markets under the
symbol “DPLS.” |
The number of shares of Common Stock outstanding is based on an
aggregate of 5,379,471,416 shares outstanding as of April 11, 2022
and excludes the shares of Common Stock issuable upon purchase of
the Shares under the EFA.
For a more detailed description of the Shares and the EFA, see
“Private Placement”.
RISK
FACTORS
Readers of this Prospectus should carefully consider the risks and
uncertainties described below.
Our failure to successfully address the risks and uncertainties
described below would have a material adverse effect on our
business, financial condition and/or results of operations, and the
trading price of our common stock may decline and investors may
lose all or part of their investment. We cannot assure you that we
will successfully address these risks or other unknown risks that
may affect our business.
As an enterprise engaged in the commercialization of new
technology, our business is inherently risky. Our common shares are
considered speculative during the development of our business
operations. Prospective investors should consider carefully the
risk factors set out below.
Risks Related to Our Business
Business interruptions, including any interruptions resulting
from COVID-19, could significantly disrupt our operations and could
have a material adverse impact on us if the situation
continues.
The ongoing coronavirus outbreak which began in China at the
beginning of 2020 has impacted various businesses throughout the
world, including travel restrictions and the extended shutdown of
certain businesses in impacted geographic regions. If the
coronavirus outbreak situation should worsen, we may experience
disruptions to our business including, but not limited to
equipment, to our workforce, or to our business relationships with
other third parties.
The extent to which the coronavirus impacts our operations or those
of our third-party partners will depend on future developments,
which are highly uncertain and cannot be predicted with confidence,
including the duration of the outbreak, new information that may
emerge concerning the severity of the coronavirus and the actions
to contain the coronavirus or treat its impact, among others. Any
such disruptions or losses we incur could have a material adverse
effect on our financial results and our ability to conduct business
as expected.
Escalating global tensions, including the conflict between
Russia and Ukraine, could negatively impact us.
The ongoing conflict between Russia and Ukraine could lead to
disruption, instability and volatility in global markets and
industries that could negatively impact our operations. The U.S.
government and other governments in jurisdictions in which we
operate have imposed severe sanctions and export controls against
Russia and Russian interests and threatened additional sanctions
and controls. The impact of these measures, as well as potential
responses to them by Russia, is currently unknown and they could
adversely affect our business, partners or customers.
If we default on the Convertible Debenture, the secured
holder could take possession of our assets, including our patents
and other intellectual property.
The Convertible Debenture (Secured) issued April 24, 2017, is
secured by our assets, which includes our patents and other
intellectual property. In the event that we default on the
obligations in the Debenture, the secured holder could take
possession of our assets, including our patents and other
intellectual property. If this were to occur, investors would
likely lose all of their investment.
We need to continue as a going concern if our business is to
succeed.
Our independent registered public accounting firm reports on our
audited financial statements for the years ended December 31, 2021
and 2020, indicate that there are a number of factors that raise
substantial risks about our ability to continue as a going concern.
Such factors identified in the report are our accumulated deficit
since inception, our failure to attain profitable operations, the
excess of liabilities over assets, and our dependence upon
obtaining adequate additional financing to pay our liabilities. If
we are not able to continue as a going concern, investors could
lose their investments.
We have made and expect to continue to make acquisitions that
could disrupt our operations and harm our operating
results.
Our growth depends upon market growth, our ability to enhance our
existing products, and our ability to introduce new products on a
timely basis. We intend to continue to address the need to develop
new products and enhance existing products through acquisitions of
other companies, product lines, technologies, and personnel.
Acquisitions involve numerous risks, including the following:
|
• |
|
Difficulties in integrating the operations,
systems, technologies, products, and personnel of the acquired
companies, particularly companies with large and widespread
operations and/or complex products; |
|
• |
|
Diversion of management’s attention from normal
daily operations of the business and the challenges of managing
larger and more widespread operations resulting from
acquisitions; |
|
• |
|
Potential difficulties in completing projects
associated with in-process research and development
intangibles; |
|
• |
|
Difficulties in entering markets in which we have
no or limited direct prior experience and where competitors in such
markets have stronger market positions; |
|
• |
|
Initial dependence on unfamiliar supply
chains |
|
• |
|
Insufficient revenue to offset increased expenses
associated with acquisitions; and |
|
• |
|
The potential loss of key employees, customers,
distributors, vendors and other business partners of the companies
we acquire following and continuing after announcement of
acquisition plans. |
Acquisitions may also cause us to:
|
• |
|
Issue common stock that would dilute our current
shareholders’ percentage ownership; |
|
• |
|
Use a substantial portion of our cash resources
or incur debt; |
|
• |
|
Significantly increase our interest expense,
leverage and debt service requirements if we incur additional debt
to pay for an acquisition; |
|
• |
|
Record goodwill and nonamortizable intangible
assets that are subject to impairment testing on a regular basis
and potential periodic impairment charges; |
|
• |
|
Incur amortization expenses related to certain
intangible assets; |
|
• |
|
Incur tax expenses related to the effect
of acquisitions on our intercompany research and development
cost sharing arrangement and legal structure; |
|
• |
|
Incur large and immediate write-offs and
restructuring and other related expenses; and |
|
• |
|
Become subject to intellectual property or other
litigation. |
Mergers and acquisitions are inherently risky and subject to many
factors outside of our control, and no assurance can be given that
our previous or future acquisitions will be successful and will not
materially adversely affect our business, operating results, or
financial condition. Failure to manage and successfully integrate
acquisitions could materially harm our business and operating
results. Prior acquisitions could result in a wide range of
outcomes, from successful introduction of new products and
technologies to a failure to do so. Even when an acquired company
has already developed and marketed products, there can be no
assurance that product enhancements will be made in a timely
fashion or that pre-acquisition due diligence will have identified
all possible issues that might arise with respect to such
products.
From time to time, we have made acquisitions that resulted in
charges in an individual quarter. These charges may occur in any
particular quarter, resulting in variability in our quarterly
earnings. In addition, our effective tax rate for future periods is
uncertain and could be impacted by mergers and acquisitions. Risks
related to new product development also apply to acquisitions.
Because of the unique difficulties and uncertainties inherent
in technology development, we face a risk of business
failure.
Potential investors should be aware of the difficulties normally
encountered by companies developing new technology and the high
rate of failure of such enterprises. The likelihood of success must
be considered in light of the problems, expenses, difficulties,
complications and delays encountered in connection with the
development of new technology with limited personnel and financial
means. These potential problems include, but are not limited to,
unanticipated technical problems that extend the time and cost of
product development, or unanticipated problems with the operation
of our technology or that with which we are licensing that also
extend the time and cost of product development.
If we do not obtain additional financing or sufficient
revenues, our business will fail.
Our current operating funds are less than necessary to fulfill our
operating costs and we will need to obtain additional financing in
order to continue our business operations. Although we are
generating revenues, we are not generating net income.
We will require additional financing to execute our business plan
through raising additional capital and/or generating greater
revenues.
Obtaining additional financing is subject to a number of factors,
including acceptance of our DarkPulse Technology and current
financial condition as well as general market conditions.
These factors affect the timing, amount, terms or conditions of
additional financing unavailable to us. If additional financing is
not arranged, we will face the risk of going out of business. Our
management is currently engaged in actively pursuing multiple
financing options in order to obtain the capital necessary to
execute our business plan.
The most likely source of future funds presently available to us is
through the additional sales of equity or through convertible debt
instruments. Any sales of share capital or conversion of
convertible debt will most likely result in dilution to existing
shareholders.
There is no history upon which to base any assumption as to the
likelihood we will prove successful, and we can provide investors
with no assurance that we will generate any operating revenues or
achieve profitable operations. If we are unsuccessful in addressing
these risks, our business will most likely fail.
Successful technical development of our products does not
guarantee successful commercialization.
We may successfully complete the technical development for one or
all of our product development programs, but still fail to develop
a commercially successful product for a number of reasons,
including among others the following:
|
· |
Ineffective
distribution and marketing; |
|
· |
Lack of sufficient
cooperation from our partners; and |
|
· |
Demonstrations of the
products not aligning with or meeting customer needs. |
Our success in the market for the products we develop will depend
largely on our ability to prove our products’ capabilities. Upon
demonstration, our products and/or technology may not have the
capabilities they were designed to have or that we believed they
would have. Furthermore, even if we do successfully demonstrate our
products’ capabilities, potential customers may be more comfortable
doing business with a larger, more established, more proven company
than us. Moreover, competing products may prevent us from gaining
wide market acceptance of our products. Significant revenue from
new product investments may not be achieved for a number of years,
if at all.
If we fail to protect our intellectual property rights, we
could lose our ability to compete in the marketplace.
Our intellectual property and proprietary rights are important to
our ability to remain competitive and for the success of our
products and our business. We rely on a combination of patent,
trademark and trade secret laws as well as confidentiality
agreements and procedures, non-compete agreements and other
contractual provisions to protect our intellectual property, other
proprietary rights and our brand. We have confidentiality
agreements in place with our consultants, customers and certain
business suppliers and plan to require future employees to enter
into confidentiality and non-compete agreements. We have little
protection when we must rely on trade secrets and nondisclosure
agreements. Our intellectual property rights may be challenged,
invalidated or circumvented by third parties. We may not be able to
prevent the unauthorized disclosure or use of our technical
knowledge or other trade secrets by employees or competitors.
Furthermore, our competitors may independently develop technologies
and products that are substantially equivalent or superior to our
technologies and/or products, which could result in decreased
revenues. Moreover, the laws of foreign countries may not protect
our intellectual property rights to the same extent as the laws of
the U.S. Litigation may be necessary to enforce our intellectual
property rights which could result in substantial costs to us and
substantial diversion of management attention. If we do not
adequately protect our intellectual property, our competitors could
use it to enhance their products. Our inability to adequately
protect our intellectual property rights could adversely affect our
business and financial condition, and the value of our brand and
other intangible assets.
Other companies may claim that we infringe their intellectual
property, which could materially increase our costs and harm our
ability to generate future revenue and profit.
We do not believe that we infringe the proprietary rights of any
third party, but claims of infringement are becoming increasingly
common and third parties may assert infringement claims against us.
It may be difficult or impossible to identify, prior to receipt of
notice from a third party, the trade secrets, patent position or
other intellectual property rights of a third party, either in the
United States or in foreign jurisdictions. Any such assertion may
result in litigation or may require us to obtain a license for the
intellectual property rights of third parties. If we are required
to obtain licenses to use any third-party technology, we would have
to pay royalties, which may significantly reduce any profit on our
products. In addition, any such litigation could be expensive and
disruptive to our ability to generate revenue or enter into new
market opportunities. If any of our products were found to infringe
other parties’ proprietary rights and we are unable to come to
terms regarding a license with such parties, we may be forced to
modify our products to make them non-infringing or to cease
production of such products altogether.
The nature of our business involves significant risks and
uncertainties that may not be covered by insurance or
indemnity.
We develop and sell products where insurance or indemnification may
not be available, including:
|
· |
Designing and
developing products using advanced technologies in intelligence and
homeland security applications that are intended to operate in high
demand, high risk situations; and |
|
· |
Designing and
developing products to collect, distribute and analyze various
types of information. |
Certain products may raise questions with respect to issues of
privacy rights, civil liberties, intellectual property, trespass,
conversion and similar concepts, which may raise new legal issues.
Indemnification to cover potential claims or liabilities resulting
from a failure of technologies developed or deployed may be
available in certain circumstances but not in others. We are not
able to maintain insurance to protect against all operational risks
and uncertainties. Substantial claims resulting from an accident,
failure of our product, or liability arising from our products in
excess of any indemnity or insurance coverage (or for which
indemnity or insurance is not available or was not obtained) could
harm our financial condition, cash flows, and operating results.
Any accident, even if fully covered or insured, could negatively
affect our reputation among our customers and the public, and make
it more difficult for us to compete effectively.
We are heavily reliant on Dennis O’Leary, our Chairman and
Chief Executive Officer, and the departure or loss of Dennis
O’Leary could disrupt our business.
We depend heavily on the continued efforts of Dennis O’Leary,
Chairman, Chief Executive Officer and director. Mr. O’Leary is
essential to our strategic vision and day-to-day operations and
would be difficult to replace. We currently do not have an
employment agreement with Mr. O’Leary, thus we cannot be certain
that he will desire to continue with us for the necessary time it
will to complete the product development and initial sales channel
development. The departure or loss of Mr. O’Leary, or the inability
to hire and retain a qualified replacement, could negatively impact
our ability to manage our business.
If we are unable to recruit and retain key management,
technical and sales personnel, our business would be negatively
affected.
For our business to be successful, we need to attract and retain
highly qualified technical, management and sales personnel. The
failure to recruit additional key personnel when needed with
specific qualifications and on acceptable terms or to retain good
relationships with our partners might impede our ability to
continue to develop, commercialize and sell our products. To the
extent the demand for skilled personnel exceeds supply, we could
experience higher labor, recruiting and training costs in order to
attract and retain such employees. We face competition for
qualified personnel from other companies with significantly more
resources available to them and thus may not be able to attract the
level of personnel needed for our business to succeed.
Material weaknesses in our internal control over financial
reporting may, until remedied, cause errors in our financial
statements or cause our filings with the SEC to not be
timely.
We believe that material weaknesses exist in our internal control
over financial reporting as of December 31, 2021, including those
related to (i) our internal audit functions and (ii) a lack of
segregation of duties within accounting functions. If our internal
control over financial reporting or disclosure controls and
procedures are not effective, there may be errors in our financial
statements that could require a restatement or our filings may not
be timely made with the Securities and Exchange Commission (the
“SEC”). We intend to implement additional corporate
governance and control measures to strengthen our control
environment as we are able, but we may not achieve our desired
objectives. Moreover, no control environment, no matter how well
designed and operated, can prevent or detect all errors or fraud.
We may identify material weaknesses and control deficiencies in our
internal control over financial reporting in the future that may
require remediation and could lead investors losing confidence in
our reported financial information, which could lead to a decline
in our stock price.
Risks Related to Our Organization and Our Common Stock
You may experience dilution of your ownership interests
because of the future issuance of additional shares of our common
or preferred stock or other securities that are convertible into or
exercisable for our common or preferred stock.
We are authorized to issue an aggregate of 20,000,000,000 shares of
common stock and 2,000,000 shares of “blank check” preferred stock.
In the future, we may issue our authorized but previously unissued
equity securities, resulting in the dilution of the ownership
interests of our present stockholders. We may issue additional
shares of our common stock or other securities that are convertible
into or exercisable for our common stock in connection with hiring
or retaining employees, future acquisitions, future sales of our
securities for capital raising purposes, or for other business
purposes. The future issuance of any such additional shares of our
common stock may create downward pressure on the trading price of
the common stock. We will need to raise additional capital in the
near future to meet our working capital needs, and there can be no
assurance that we will not be required to issue additional shares,
warrants or other convertible securities in the future in
conjunction with these capital raising efforts, including at a
price (or exercise or conversion prices) below the price an
investor paid for stock.
Because the SEC imposes additional sales practice
requirements on brokers who deal in our shares that are penny
stocks, some brokers may be unwilling to trade them. This means
that investors may have difficulty reselling their shares and may
cause the price of the shares to decline.
Our shares qualify as penny stocks and are covered by Section 15(g)
of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), which imposes additional sales practice
requirements on broker/dealers who sell our securities in this
offering or in the aftermarket. In particular, prior to selling a
penny stock, broker/dealers must give the prospective customer a
risk disclosure document that: contains a description of the nature
and level of risk in the market for penny stocks in both public
offerings and secondary trading; contains a description of the
broker/dealers’ duties to the customer and of the rights and
remedies available to the customer with respect to violations of
such duties or other requirements of Federal securities laws;
contains a brief, clear, narrative description of a dealer market,
including “bid” and “ask” prices for penny stocks and the
significance of the spread between the bid and ask prices; contains
the toll free telephone number for inquiries on disciplinary
actions established pursuant to section 15(A)(i); defines
significant terms used in the disclosure document or in the conduct
of trading in penny stocks; and contains such other information,
and is in such form (including language, type size, and format), as
the SEC requires by rule or regulation. Further, for sales of our
securities, the broker/dealer must make a special suitability
determination and receive from you a written agreement before
making a sale to you. Because of the imposition of the foregoing
additional sales practices, it is possible that brokers will not
want to make a market in our shares. This could prevent reselling
of shares and may cause the price of the shares to decline.
We do not expect to declare or pay any dividends.
We have not declared or paid any dividends on our common stock
since our inception, and we do not anticipate paying any such
dividends for the foreseeable future.
Volatility of Stock Price.
Our common shares are currently publicly traded on the OTC Markets
under the symbol “DPLS.” In the future, the trading price of our
common shares may be subject to wide fluctuations. Trading prices
of the common shares may fluctuate in response to a number of
factors, many of which will be beyond our control. In addition, the
stock market in general, and the market for technology companies in
particular, has experienced extreme price and volume fluctuations
that have often been unrelated or disproportionate to the operating
performance of such companies. Market and industry factors may
adversely affect the market price of the common shares, regardless
of our operating performance. Readers should carefully consider the
risks and uncertainties described below before deciding whether to
invest in shares of our common stock.
Our failure to successfully address the risks and uncertainties
described below would have a material adverse effect on our
business, financial condition and/or results of operations, and the
trading price of our common stock may decline and investors may
lose all or part of their investment. We cannot assure you that we
will successfully address these risks or other unknown risks that
may affect our business.
As an enterprise engaged in the development of new technology, our
business is inherently risky. Our common shares are considered
speculative during the development of our new business
operations. Prospective investors should consider carefully
the risk factors set out herein. The market price of our common
stock has fluctuated significantly.
Being a public company is expensive and administratively
burdensome.
As a public reporting company, we are subject to the information
and reporting requirements of the Securities Act, the Exchange Act
and other federal securities laws, rules and regulations related
thereto, including compliance with the Sarbanes-Oxley Act.
Complying with these laws and regulations requires the time and
attention of our Board of Directors and management team, and
increases our expenses. We estimate we will incur approximately
$200,000 to $300,000 annually in connection with being a public
company.
Among other things, we are required to:
|
· |
Maintain and evaluate
a system of internal controls over financial reporting in
compliance with the requirements of Section 404 of the
Sarbanes-Oxley Act and the related rules and regulations of the SEC
and the Public Company Accounting Oversight Board; |
|
· |
Prepare and distribute
periodic reports in compliance with our obligations under federal
securities laws; |
|
· |
Institute a more
comprehensive compliance function, including with respect to
corporate governance; and |
|
· |
Involve, to a greater
degree, our outside legal counsel and accountants in the above
activities. |
The costs of preparing and filing annual and quarterly reports,
proxy statements and other information with the SEC and furnishing
audited reports to stockholders are expensive and much greater than
that of a privately-held company, and compliance with these rules
and regulations may require us to hire additional financial
reporting, internal controls and other finance personnel, and will
involve a material increase in regulatory, legal and accounting
expenses and the attention of management. There can be no assurance
that we will be able to comply with the applicable regulations in a
timely manner, if at all. In addition, being a public company makes
it more expensive for us to obtain director and officer liability
insurance. In the future, we may be required to accept reduced
coverage or incur substantially higher costs to obtain this
coverage.
If we fail to establish and maintain an effective system of
internal control, we may not be able to report our financial
results accurately or to prevent fraud. Any inability to report and
file our financial results accurately and timely could harm our
reputation and adversely impact the trading price of our common
stock.
Effective internal control is necessary for us to provide reliable
financial reports and prevent fraud. If we cannot provide reliable
financial reports or prevent fraud, we may not be able to manage
our business as effectively as we would if an effective control
environment existed, and our business and reputation with investors
may be harmed. As a result, our small size and any current internal
control deficiencies may adversely affect our financial condition,
results of operation and access to capital. We have not performed
an in-depth analysis to determine if historical un-discovered
failures of internal controls exist, and may in the future discover
areas of our internal control that need improvement.
Public company compliance may make it more difficult to
attract and retain officers and directors.
The Sarbanes-Oxley Act and new rules subsequently implemented by
the SEC have required changes in corporate governance practices of
public companies. As a public company, we expect these new rules
and regulations to increase our compliance costs in 2022 and beyond
and to make certain activities more time consuming and costly. As a
public company, we also expect that these new rules and regulations
may make it more difficult and expensive for us to obtain director
and officer liability insurance in the future and we may be
required to accept reduced policy limits and coverage or incur
substantially higher costs to obtain the same or similar coverage.
As a result, it may be more difficult for us to attract and retain
qualified persons to serve on our Board of Directors or as
executive officers.
You could lose all of your investment.
An investment in our securities is speculative and involves a high
degree of risk. Potential investors should be aware that the value
of an investment in the Company may go down as well as up. In
addition, there can be no certainty that the market value of an
investment in the Company will fully reflect its underlying value.
You could lose your entire investment.
The ability of our Board of Directors to issue additional
stock may prevent or make more difficult certain transactions,
including a sale or merger of the Company.
Our Board of Directors is authorized to issue up to 2,000,000
shares of preferred stock with powers, rights and preferences
designated by it. Shares of voting or convertible preferred stock
could be issued, or rights to purchase such shares could be issued,
to create voting impediments or to frustrate persons seeking to
effect a takeover or otherwise gain control of the Company.
The ability of the Board of Directors to issue such
additional shares of preferred stock, with rights and preferences
it deems advisable, could discourage an attempt by a party to
acquire control of the Company by tender offer or other means.
Such issuances could therefore deprive stockholders of
benefits that could result from such an attempt, such as the
realization of a premium over the market price for their shares in
a tender offer or the temporary increase in market price that such
an attempt could cause. Moreover, the issuance of such
additional shares of preferred stock to persons friendly to the
Board of Directors could make it more difficult to remove incumbent
officers and directors from office even if such change were to be
favorable to stockholders generally.
Our stock may be traded infrequently and in low volumes, so
you may be unable to sell your shares at or near the quoted bid
prices if you need to sell your shares.
Until our common stock is listed on a national securities exchange
such as the New York Stock Exchange or the Nasdaq, we expect our
common stock to remain eligible for quotation on the OTC Markets,
or on another over-the-counter quotation system. In those venues,
however, the shares of our common stock may trade infrequently and
in low volumes, meaning that the number of persons interested in
purchasing our common shares at or near bid prices at any given
time may be relatively small or non-existent. An investor may find
it difficult to obtain accurate quotations as to the market value
of our common stock or to sell his or her shares at or near bid
prices or at all. In addition, if we fail to meet the criteria set
forth in SEC regulations, various requirements would be imposed by
law on broker-dealers who sell our securities to persons other than
established customers and accredited investors. Consequently, such
regulations may deter broker-dealers from recommending or selling
our common stock, which may further affect the liquidity of our
common stock. This would also make it more difficult for us to
raise capital.
There currently is no active public market for our common
stock and there can be no assurance that an active public market
will ever develop. Failure to develop or maintain a trading market
could negatively affect the value of our common stock and make it
difficult or impossible for you to sell your shares.
There is currently no active public market for shares of our common
stock and one may never develop. Our common stock is quoted on the
OTC Markets. The OTC Markets is a thinly traded market and lacks
the liquidity of certain other public markets with which some
investors may have more experience. We may not ever be able to
satisfy the listing requirements for our common stock to be listed
on a national securities exchange, which is often a more
widely-traded and liquid market. Some, but not all, of the factors
which may delay or prevent the listing of our common stock on a
more widely-traded and liquid market include the following: our
stockholders’ equity may be insufficient; the market value of our
outstanding securities may be too low; our net income from
operations may be too low; our common stock may not be sufficiently
widely held; we may not be able to secure market makers for our
common stock; and we may fail to meet the rules and requirements
mandated by the several exchanges and markets to have our common
stock listed. Should we fail to satisfy the initial listing
standards of the national exchanges, or our common stock is
otherwise rejected for listing, and remains listed on the OTC
Markets or is suspended from the OTC Markets, the trading price of
our common stock could suffer and the trading market for our common
stock may be less liquid and our common stock price may be subject
to increased volatility, making it difficult or impossible to sell
shares of our common stock.
Our common stock is subject to the “penny stock” rules of the
SEC and the trading market in the securities is limited, which
makes transactions in the stock cumbersome and may reduce the value
of an investment in the stock.
Rule 15g-9 under the Exchange Act establishes the definition of a
“penny stock,” for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or
with an exercise price of less than $5.00 per share, subject to
certain exceptions. For any transaction involving a penny
stock, unless exempt, the rules require: (a) that a broker or
dealer approve a person’s account for transactions in penny stocks;
and (b) the broker or dealer receive from the investor a written
agreement to the transaction, setting forth the identity and
quantity of the penny stock to be purchased.
In order to approve a person’s account for transactions in penny
stocks, the broker or dealer must: (a) obtain financial information
and investment experience objectives of the person and (b) make a
reasonable determination that the transactions in penny stocks are
suitable for that person and the person has sufficient knowledge
and experience in financial matters to be capable of evaluating the
risks of transactions in penny stocks.
The broker or dealer must also deliver, prior to any transaction in
a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form: (a) sets forth
the basis on which the broker or dealer made the suitability
determination; and (b) confirms that the broker or dealer received
a signed, written agreement from the investor prior to the
transaction. Generally, brokers may be less willing to
execute transactions in securities subject to the “penny stock”
rules. This may make it more difficult for investors to dispose of
our common stock and cause a decline in the market value of our
common stock.
Disclosure also has to be made about the risks of investing in
penny stocks in both public offerings and in secondary trading and
about the commissions payable to both the broker or dealer and the
registered representative, current quotations for the securities
and the rights and remedies available to an investor in cases of
fraud in penny stock transactions. Finally, monthly
statements have to be sent disclosing recent price information for
the penny stock held in the account and information on the limited
market in penny stocks.
Our stock price may be volatile.
The market price of our common stock is likely to be highly
volatile and could fluctuate widely in price in response to various
factors, many of which are beyond our control, including the
following:
|
· |
The continued effects of the
COVID-19 pandemic and its variants; |
|
|
|
|
· |
The impact of conflict between the
Russian Federation and Ukraine on our operations; |
|
|
|
|
· |
Geo-political events, such as the
crisis in Ukraine, government responses to such events and the
related impact on the economy both nationally and
internationally; |
|
|
|
|
· |
Changes in our industry; |
|
· |
Competitive pricing
pressures; |
|
· |
Our ability to obtain
working capital financing; |
|
· |
Additions or
departures of key personnel; |
|
· |
Sales of our common
stock; |
|
· |
Our ability to execute
our business plan; |
|
· |
Operating results that
fall below expectations; |
|
· |
Loss of any strategic
relationship; |
|
· |
Regulatory
developments; and |
|
· |
Economic and other
external factors. |
In addition, the securities markets have from time-to-time
experienced significant price and volume fluctuations that are
unrelated to the operating performance of particular companies.
These market fluctuations may also materially and adversely affect
the market price of our common stock.
Offers or availability for sale of a substantial number of
shares of our common stock may cause the price of our common stock
to decline.
If our stockholders sell substantial amounts of our common stock in
the public market, including upon the expiration of any statutory
holding period under Rule 144, or issued upon the conversion of
preferred stock or exercise of warrants, it could create a
circumstance commonly referred to as an "overhang" and in
anticipation of which the market price of our common stock could
fall. The existence of an overhang, whether or not sales have
occurred or are occurring, also could make more difficult our
ability to raise additional financing through the sale of equity or
equity-related securities in the future at a time and price that we
deem reasonable or appropriate.
Risks Related to the Offering
Our existing stockholders may experience significant dilution
from the sale of our common stock pursuant to the GHS Equity
Financing Agreement.
The sale of our common stock to GHS in accordance with the EFA may
have a dilutive impact on our shareholders. As a result, the market
price of our common stock could decline. In addition, the lower our
stock price is at the time we exercise Puts, the more shares of our
common stock we will have to issue to GHS in order to exercise a
Put under the EFA. If our stock price decreases, then our existing
shareholders would experience greater dilution for any given dollar
amount raised through the offering.
The perceived risk of dilution may cause our stockholders to sell
their shares, which may cause a decline in the price of our common
stock. Moreover, the perceived risk of dilution and the resulting
downward pressure on our stock price could encourage investors to
engage in short sales of our common stock. By increasing the number
of shares offered for sale, material amounts of short selling could
further contribute to progressive price declines in our common
stock.
The issuance of shares pursuant to the EFA may have a
significant dilutive effect.
Depending on the number of shares we issue pursuant to the EFA, it
could have a significant dilutive effect upon our existing
shareholders. Although the number of shares that we may issue
pursuant to the EFA will vary based on our stock price (the higher
our stock price, the less shares we have to issue), there may be a
potential dilutive effect to our shareholders, based on different
potential future stock prices, if the full amount of the EFA is
realized. Dilution is based upon common stock put to GHS and the
stock price discounted to GHS’s purchase price.
GHS will pay less than the then-prevailing market price of
our common stock which could cause the price of our common stock to
decline.
Our common stock to be issued under the EFA will be purchased at an
8% discount, or 92% of the volume-weighted average price for the
Company’s common stock during the ten consecutive trading days
immediately preceding each Put.
GHS has a financial incentive to sell our shares immediately upon
receiving them to realize the profit between the discounted price
and the market price. If GHS sells our shares, the price of our
common stock may decrease. If our stock price decreases, GHS may
have further incentive to sell such shares. Accordingly, the
discounted sales price in the EFA may cause the price of our common
stock to decline.
We may not have access to the full amount under the financing
agreement.
The lowest volume-weighted average price for the ten days ended
April 11, 2022 was $0.0479. At that price we would be able to sell
shares to GHS under the EFA at the discounted price of $0.044068.
At that discounted price, the remaining 130,350,482 shares would
only represent $5,744,285, which is below the full amount of the
EFA. In addition, any single drawdown must be at least $10,000 and
cannot exceed $3,000,000 and any single drawdown may not exceed
200% of the average daily trading dollar volume of our Common Stock
during the ten trading days preceding the put.
There could be unidentified risks involved with an investment
in our securities.
The foregoing risk factors are not a complete list or explanation
of the risks involved with an investment in the securities.
Additional risks will likely be experienced that are not presently
foreseen by us. Prospective investors must not construe this the
information provided herein as constituting investment, legal, tax
or other professional advice. Before making any decision to invest
in our securities, you should read this entire Prospectus and
consult with your own investment, legal, tax and other professional
advisors. An investment in our securities is suitable only for
investors who can assume the financial risks of an investment in us
for an indefinite period of time and who can afford to lose their
entire investment. We make no representations or warranties of any
kind with respect to the likelihood of the success or the business
of our Company, the value of our securities, any financial returns
that may be generated or any tax benefits or consequences that may
result from an investment in us.
CAUTIONARY NOTE
REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains various “forward-looking statements.” You
can identify forward-looking statements by the use of
forward-looking terminology such as “believes,” “expects,” “may,”
“would,” “could,” “should,” “seeks,” “approximately,” “intends,”
“plans,” “projects,” “estimates” or “anticipates” or the negative
of these words and phrases or similar words or phrases. You can
also identify forward-looking statements by discussions of
strategy, plans or intentions. These statements may be impacted by
a number of risks and uncertainties.
The forward-looking
statements are based on our beliefs, assumptions and expectations
of our future performance taking into account all information
currently available to us. These beliefs, assumptions and
expectations are subject to risks and uncertainties and can change
as a result of many possible events or factors, not all of which
are known to us. If a change occurs, our business, financial
condition, liquidity and results of operations may vary materially
from those expressed in our forward-looking statements. You should
carefully consider these risks before you make an investment
decision with respect to our securities. For a further discussion
of these and other factors that could impact our future results,
performance or transactions, see the section entitled “Risk Factors.”
PRIVATE
PLACEMENT
Equity Financing Agreement
On November 9, 2021, we entered an EFA and Registration Rights
Agreement (the “Registration Rights Agreement”) with GHS,
pursuant to which GHS agreed to purchase up to $30,000,000 in
shares of our Common Stock, from time to time over the course of 24
months (the “Contract Period”) after effectiveness of a
registration statement on Form S-1 (the “Registration
Statement”) of the underlying shares of Common Stock.
The EFA grants us the right, from time to time at our sole
discretion (subject to certain conditions) during the Contract
Period, to direct GHS to purchase shares of Common Stock on any
business day (a “Put”), provided that at least ten Trading
Days (as defined in the EFA) have passed since the most recent Put.
The purchase price of the shares of Common Stock contained in a Put
shall be 92% of the Market Price with “Market Price” defined as the
lowest volume weighted average price (VWAP) price of the Common
Stock during the Pricing Period (as defined in the EFA). No Put
will be made in an amount less than $10,000 or greater than
$3,000,000. In no event are we entitled to make a Put or is GHS
entitled to purchase that number of shares of Common Stock of the
Company, which when added to the sum of the number of shares of
Common Stock beneficially owned (as such term is defined under
Section 13(d) and Rule 13d-3 of the Exchange Act), by GHS, would
exceed 4.99% of the number of shares of Common Stock outstanding on
such date, as determined in accordance with Rule 13d-1(j) of the
Exchange Act.
The EFA will terminate upon any of the following events: when GHS
has purchased an aggregate of $30,000,000 in the Common Stock of
the Company pursuant to the EFA; on the date that is 24 months from
the date of the EFA; or by mutual written consent of the parties.
Actual sales of shares of Common Stock to GHS under the EFA will
depend on a variety of factors to be determined by us from time to
time, including, among others, market conditions, the trading price
of the Common Stock and determinations by us as to the appropriate
sources of funding for the Company and its operations. The net
proceeds under the EFA to us will depend on the frequency and
prices at which we sell shares of our stock to GHS.
The Registration Rights Agreement provides that we shall (i) use
our best efforts to file with the SEC the Registration Statement
within 45 days of the date of the Registration Rights Agreement;
and (ii) have the Registration Statement declared effective by the
SEC within 30 days after the date the Registration Statement is
filed with the SSEC, but in no event more than 90 days after the
Registration Statement is filed.
We to use the proceeds from the Puts for operational expenses and
also potential acquisitions deemed beneficial to the
operational capabilities of the Company.
See “Plan of
Distribution” elsewhere in this prospectus for more
information.
USE OF
PROCEEDS
The Selling Security Holder will receive all the proceeds from the
sales of the Shares under this prospectus. We will not receive any
proceeds from these sales. To the extent we receive proceeds from
the Puts to the Selling Security Holder, we will use those proceeds
for operations and acquisitions. We have agreed to bear the certain
expenses relating to the registration of the shares of Common Stock
being registered herein for Selling Security Holder.
See “Plan of
Distribution” elsewhere in this prospectus for more
information.
SELLING SECURITY
HOLDER
This prospectus covers the offering of up to 300,000,000 shares of
Common Stock (of which 169,649,518 have been sold) being offered by
the Selling Security Holder, which includes shares of Common Stock
acquirable upon the issuance of a Put to the Selling Security
Holder, as described herein. We are registering the Shares in order
to permit the Selling Security Holder to offer their shares of
Common Stock for resale from time to time.
The table below lists the Selling Security Holder and other
information regarding the “beneficial ownership” of the shares of
Common Stock by the Selling Security Holder. In accordance with
Rule 13d-3 of the Exchange Act, “beneficial ownership” includes any
shares of Common Stock as to which the Selling Security Holder has
sole or shared voting power or investment power and any shares of
Common Stock the Selling Security Holder has the right to acquire
within 60 days.
The Selling Security Holder is an “underwriter” within the meaning
of Section 2(a)(11) of the Securities Act.
The second column indicates the number of shares of Common Stock
beneficially owned by the Selling Security Holder, based on its
ownership as of April 11, 2022. The second column also assumes
purchase of all shares of stock to be acquired under the maximum
amount of securities to be sold by the Company to the Selling
Security Holder, without regard to any limitations on purchase
described in this prospectus or in the EFA.
The third column lists the shares of Common Stock being offered by
this prospectus by the Selling Security Holder. Such aggregate
amount of Common Stock does not take into account any applicable
limitations on purchase of the securities under the EFA.
This prospectus covers the resale of (i) all of the shares of
Common Stock issued and issuable upon the Company issuing a Put,
and (ii) any securities issued or then issuable upon any full
anti-dilution protection, stock split, dividend or other
distribution, recapitalization or similar event with respect to the
common shares.
Because the issuance price of the common shares may be adjusted,
the number of shares of Common Stock that will actually be issued
upon issuance of the common shares may be more or less than the
number of shares of Common Stock being offered by this prospectus.
The Selling Security Holder can offer all, some or none of its
shares of Common Stock, thus we have no way of determining the
number of shares of Common Stock it will hold after this offering.
Therefore, the fourth and fifth columns assume that the Selling
Security Holder will sell all shares of Common Stock covered by
this prospectus. See “Plan of
Distribution.”
The Selling Security Holder identified below has confirmed to us
that it is not a broker-dealer or an affiliate of a broker-dealer
within the meaning of United States federal securities laws.
|
|
Number of
Shares of
Common Stock
Owned Prior to
Offering(1)
|
|
|
Maximum
Number of
Shares of
Common Stock
to be Sold
Pursuant to this
Prospectus
|
|
|
Number of
Shares of
Common Stock
Owned After
Offering
|
|
|
Percentage
Beneficially
Owned After
Offering
|
|
GHS Investments, LLC
(1) |
|
|
0 |
|
|
|
300,000,000 |
(2) |
|
|
– |
|
|
|
– |
|
TOTAL |
|
|
0 |
|
|
|
300,000,000 |
|
|
|
– |
|
|
|
– |
|
__________
(1) |
GHS
Investments, LLC is a limited liability company organized under the
laws of Nevada. Mark Grober has dispositive power over the shares
owned by GHS. |
(2) |
300,000,000 shares to be issued pursuant to the
EFA (of which 169,649,518 have been sold). |
Material Relationships with Selling Security
Holder
The Selling Security Holder has not at any time during the past
three years acted as one of our employees, officers or directors or
had a material relationship with us except (i) with respect to
transactions described above in “Private Placement,” and (ii) the
Purchase Agreement dated August 19, 2021 with GHS.
MARKET PRICE OF
COMMON STOCK AND OTHER STOCKHOLDER MATTERS
Our Common Stock is currently quoted on the OTC Markets, which is
sponsored by OTC Markets Group, Inc. The OTC Markets is a network
of security dealers who buy and sell stock. The dealers are
connected by a computer network that provides information on
current “bids” and “asks,” as well as volume information. Our
shares are quoted on the OTC Markets under the symbol “DPLS.”
The table below sets forth for the periods indicated the quarterly
high and low bid prices as reported by OTC Markets. Limited trading
volume has occurred during these periods. These quotations reflect
inter-dealer prices, without retail mark-up, mark-down, or
commission and may not necessarily represent actual
transactions.
2022: |
|
High |
|
|
Low |
|
First Quarter |
|
$ |
0.089 |
|
|
$ |
0.0252 |
|
2021: |
|
High |
|
|
Low |
|
First Quarter |
|
$ |
0.0510 |
|
|
$ |
0.0007 |
|
Second Quarter |
|
$ |
0.0969 |
|
|
$ |
0.0106 |
|
Third Quarter |
|
$ |
0.2020 |
|
|
$ |
0.0653 |
|
Fourth Quarter |
|
$ |
0.1400 |
|
|
$ |
0.0511 |
|
2020: |
|
High |
|
|
Low |
|
First Quarter |
|
$ |
0.0002 |
|
|
$ |
0.0001 |
|
Second Quarter |
|
$ |
0.0002 |
|
|
$ |
0.0001 |
|
Third Quarter |
|
$ |
0.0006 |
|
|
$ |
0.0001 |
|
Fourth Quarter |
|
$ |
0.0011 |
|
|
$ |
0.0001 |
|
The Company’s common stock is considered to be penny stock under
rules promulgated by the SEC. Under these rules, broker-dealers
participating in transactions in these securities must first
deliver a risk disclosure document which describes risks associated
with these stocks, broker-dealers’ duties, customers’ rights and
remedies, market and other information, and make suitability
determinations approving the customers for these stock transactions
based on financial situation, investment experience and objectives.
Broker-dealers must also disclose these restrictions in writing,
provide monthly account statements to customers, and obtain
specific written consent of each customer. With these restrictions,
the likely effect of designation as a penny stock is to decrease
the willingness of broker-dealers to make a market for the stock,
to decrease the liquidity of the stock and increase the transaction
cost of sales and purchases of these stocks compared to other
securities.
The high and low bid price for shares of our Common Stock on April
11, 2022, was $0.0515 and $0.0451, respectively, based upon bids
that represent prices quoted by broker-dealers on the OTC
Markets.
Approximate Number of Equity Security Holders
As of April 11, 2022, there were approximately 920 stockholders of
record. Because shares of our Common Stock are held by
depositaries, brokers and other nominees, the number of beneficial
holders of our shares is substantially larger than the number of
stockholders of record.
Dividends
We have not declared or paid a cash dividend to our stockholders
since we were organized and does not intend to pay dividends in the
foreseeable future. Our board of directors presently intends to
retain any earnings to finance our operations and does not expect
to authorize cash dividends in the foreseeable future. Any payment
of cash dividends in the future will depend upon our earnings,
capital requirements and other factors.
Section 15(g) of the Securities Exchange Act of
1934
Our shares are covered by section 15(g) of the Exchange Act that
imposes additional sales practice requirements on broker/dealers
who sell such securities to persons other than established
customers and accredited investors (generally institutions with
assets in excess of $5,000,000 or individuals with net worth in
excess of $1,000,000 or annual income exceeding $200,000 or
$300,000 jointly with their spouses). For transactions covered by
the Rule, the broker/dealer must make a special suitability
determination for the purchase and have received the purchaser's
written agreement to the transaction prior to the sale.
Consequently, the Rule may affect the ability of broker/dealers to
sell our securities and also may affect your ability to sell your
shares in the secondary market.
Section 15(g) also imposes additional sales practice requirements
on broker/dealers who sell penny securities. These rules require a
one-page summary of certain essential items. The items include the
risk of investing in penny stocks in both public offerings and
secondary marketing; terms important to in understanding of the
function of the penny stock market, such as bid and offer
quotes, a dealers spread and broker/dealer compensation; the
broker/dealer compensation, the broker/dealers’ duties to its
customers, including the disclosures required by any other penny
stock disclosure rules; the customers’ rights and remedies in cases
of fraud in penny stock transactions; and, the FINRA’s toll free
telephone number and the central number of the North American
Securities Administrators Association, for information on the
disciplinary history of broker/dealers and their associated
persons.
Penny Stock
Our stock is considered a penny stock. The SEC has adopted rules
that regulate broker-dealer practices in transactions in penny
stocks. Penny stocks are generally equity securities with a market
price of less than $5.00, other than securities registered on
certain national securities exchanges or quoted on the NASDAQ
system, provided that current price and volume information with
respect to transactions in such securities is provided by the
exchange or system. The penny stock rules require a broker-dealer,
prior to a transaction in a penny stock, to deliver a standardized
risk disclosure document prepared by the SEC, that: (a) contains a
description of the nature and level of risk in the market for penny
stocks in both public offerings and secondary trading; (b) contains
a description of the broker’s or dealer’s duties to the customer
and of the rights and remedies available to the customer with
respect to a violation of such duties or other requirements of the
securities laws; (c) contains a brief, clear, narrative description
of a dealer market, including bid and ask prices for penny stocks
and the significance of the spread between the bid and ask price;
(d) contains a toll-free telephone number for inquiries on
disciplinary actions; (e) defines significant terms in the
disclosure document or in the conduct of trading in penny stocks;
and (f) contains such other information and is in such form,
including language, type size and format, as the SEC shall require
by rule or regulation.
The broker-dealer also must provide, prior to effecting any
transaction in a penny stock, the customer with: (a) bid and offer
quotations for the penny stock; (b) the compensation of the
broker-dealer and its salesperson in the transaction; (c) the
number of shares to which such bid and ask prices apply, or other
comparable information relating to the depth and liquidity of the
market for such stock; and (d) a monthly account statement showing
the market value of each penny stock held in the customer’s
account. In addition, the penny stock rules require that prior to a
transaction in a penny stock not otherwise exempt from those rules,
the broker-dealer must make a special written determination that
the penny stock is a suitable investment for the purchaser and
receive the purchaser’s written acknowledgment of the receipt of a
risk disclosure statement, a written agreement as to transactions
involving penny stocks, and a signed and dated copy of a written
suitability statement.
These disclosure requirements may have the effect of reducing the
trading activity for our Common Stock. Therefore, stockholders may
have difficulty selling our securities.
Rule 10B-18 Transactions
During the year ended December 31, 2021, there were no repurchases
of our common stock by the Company.
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATION
This Management’s Discussion and Analysis of Financial Condition
and Results of Operations contain certain forward-looking
statements. Historical results may not indicate future performance.
Our forward-looking statements reflect our current views about
future events; are based on assumptions and are subject to known
and unknown risks and uncertainties that could cause actual results
to differ materially from those contemplated by these statements.
Factors that may cause differences between actual results and those
contemplated by forward-looking statements include, but are not
limited to, those discussed in the “Risk Factors” section. We
undertake no obligation to publicly update or revise any
forward-looking statements, including any changes that might result
from any facts, events, or circumstances after the date hereof that
may bear upon forward-looking statements. Furthermore, we cannot
guarantee future results, events, levels of activity, performance,
or achievements
Critical Accounting Policies
The following discussions are based upon our financial statements
and accompanying notes, which have been prepared in accordance with
accounting principles generally accepted in the United States.
The preparation of these financial statements requires management
to make estimates, judgments and assumptions that affect the
reported amounts of assets, liabilities, revenues and expenses, and
related disclosures of contingencies. We continually evaluate the
accounting policies and estimates used to prepare the financial
statements. We base our estimates on historical experiences and
assumptions believed to be reasonable under current facts and
circumstances. Actual amounts and results could differ from these
estimates made by management.
Business Overview
DarkPulse is a technology company focused on the manufacture, sale,
installation, and monitoring of laser sensing systems based on its
patented BOTDA dark-pulse sensor technology. The Company develops,
markets, and distributes a full suite of engineering, monitoring,
installation and security management solutions for critical
infrastructure/key resources to both industries and governments.
Coupled with our patented DarkPulse Technology, DarkPulse provides
its customers a comprehensive data stream of critical metrics for
assessing the health and security of their infrastructure. Our
systems provide rapid, precise analysis and responsive activities
predetermined by the end-user customer. The Company’s activities
since inception have consisted of developing various solutions,
obtaining patents and trademarks related to its technology, raising
capital, acquisition of companies deemed to expand global
operations and/or capabilities, creating key partnerships to expand
our suite of products and services. Our activities have evolved to
a sales-focused mission since the successful completion of our
BOTDA system in December 2020.
Headquartered in New York, DarkPulse is a globally based technology
company with presence in United Kingdom, India, Dubai, Russian
Federation, Turkey, Azerbaijan, Iraq, Libya, Egypt, United States
and Canada. In addition to the Company’s BOTDA systems, through a
series of strategic acquisitions the Company offers the
manufacture, sale, installation, and monitoring of laser sensing
systems, O & G pipeline leak detection, physical security
services, telecommunications and satellite communications services,
drone and rover systems, and BDaaS. The Company is focused on
expanding services through acquisitions and partnerships to address
global infrastructure and critical environmental resource
challenges. DarkPulse offers a full suite of engineering and
environmental solutions that provide safety and security
infrastructure projects. The sensing and monitoring capabilities
offered by DarkPulse and our subsidiary companies operate in the
Air, Land, Sea. Our patented technology provides rapid, precise
analysis to protect and safeguard oil and gas pipelines above or
below ground, physical security countermeasures, mining operations,
and other critical infrastructure / key resources subject to
vulnerability or risk. Our patented Brillouin scattering
distributed fiber sensing system is best in class. The Company is
able to monitor areas in around critical infrastructure buried or
above ground including pipelines 100km or more in length and/ or
localized pipes as small as 8 CM DIA, detecting internal anomalies
before catastrophic failure. We are developing an Intelligent Rock
Bolt, to prevent causalities and fatalities in mining operations
and include a real time sensor system that can detect the location
& movement of personnel & equipment throughout a mining
operation. We monitor airflow, air quality, temperature, seismic
events, etc. Our sensors cover extended areas, protecting an area
from intrusion by detecting events at any location along the
sensing cable. Working safely every day is our first core value and
employees at DarkPulse and our subsidiary companies are recognized
experts in their fields, providing comprehensive services for all
our clients' needs.
Our Operating Units
Our operating units consist of, Optilan, a company headquartered in
Coventry, United Kingdom whose focus is in telecommunications,
energy, rail, critical network infrastructure, pipeline integrity
systems, renewables and security; Remote Intelligence, a company
headquartered in Pennsylvania who provides unmanned aerial drone
and UGC (unmanned ground crawler) services to a variety of clients
from industrial mapping and ecosystem services, to search and
rescue, to pipeline security; Wildlife Specialists, a company
headquartered in Pennsylvania who provides clients with
comprehensive wildlife and environmental assessment, planning, and
monitoring services; TerraData Unmanned, a company headquartered in
Florida who custom manufactures NDAA compliant drones and unmanned
ground crawlers to meet the needs of its customers; and TJM West
Electronics, a company headquartered in Arizona who is a U.S.
manufacturer and test of advanced electronics, cables and
sub-assemblies specializing in advanced package and complex CCA and
hardware.
Recent Events
Acquisitions
On August 9, 2021, we entered into a Share Purchase Agreement with
Optilan Guernsey Limited and Optilan Holdco 2 Limited (the
“Sellers”), pursuant to which we purchased from the Sellers
all of the issued and outstanding equity interests of Optilan
HoldCo 3 Limited, a private company incorporated in England and
Wales (“Optilan”) for £1.00 and also a commitment to enter
into the Subscription (as defined below). Optilan is now a
wholly-owned subsidiary of the Company.
On August 9, 2021, we entered into a Subscription Agreement with
Optilan (the “Subscription”), pursuant to which we agreed to
purchase an aggregate of 4,000,000 Ordinary Shares of Optilan for
an aggregate purchase price of £4,000,000.
On August 30, 2021, we closed two separate Membership Interest
Purchase Agreements (the “MPAs”) with Remote Intelligence,
Limited Liability Company, a Pennsylvania limited liability company
(“RI”) and Wildlife Specialists, LLC, a Pennsylvania limited
liability company (“WS”) pursuant to which we agreed to pay
to the majority shareholder of each of RI and WS an aggregate of
15,000,000 shares of our Common Stock, $500,000 to be paid on the
closing date, and an additional $500,000 to be paid 12 weeks from
closing date in exchange for 60% ownership of each of RI and WS. RI
and WS are now subsidiaries of the Company.
On September 8, 2021, we entered into and closed the Stock Purchase
Agreement (the “TJM SPA”) with TJM Electronics West, Inc.,
an Arizona corporation (“TJM”), and TJM’s shareholders,
pursuant to which we agreed to purchase all of the equity interests
in TJM in exchange for $450,000, subject to adjustments as defined
in the TJM SPA. TJM is now a wholly-owned subsidiary of the
Company.
Effective October 1, 2021, we entered into and closed the
Membership Purchase Agreement (the “TerraData MPA”) with
TerraData Unmanned, PLLC, a Florida limited liability company
(“TerraData”), and Justin Dee, the sole shareholder of
TerraData, pursuant to which we agreed to purchase 60% of the
equity interests in TerraData in exchange for 3,725,386 shares of
our Common Stock and $400,000, subject to adjustments as defined in
the TerraData MPA, to be paid within 12 weeks of closing. TerraData
is now a subsidiary of the Company.
Financings
On January 4, 2021, we entered into a securities purchase agreement
with Geneva Roth Remark Holdings, Inc. (“Geneva”) issuing to
Geneva a convertible promissory note in the aggregate principal
amount of $42,350 with a $3,850 original issue discount and $3,500
in transactional expenses due to Geneva and its counsel. The note
bears interest at 8% per annum and may be converted into common
shares of our Common Stock at a conversion price equal to 70% of
the lowest trading price of our common stock during the 20 prior
trading days. We received $35,000 net cash. On July 12, 2021,
Geneva converted $42,350 of principal and $1,540 into 1,784,146
shares of common stock.
On February 3, 2021, we entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $94,200 with a $15,700
original issue discount and $3,500 in transactional expenses due to
Geneva and its counsel. The note bears interest at 4.5% per annum
and may be converted into common shares of our Common Stock at a
conversion price equal to 81% of the lowest two trading prices of
our Common Stock during the 10 prior trading days. We received
$75,000 net cash.
On July 14, 2021, the note was paid in full, including all accrued
and unpaid interest.
On February 18, 2021, we entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $76,200 with a $12,700
original issue discount and $3,500 in transactional expenses due to
Geneva and its counsel. The note bears interest at 4.5% per annum
and may be converted into common shares of our Common Stock at a
conversion price equal to 81% of the lowest two trading prices of
our Common Stock during the 10 prior trading days. We received
$60,000 net cash.
On July 14, 2021, the note was paid in full, including all accrued
and unpaid interest.
On April 5, 2021, we entered into a securities purchase agreement
with Geneva Roth issuing to Geneva a convertible promissory note in
the aggregate principal amount of $64,200 with a $10,700 original
issue discount and $3,500 in transactional expenses due to Geneva
and its counsel. The note bears interest at 4.5% per annum and may
be converted into common shares of our Common Stock at a conversion
price equal to 81% of the lowest two trading prices of our Common
Stock during the 10 prior trading days. We received $50,000 net
cash. On July 14, 2021, the note was paid in full, including all
accrued and unpaid interest.
On April 26, 2021, we entered a Securities Purchase Agreement and
Registration Rights Agreement with FIRSTFIRE GLOBAL OPPORTUNITIES
FUND, LLC, a Delaware limited liability company (the
“FirstFire”), pursuant to which we issued to FirstFire a
Convertible Promissory Note in the principal amount of $825,000
(the “FirstFire Note”). The purchase price of the FirstFire
Note is $750,000. The FirstFire Note matures on January 26, 2022
upon which time all accrued and unpaid interest will be due and
payable. Interest accrues on the FirstFire Note at 10% per annum
guaranteed until the FirstFire Note becomes due and payable,
whether at maturity or upon acceleration or by prepayment or
otherwise. The FirstFire Note is convertible at any time after 180
days from issuance, upon the election of the FirstFire, into shares
of our Common Stock at $0.015 per share. The FirstFire Note is
subject to various “Events of Default,” which are disclosed in the
FirstFire Note. Upon the occurrence of an “Event of Default,” the
conversion price would become $0.005. On November 17, 2021,
FirstFire converted $825,000 of principal and $61,875 of interest
into 177,375,000 shares of common stock.
See “Legal Proceedings” for additional information regarding the
FirstFire Note.
On July 14, 2021, we entered a Securities Purchase Agreement with
GS Capital Partners, LLC (the “GS”), pursuant to which we
issued to GS a 6% Redeemable Note in the principal amount of
$2,000,000 (the “GS Note”). The purchase price of the GS
Note is $1,980,000. The GS Note matures on July 14, 2022 upon which
time all accrued and unpaid interest will be due and payable.
Interest accrues on the GS Note at 6% per annum until the GS Note
becomes due and payable. The GS Note is subject to various “Events
of Default,” which are disclosed in the GS Note. Upon the
occurrence of an “Event of Default,” the interest rate on the GS
Note will be 18%. The GS Note is not convertible into shares of our
Common Stock and is not dilutive to existing or future shareholders
and we plan on using a portion of the proceeds of the GS Note to
retire existing convertible debt.
On August 19, 2021, we entered into the Purchase Agreement with
GHS, for the offering of up to $45,000,000 worth of Common Stock.
Pursuant to the Purchase Agreement, on August 19, 2021, we and GHS
agreed that we would issue and sell to GHS, and GHS would purchase
from the Company, 31,799,260 shares of Common Stock for total
proceeds to the Company, net of discounts, of $3,300,000, at an
effective price of $0.1038 per share (the “First Closing”).
We received approximately $2,790,000 in net proceeds from the First
Closing after deducting the fees and other estimated offering
expenses payable by us. We used the net proceeds from the First
Closing for working capital and for general corporate purposes. The
shares were issued to GHS in a registered direct offering, pursuant
to a prospectus supplement to our currently effective registration
statement on Form S-3 (File No. 333-257826), which was initially
filed with the SEC on July 12, 2021, and was declared effective on
August 18, 2021.
Pursuant to the Purchase Agreement, on August 31, 2021, we and GHS
agreed that the Company would issue and sell to GHS, and GHS would
purchase from us, 27,297,995 shares of Common Stock
for total proceeds to us, net of discounts, of $3,300,000, at an
effective price of $0.120888 per share (the
“Second Closing”). We received approximately $2,885,000 in
net proceeds from the Second Closing after deducting the fees and
other estimated offering expenses payable by us. We used the net
proceeds from the Second Closing for working capital and for
general corporate purposes. The shares were issued to GHS in a
registered direct offering, pursuant to a prospectus supplement to
our currently effective registration statement on Form S-3 (File
No. 333-257826), which was initially filed with the SEC on July 12,
2021, and was declared effective on August 18, 2021.
Pursuant to the Purchase Agreement, on September 22, 2021, we and
GHS agreed that we would issue and sell to GHS, and GHS would
purchase from us, 25,630,272 shares of Common Stock for total
proceeds to us, net of discounts, of $2,000,000, at an effective
price of $0.085836 per share (the “Third Closing”). We
received approximately $1,915,000 in net proceeds from the Third
Closing after deducting the fees and other estimated offering
expenses payable by us. We used the net proceeds from the Third
Closing for working capital and for general corporate purposes. The
shares were issued to GHS in a registered direct offering, pursuant
to a prospectus supplement to our currently effective registration
statement on Form S-3 (File No. 333-257826), which was initially
filed with the SEC on July 12, 2021, and was declared effective on
August 18, 2021.
Pursuant to the Purchase Agreement, on October 1, 2021, we and GHS
agreed that we would issue and sell to GHS, and GHS would purchase
from us, 37,187,289
shares of Common Stock for total proceeds to us, net of discounts,
of $3,000,000, at an effective price of $0.08874 per share (the
“Fourth Closing”). We received approximately $2,850,000 in
net proceeds from the Fourth Closing after deducting the fees and
other estimated offering expenses payable by us. We used the net
proceeds from the Fourth Closing for working capital and for
general corporate purposes. The shares were issued to GHS in a
registered direct offering, pursuant to a prospectus supplement to
our currently effective registration statement on Form S-3 (File
No. 333-257826), which was initially filed with the SEC on July 12,
2021, and was declared effective on August 18, 2021.
Pursuant to the Purchase Agreement, on October 14, 2021, we and GHS
agreed that we would issue and sell to GHS, and GHS would purchase
from us, 14,282,304
shares of Common Stock for total proceeds to us, net of discounts,
of $1,055,000, at an effective price of $0.08125 per share (the
“Fifth Closing”). We received approximately $1,002,250 in
net proceeds from the Fifth Closing after deducting the fees and
other estimated offering expenses payable by us. We used the net
proceeds from the Fifth Closing for working capital and for general
corporate purposes. The shares were issued to GHS in a registered
direct offering, pursuant to a prospectus supplement to our
currently effective registration statement on Form S-3 (File No.
333-257826), which was initially filed with the SEC on July 12,
2021, and was declared effective on August 18, 2021.
On November 9, 2021, we entered an Equity Financing Agreement (the
“Equity Financing Agreement”) and Registration Rights
Agreement (the “GHS Registration Rights Agreement”) with
GHS, pursuant to which GHS agreed to purchase up to $30,000,000 in
shares of our Common Stock, from time to time over the course of 24
months (the “Contract Period”) after effectiveness of a
registration statement on Form S-1 (the “Registration
Statement”) of the underlying shares of Common Stock.
The GHS Registration Rights Agreement provides that we shall (i)
use our best efforts to file with the SEC a Registration Statement
within 45 days of the date of the GHS Registration Rights
Agreement; and (ii) have the Registration Statement declared
effective by the SEC within 30 days after the date the GHS
Registration Statement is filed with the SEC, but in no event more
than 90 days after the GHS Registration Statement is filed.
Pursuant to the Equity Financing Agreement, on December 21, 2021,
we and GHS agreed that the Company would issue and sell to GHS, and
GHS would purchase from us, 43,777,478 shares of Common Stock for
total proceeds to us, net of discounts, of $2,548,326, at an
effective price of $0.0696 per share (the “First EFA
Closing”). We received approximately $2,296,469 in net proceeds
from the First EFA Closing after deducting the fees and other
estimated offering expenses payable by us. We used the net proceeds
from the First EFA Closing for working capital and for general
corporate purposes.
Pursuant to the Equity Financing Agreement, on January 12, 2022, we
and GHS agreed that the Company would issue and sell to GHS, and
GHS would purchase from us, 23,372,430 shares of Common Stock for
total proceeds to us, net of discounts, of $1,150,000, at an
effective price of $0.054124 per share (the “Second EFA
Closing”). We received approximately $1,033,975 in net proceeds
from the Second EFA Closing after deducting the fees and other
estimated offering expenses payable by us. We used the net proceeds
from the Second EFA Closing for working capital and for general
corporate purposes.
Pursuant to the Equity Financing Agreement, on January 21, 2022, we
and GHS agreed that the Company would issue and sell to GHS, and
GHS would purchase from us, 33,454,988 shares of Common Stock for
total proceeds to us, net of discounts, of $1,150,000, at an
effective price of $0.037812 per share (the “Third EFA
Closing”). We received approximately $1,033,975 in net proceeds
from the Third EFA Closing after deducting the fees and other
estimated offering expenses payable by us. We used the net proceeds
from the Third EFA Closing for working capital and for general
corporate purposes.
Pursuant to the Equity Financing Agreement, on February 7, 2022, we
and GHS agreed that the Company would issue and sell to GHS, and
GHS would purchase from us, 16,040,411 shares of Common Stock for
total proceeds to us, net of discounts, of $500,000, at an
effective price of $0.0342884 per share (the “Fourth EFA
Closing”). We received approximately $448,975 in net proceeds
from the Fourth EFA Closing after deducting the fees and other
estimated offering expenses payable by us. We used the net proceeds
from the Fourth EFA Closing for working capital and for general
corporate purposes.
On February 21, 2022, we sold 75,798,921 shares of our Common Stock
at $0.032982 per share for total consideration of $2,500,000.
On March 3, 2022, we sold 16,579,569 shares of our Common Stock at
$0.0301576 per share for total consideration of $500,000.
On March 14, 2022, we sold 5,617,347 shares of our Common Stock at
$0.071208 per share for total consideration of $400,000.
Pursuant to the Equity Financing Agreement, on March 23, 2022, we
and GHS agreed that the Company would issue and sell to GHS, and
GHS would purchase from us, 29,257,395 shares of Common Stock for
total proceeds to us, net of discounts, of $1,500,000, at an
effective price of $0.056396 per share (the “Fifth EFA
Closing”). We received approximately $1,348,975 in net proceeds
from the Fifth EFA Closing after deducting the fees and other
estimated offering expenses payable by us. We used the net proceeds
from the Fifth EFA Closing for working capital and for general
corporate purposes.
Pursuant to the Equity Financing Agreement, on April 11, 2022, we
and GHS agreed that the Company would issue and sell to GHS, and
GHS would purchase from us, 23,746,816 shares of Common Stock for
total proceeds to us, net of discounts, of $1,000,000, at an
effective price of $0.04211091 per share (the “Sixth EFA
Closing”). We received approximately $898,975 in net proceeds
from the Sixth EFA Closing after deducting the fees and other
estimated offering expenses payable by us. We used the net proceeds
from the Sixth EFA Closing for working capital and for general
corporate purposes.
Partnerships
We have entered into a consulting agreement with the Bachner Group
to assist in the successful transformation from an R&D focused
company to a sales-focused company, and assist us with federal
contract opportunities.
Other Events
On August 3, 2021, we entered into an Engagement Agreement and
Terms and Conditions (the “EIAP Agreement”) with Energy
& Industrial Advisory Partners, LLC (“EIAP”). Pursuant
to the EIAP Agreement, we have engaged EIAP to serve as an advisor
to us in the proposed transaction for agreed target company or any
of its subsidiaries and/or the whole or any part of its or their
business or assets (the “Transaction”). EIAP will receive a
monthly retainer of $10,000 per month payable upon receipt of an
invoice. EIAP will also receive a consulting bonus fee of $350,000
payable upon completion of the Transaction. In the event of
successful completion of the Transaction as a result of EIAP’s
involvement, EIAP agrees to deduct the total retainer fee from the
consulting bonus fee. The EIAP Agreement may be terminated, with or
without cause, by either party upon ten days’ written prior notice
thereof to the other party. If (a) during the term of the EIAP
Agreement, or (b) within two years following the date of the EIAP
Agreement’s termination by us (provided that such two-year period
shall be extended by the same period of time that we take to settle
in full all fees, expenses and/or outlays due or to become due to
EIAP as at the date of the EIAP Agreement’s termination), we
complete a transaction with the target company or a similar
transaction to the Transaction, then we will pay the consulting
bonus fee at the completion of the transaction.
Going Concern Uncertainty
As shown in the accompanying financial statements, the Company
generated net losses of $4,826,320 and $275,842 during the years
ended December 31, 2021 and 2020, respectively. As of December 31,
2021, the Company’s current liabilities exceeded its current assets
by $10,120,885. As of December 31, 2021, the Company had $3,658,846
of cash.
We will require additional funding to finance the growth of our
operations and achieve our strategic objectives. These factors, as
relative to capital raising activities, create doubt as to our
ability to continue as a going concern. We are seeking to raise
additional capital and are targeting strategic partners in an
effort to accelerate the sales and marketing of our products and
begin generating revenues. Our ability to continue as a going
concern is dependent upon the success of future capital offerings
or alternative financing arrangements, expansion of our operations
and generating sales. The accompanying financial statements do not
include any adjustments that might be necessary should we be unable
to continue as a going concern. Management is actively pursuing
additional sources of financing sufficient to generate enough cash
flow to fund its operations; however, management cannot make any
assurances that such financing will be secured.
Results of Operations
For the Years Ended
December 31, 2021 and 2020
Revenues
For the year ended December 31, 2021, total revenues were
$7,783,340 compared to $0 for the same period in 2020, an increase
of $7,783,340. This increase primarily consisted of revenues of
$7,247,932 from the acquisition of Optilan in August 2021, $277,747
from the acquisition of Wildlife Specialists in August 2021
and $174,266 from the acquisition of TJM Electronics in September
2021 as well as $13,078 from DarkPulse.
Cost of Goods Sold and Gross Profit
For the year ended December 31, 2021, cost of goods sold were
$6,685,210 compared to $0 for the same period in 2020, an increase
of $6,685,210.
Gross profit for the year ended December 31, 2021 was $1,098,130
with a gross profit margin of 14.11% compared to $0 for the same
period in 2020 with no gross profit margin.
Operating Expenses
Selling, general and administrative expenses for year ended
December 31, 2021 increased by $3,769,708, or 2,526%, to $3,918,967
from $149,259 for the year ended December 31, 2020.
The increase primarily consisted of an increase to the operations
from our various acquisitions.
Payroll related expenses for year ended December 31, 2021,
increased by $2,653,496 to $2,653,683 from $187 for the year ended
December 31, 2020. The increase primarily consisted of an increase
to the numbers of employees inherited from our various
acquisitions.
Professional fees for the year ended December 31, 2021, increased
by $2,879,830 to $2,930,245 from $50,415 for the year ended
December 31, 2020. This increase primarily consisted of increased
legal expenditures associated with the increase in litigation as
well as fees associated with the various capital raises in
2021.
Depreciation and amortization for year ended December 31, 2021,
increased by $207,278 to $258,306 from $51,028 for the year
ended
December 31, 2020. This increase is primarily due to the increase
in depreciable assets we acquired from new acquisitions.
Other Income (Expense)
For the year ended December 31, 2021, we had other income
$4,021,700 compared to other expense of $17,103 for the same period
in 2020, an increase in income of $4,038,803. This increase in
other income increase primarily consisted of changes of $3,421,633
of gain related to the extinguishment of debt, $653,501 increase in
the fair value of the Company’s derivative instruments, $11,600 of
gain on foreign currency exchange rate variance, a decrease in
interest expense of $4,706 due to increased borrowings offset by
$31,636 loss on convertible notes.
Net Income (Loss)
As a result of the above, we reported a net loss of $4,826,320 for
the year ended December 31, 2021 compared to a net loss of $275,842
for the year ended December 31, 2020.
Liquidity and Capital Resources
December 31, 2021 Compared
to December 31, 2020
We require working capital to fund the continued development and
commercialization of our proprietary fiber optic sensing devices,
and for operating expenses. During the year ended December 31,
2021, we had $17,696,027 in new cash proceeds compared to year
ended December 31, 2020, when we had $0 in new cash proceeds.
As of December 31, 2021, we had cash of $3,658,846, compared to
$337 as of December 31, 2020.
We currently do not have sufficient cash to fund our operations for
the next 12 months and we will require working capital to complete
development, testing and marketing of our products and to pay for
ongoing operating expenses. We anticipate adding consultants for
technology development and the corresponding operations of the
Company, but this will not occur prior to obtaining additional
capital. Management is currently in the process of looking for
additional investors. Currently, loans from banks or other lending
sources for lines of credit or similar short-term borrowings are
not available to us. We have been able to raise working capital to
fund operations through the issuances of convertible notes or
obtained through the issuance of the Company’s restricted common
stock. As of December 31, 2021, our current liabilities exceeded
our current assets by $10,120,885.
Cash Flows from Operating Activities
During the year ended December 31, 2021, net cash used by operating
activities was $11,715,101, resulting from our net loss of
$4,826,320 and an increase in expenses related to our convertible
notes payables, including amortization of debt discount of $515,975
and loan acquisition costs of $480,450, increase in stock-based
compensation of $1,346,808, increase in inventory of $1,175,869 and
operating lease liabilities of $2,451,692. These increases were
offset by a decrease in derivative liability of $687,124, increase
in accounts payable and accrued expenses of $2,041,588 and an
increase from the gain on the extinguishment of debt of $3,488,860,
increase in accounts receivable of $771,432, unbilled revenue of
$822,031 and increase in contract liability of $922,631.
By comparison, during the year ended December 31, 2020, net cash
used by operating activities was $8,192, resulting from our net
loss of $275,842 partially offset by non-cash expenses totaling
$14,445 and increases in accounts payable and accrued liabilities
of $269,589.
Cash Flows from Investing Activities
During the year ended December 31, 2021, we had net cash used in
investing activities of $1,689,153. During the year ended December
31, 2020, net cash used by investing activities was $4,969, of
capitalized patents costs of $4,969.
Cash Flows from Financing Activities
During the year ended December 31, 2021, net cash provided by
financing activities was $17,311,427, comprised of proceeds from
the sale of common stock from offering of $14,593,327, the issuance
of convertible debt in the amount of $1,102,700, the issuance of
notes payable of $2,000,000 offset by payments on convertible debt
of $384,600.
During the year ended December 31, 2020, net cash used by financing
activities was $4,096, comprised of proceeds from issuance of
convertible notes payable of $40,000, offset by repayments of
related party notes payable of $44,096.
Factors That May Affect Future Results
Management’s Discussion and Analysis contains information based on
management’s beliefs and forward-looking statements that involve a
number of risks, uncertainties, and assumptions. There can be no
assurance that actual results will not differ materially from the
forward-looking statements as a result of various factors,
including but not limited to, our ability to obtain the equity
funding or borrowings necessary to market and launch our products,
our ability to successfully serially produce and market our
products; our success establishing and maintaining collaborative
licensing and supplier arrangements; the acceptance of our products
by customers; our continued ability to pay operating costs; our
ability to meet demand for our products; the amount and nature of
competition from our competitors; the effects of technological
changes on products and product demand; and our ability to
successfully adapt to market forces and technological demands of
our customers.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are
reasonably likely to have a current or future material effect on
our consolidated financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity
capital expenditures or capital resources.
Recent Accounting Pronouncements
We have provided a discussion of recent accounting pronouncements
in Note 1 to the Condensed Financial Statements.
BUSINESS
Organization
DarkPulse is a technology-security company incorporated in 1989 as
Klever. One of our principal wholly-owned subsidiaries, DPTI,
originally started as a technology spinout from the University of
New Brunswick, Fredericton, Canada. DPI is comprised of multiple
security platforms: Patented BOTDA Fiber Optic sensor systems and
Satellite Communications services.
In December 2010, DPTI entered into an Assignment Agreement with
the University, pursuant to which the University sold, transferred,
and assigned to us Patents in exchange for the issuance of a
debenture to the University in the amount of C$1,500,000 (Canadian
dollars). In April 2017, DPTI issued the Debenture. The Patents and
the Debenture were initially recorded in our accounts at
$1,491,923, based upon the exchange rate between the U.S. dollar
and the Canadian dollar on December 16, 2010, the date of the
original debenture. In addition to the repayment of principal and
interest, the Debenture requires DPTI to pay the University a 2%
royalty on sales of any and all products or services which
incorporate the Patents for a period of five years commencing on
April 24, 2018, as well as to reimburse the University for its
patent-related costs.
On April 27, 2018, Klever entered into an Merger involving Klever
as the surviving parent corporation and acquiring DPTI as its
wholly-owned subsidiary. On July 18, 2018, the parties closed the
Merger Agreement, as amended on July 7, 2018, and the name of the
Company was subsequently changed to “DarkPulse, Inc.” With the
change of control of the Company, the Merger was accounted for as a
recapitalization in a manner similar to a reverse acquisition.
On July 20, 2018, we filed a Certificate of Amendment to our
Certificate of Incorporation with the State of Delaware, changing
the name of the Company to “DarkPulse, Inc.” We filed a corporate
action notification with FINRA, and our ticker symbol was changed
to “DPLS.”
Our security and monitoring systems will be delivered in
applications for critical infrastructure/ key resources such as but
not limited to border security, pipelines, the oil and gas industry
and mine safety. Current uses of fiber optic distributed sensor
technology have been limited to quasi-static, long-term structural
health monitoring due to the time required to obtain the data and
its poor precision. Our patented BOTDA dark-pulse sensor technology
allows for the monitoring of highly dynamic environments due to its
greater resolution and accuracy.
Our Operating
Units
Optilan
Founded in 1990, Optilan is a leading independent security and
communications systems integrator worldwide. Providing specialist
technologies and techniques Optilan helps to protect businesses and
organizations from external threats. Telecommunications, Energy,
Rail, Critical Network Infrastructure, Pipeline Integrity Systems,
Renewables and Security. Headquartered in Warwick, United Kingdom
with a 30-year pedigree, at Optilan our customers trust us to keep
the integrity of their assets safe and secure, by managing the life
cycle delivery risk of our solutions. By fostering a collaborative
design approach to complex problems, we provide innovative
solutions, custom fit to even the most demanding of sites and scale
of projects. Importantly, our commitment to our safety culture
remains unaverred, to ensure that everyone goes home safely every
day. We orchestrate business resilience with a suite of end-to-end
solutions, combined with connectivity and professional service at a
global level. Today's business environment is more dynamic than
ever, with continuous change and disruption accepted as the new
normal. We complement our tailored, integrated expertise with a
curated ecosystem of leading manufacturers, to achieve both high
quality and enduring results. We are proud to foster a unique
culture full of talented individuals. Our sector focus ensures that
our account teams are fully accredited in their operational areas.
We are committed to creating individually tailored solutions, using
collaborative techniques and programming tools to deliver the
networks of the future. Optilan has provided integrated solutions
for leading Oil and Gas, Industrial and Energy companies around the
world. As an industry leader in deploying communication networks
with exceptional reliability, our reputation for delivering the
highest quality products remains unsurpassed. This spans mobile,
broadband, security systems and customer premise works. Our
professionals have the skill to adopt and embed our expertise into
existing platforms, processes, and cultures, delivering exceptional
value for our clients. Beyond our operational scope, we strive to
consider the impact of our global footprint and mitigate associated
environmental and sustainability risks. These factors combined set
Optilan apart and establish why customers continue to trust and
invest in our services.
Remote Intelligence
Remote Intelligence provides Unmanned Aerial Drone and UGC
(unmanned ground crawler) Services to a variety of clients; from
Industrial Mapping and Ecosystem Services, to Search and Rescue, to
Pipeline Security, we provide sales and consulting services for all
markets. Remote Intelligence started in 2013 with a simple vision;
to use the new and developing field of unmanned aerial vehicles to
produce higher quality, safer and more effective products for a
variety of markets. We strive to Equip, Educate and Advance the use
of the most advanced Unmanned Aerial Systems and Unmanned Ground
Crawlers in the United States and around the world for commercial,
government and domestic use. Our top priorities as we do that are
to find safe and ethical ways to use this new and exciting field of
technology to make life better. Providing holistic intelligence
consultation and solutions including full-service Methane Detection
and Monitoring. Quick, comprehensive site mapping and aerial
inspection services. We specialize in fully integrated,
geo-rectified, 3D modeled mapping and AI for industrial
applications, specializing in the energy and environmental
industries, with AI and live streaming capabilities anywhere in the
world. Also providing aerial survey, video inspection services,
emergency support services, wildlife and habitat surveys, and
comprehensive system design, training, and sales for both the
commercial and private sectors. Integrating the latest tech
solutions like artificial intelligence. Globally connected with a
base of operation in Wellsboro Pennsylvania.
TerraData Unmanned
Comprised of a team with more than 30 years cumulative experience
in the unmanned industry, TerraData custom manufactures NDAA
compliant drones and unmanned ground crawlers to meet the needs of
its customers. TerraData has successfully delivered a custom drone
platform per a customer’s specifications which exceeds current
industry offering by more than 30 minutes. The team has
manufactured, and successfully flight tested a Quad Copter drone
with 1.5KG payload capabilities that delivers more than 60 minutes
of continuous flight. This cutting-edge design is a combination of
proprietary software and hardware. The custom platform offers NDAA
compliant autopilot, communications links, TSO Certified GPS unit
and ground control station. Future designs include integrating RTK
for mapping, methane detectors, and true terrain following
capabilities. There are also improvements scheduled that are
intended to further extend the endurance and provide over 4KG of
payload capacity, not including batteries. TerraData has also
announced the research, development and successful testing of an
autonomous crawler soon to be released to the market with Methane
and Multi Gas Detection capabilities. Working seamlessly with its
partners at DarkPulse and its subsidiary companies, TerraData can
custom design, build and operate a system to meet our customers'
needs 24 hours a day 365 days a year around the block or around the
globe.
Wildlife Specialists
Wildlife Specialists, LLC was founded in 2007 to provide clients
with comprehensive wildlife and environmental assessment, planning,
and monitoring services. We currently maintain two regional offices
located in north central and southeastern Pennsylvania and are
available to provide services to clients nationwide and around the
globe. Our staff are well-established professionals who have a wide
range of experience in wildlife management, research, and
monitoring at the local and statewide levels throughout the United
States. In addition, we have specific expertise in providing the
full range of sensitive species and habitat assessments necessary
for your development projects. Wildlife Specialists’ mission is to
provide consulting services that use the latest technology to
produce the highest quality results compatible with our clients’
management goals and the appropriate protocols developed by state
and federal wildlife management agencies. Wildlife Specialists is
fully insured to industry standards and committed to the safety of
our staff, our clients, and the public. We have maintained safety
certification through ISNetWorld and other 3rd party certifiers. We
are also officially PennDOT, GSA, Small Business and HUBZone
Certified.
TJM West Electronics
TJM West Electronics is an ISO9001 and AS9100 certified electronics
and electro-mechanical assembly operation. We operate out of a high
tech, 20,000 Sq ft facility in Tempe, Arizona. Our assembly team is
trained to IPC 610 and J-STD-001 standards, Class 2 and 3. We have
been in business since 1999. Our latest website was developed to be
a customer interface for rapid costing, build scheduling, open
order status, and complete manufacturing history data records.
Registered users can enter build and fabrication parameters for
quantities of 2-20 units. Our calculator provides itemized labor,
PCB fabrication cost and delivery. Registered users can also access
factory floor for the updated status and delivery date of open
orders, a review of configuration, quotes and full quality history
database.
As a U.S. manufacturer and test of advanced electronics, cables and
sub-assemblies. we specialize in advanced package and complex CCA
and hardware. Certified to space and flight AS9100D, TJM has over
20 years supplying ultra-high reliability, and fully documented
electronic Hardware. Per AS9100D, TJM maintains all material
certifications, process and measurement reports electronically as
part of a complete quality history record. Manufacturing PCB Design
services on the most popular platforms including Cadence, Altium,
and Mentor. Design output data integrates seamlessly to our
automated manufacturing line. Test Development ICT to functional
and burn-in. We develop a test plan and hardware system to deliver
your 100% verified product. Low Cost, High Reliability
Manufacturing is the net result of quality planning, optimizing
automation technology, operational efficiency, and communication.
High value, low-cost domestic solution to replace offshore
manufacturing. Protect your IP and keep direct line-of sight of
manufacturing with products made in the USA. TJM West Is your one
stop shop.
Acquisitions
On August 9, 2021, we entered into a Share Purchase Agreement with
Optilan Guernsey Limited and Optilan Holdco 2 Limited, pursuant to
which we purchased from the sellers all of the issued and
outstanding equity interests of Optilan for £1.00 and also a
commitment to enter into a subscription agreement. Optilan is now a
wholly-owned subsidiary of the Company.
On August 9, 2021, we entered into a Subscription Agreement with
Optilan, pursuant to which we agreed to purchase an aggregate of
4,000,000 Ordinary Shares of Optilan for an aggregate purchase
price of £4,000,000.
On August 30, 2021, we closed two separate Membership Interest
Purchase Agreements with RI and WS pursuant to which we agreed to
pay to the majority shareholder of each of RI and WS an aggregate
of 15,000,000 shares of our Common Stock, $500,000 to be paid on
the closing date, and an additional $500,000 to be paid 12 weeks
from closing date in exchange for 60% ownership of each of RI and
WS. RI and WS are now subsidiaries of the Company.
On September 8, 2021, we entered into and closed the Stock Purchase
Agreement with TJM and TJM’s shareholders, pursuant to which we
agreed to purchase all of the equity interests in TJM in exchange
for $450,000, subject to adjustments as defined in the Stock
Purchase Agreement. TJM is now a wholly-owned subsidiary of the
Company.
Effective October 1, 2021, we entered into and closed the
Membership Purchase Agreement with TerraData and Justin Dee, the
sole shareholder of TerraData, pursuant to which we agreed to
purchase 60% of the equity interests in TerraData in exchange for
3,725,386 shares of our Common Stock and $400,000, subject to
adjustments as defined in the Membership Purchase Agreement, to be
paid within 12 weeks of closing. TerraData is now a subsidiary of
the Company.
Our Business
We offer a full suite of engineering, installation and security
management solutions to industries and governments. Coupled with
our patented DarkPulse
Technology, we provide our customers a comprehensive data
stream of critical metrics for assessing the health and security of
their infrastructure. Our comprehensive system provides for rapid,
precise analysis and responsive activities predetermined by the
end-user customer. These responses include the use of “smart”
AI platformed cameras, facial recognition technologies and multiple
drone platforms. Our User Interface (UI) is cloud based which
offers end-users access to their systems on any device located
anywhere in the world. Additional programming of the UI is being
completed within a game engine that will also offer access via
Virtual Reality headsets, allowing end-users to virtually
inspection their assets.
Historically, distributed sensor systems have been too costly, slow
and limited in their capabilities to attain widespread use. In
addition, Brillouin-based sensors have been plagued with
temperature and strain cross-sensitivity, i.e. the inability to
distinguish between temperature and strain change along the same
fiber. The loss of spatial resolution with an increase in fiber
length has also limited the use of distributed sensor systems. Due
to these shortcomings, existing technologies are unable to succeed
within today’s dynamic environments, and needs for more advanced
sensor technologies have remained unsatisfied.
By contrast to existing technologies, the DarkPulse Technology is a
distributed-fiber sensing system, based on
dark-pulse Brillouin scattering, which reports in
real-time on conditions such as temperature, stress, strain
corrosion and structural health monitoring of Critical
Infrastructure/Key Resources including Bridges, Buildings, Roadways
pipelines and mining installations.
DarkPulse Technology’s differentiators from and advantages over
existing technologies:
|
· |
Real-time Reporting: Higher data acquisition
speeds allowing for structural monitoring of dynamic
systems |
|
|
|
|
· |
Cost
to Customer: Significantly lower acquisition and operating
costs |
|
|
|
|
· |
Precision: A greater magnitude of precision and
spatial resolution than other systems currently
available |
|
|
|
|
· |
Applications: Wider range of capabilities than
other systems currently available |
|
|
|
|
· |
Power
consumption: Lower power consumption than existing systems allowing
for off-grid installations |
|
|
|
|
· |
Integration: Capable of integrating with existing
systems |
|
|
|
|
· |
Central station monitoring/cloud based
GUI |
We believe that these key advantages should allow us not only to
enter existing markets, but more importantly, to open new market
opportunities with new applications. We intend to leverage new
applications to target clients that have been unable to make use of
distributed fiber optic technology to date.
Revenue Generation
We intend to generate revenue from the following sources:
|
· |
Hardware equipment
sales, warranties, service contracts and licensing to large
enterprises and governments; |
|
· |
Recurring subscription
fees paid by enterprise/government users for access to our 24/7
monitoring services of their critical infrastructure; |
|
· |
Recurring subscription
fees paid by enterprise/government users for access to our
applications by enterprises/governments; |
|
· |
Recurring subscription
fees paid by enterprise users for access to data stored in the
cloud that may be integrated into large, third-party providers such
as Oracle, Google Cloud; and Microsoft; among others;
and |
|
· |
Recurring subscription
fees paid by enterprise/government users who subscribe to bundled
service offerings. |
Our Market
Current uses of fiber optic distributed sensor technology have been
limited to quasi-static, long-term structural health monitoring due
to the time required to obtain the data and its poor precision. Our
DarkPulse Technology allows for the monitoring of highly dynamic
environments due to its magnitude of increased resolution and
greater accuracy. The resulting high speed, real-time monitoring
capabilities of our DarkPulse Technology should satisfy a broad
range of existing and emerging requirements. Use of the DarkPulse
Technology by our customers should result in lower production costs
with increased sensing capabilities that can integrate with
existing technology and be upgraded cost effectively.
Due to the characteristics of the fiber used in fiber optic
sensing, the uses of our DarkPulse Technology are wide ranging.
Optical fiber is hard-wearing, which allows it to be used in
environments where other technologies fail (for example, at
temperatures ranging from -40°C to 300°C and 1000psi).
Additionally, DarkPulse Technology’s sensors allow for live sensing
due to the speed at which the analysis takes place.
Our management team is continually identifying markets in which our
DarkPulse Technology may be readily applied. Once these markets (as
described below) have been addressed, our DarkPulse Technology may
be adapted and applied to new markets.
Structural Monitoring
|
· |
Buildings and
Skyscrapers |
|
· |
Bridges, Tunnels and
Dams |
|
· |
Roads and Railway
tracks |
Temperature Sensing
|
· |
Fire Alarm and
Environment control |
|
· |
Low cost and
maintenance |
|
· |
Ability to withstand
harsh working environment |
Security & Defense
|
· |
National Border
Protection |
|
· |
Protection of Military
and other sensitive installations |
Consulting Services:
|
· |
Consulting (as
stand-alone or presales) |
|
· |
Post sales deployment
and Support |
|
· |
Managed services
(monitoring, etc.) |
Additional Potential Markets:
|
· |
Monitoring of
composite structures in aircraft |
|
· |
Dynamic stress
monitoring of runways |
|
· |
Dynamic ship hull
stress monitoring, especially with a view to double-hull oil
tankers |
|
· |
Smart grid and power
conservation applications based on cooling and/or heat proximity –
for instance, computer rooms, cell towers for heat soak |
|
· |
Monitor low
temperatures as part of control systems |
|
· |
Monitoring of
temperatures in extreme refrigeration environments |
|
· |
Avalanche early
warning systems |
Marketing
We utilize our DarkPulse Technology as the foundation of our
ongoing marketing initiatives. Most notably, the greater magnitude
of increased capabilities DarkPulse Technology versus existing
bright-pulsing technologies. Existing bright-pulse Brillouin-based
sensors have historically been plagued with temperature and strain
cross-sensitivity, i.e. the inability to distinguish between
temperature and strain change along the same fiber. The loss of
spatial resolution with an increase in fiber length is also a
limiting factor for the use of distributed sensor systems. Because
of these shortcomings, existing bright-pulse Brillouin-based
technologies are unable to succeed within today’s dynamic
environments, which coincides with our DarkPulse Technology’s
increased capabilities over bright-pulse systems. Our marketing
initiatives include daily, broad-based social media engagement,
management of our website, email campaigns, national television
commercials, magazine ads, and other ongoing initiatives designed
to increase awareness of our products and services and drive
conversion and adoption rates.
Competition
The overall optical sensing market is projected to reach USD $3.47
billion by 2023 from USD $1.13 billion in 2016, at a CAGR of 15.47%
between 2017 and 2023. We are active in the optical sensing market,
including Oil & Gas pipeline health monitoring, National Border
Security applications, and the mining industry. We believe that
fiber sensing applications which incorporate our DarkPulse
Technology may provide significant competitive advantages over
structural health monitoring applications offered by the long-term
leaders in the field, such as Schlumberger, Hewlett-Packard, and
Yokogawa, which collectively account for a significant portion of
industry sales. These companies, as well as others, have numerous
differences in feature sets and functionality, but all share
certain basic attributes: a bright-pulse technology as the core of
their systems architecture. An architecture designed using
bright-pulsing technology has limited sensing capabilities and
resolutions of one meter allowing for mostly long-term quasi-static
deployments.
However, we utilize our DarkPulse Technology allowing for multiple
applications into those markets unavailable to companies using
bright-pulse technology. While many of the companies using
bright-pulse technology have attempted to incorporate various
sensing techniques into a legacy technology, none have been able to
offer the order of magnitude resolutions offered by our DarkPulse
Technology. This magnitude in resolution coupled with the DarkPulse
Technology’s increased data collection speeds allows our DarkPulse
Technology to be installed into areas of the market that our
competitors cannot. Our future financial condition and operating
results depend on our ability to provide a high-quality solution as
well as increased distribution of the solutions in each of the
markets in which we compete or intend to compete within.
The markets for our products and services are highly competitive
and we are confronted by aggressive competition. These markets are
characterized by frequent product introductions and rapid
technological advances. Our financial condition and operating
results can be adversely affected by these and other industry-wide
downward pressures on gross margins. Principal competitive factors
important to us include price, product features, relative price and
performance, product quality and reliability, marketing and
distribution capability, service and support and corporate
reputation.
Intellectual Property
Our policy is to protect our technology by, among other things,
patents, trade secret protection and copyrights. We have taken
security measures to protect our trade secrets and proprietary
know-how, to the greatest extent possible. Our means of protecting
our proprietary rights may not prove to be adequate and our
competitors may independently develop technology or products that
are similar to ours or that compete with ours. Trade secret, patent
and copyright laws afford only certain protections for our
technology and products. The laws of many countries do not protect
our proprietary rights to as great an extent as do the laws of the
United States. Despite our efforts to protect our proprietary
rights, unauthorized parties may attempt to obtain and use
information that we regard as proprietary. Third parties may also
design around our proprietary rights, which may render our
protected technology and products less valuable, if the design
around is favorably received in the marketplace.
In addition, any of our products or technology covered by patents
or other intellectual property rights, could cause us to be subject
to various legal actions. Litigation may be necessary to enforce
our intellectual property rights, to protect our trade secrets, to
determine the validity and scope of the proprietary rights of
others, or to defend against claims of infringement, invalidity,
misappropriation, or other claims.
Through DPTI’s April 2017 Intellectual Property agreement with the
University, DPTI was sold, transferred, and assigned U.S. Patent
Nos. 7,245,790, 8,643,829, and 9,534,965, each of which are related
to our BOTDA dark-pulse technology. In addition, Canadian Patent
No. 2,502,275 was also assigned.
Suppliers
We currently rely on a full-time, dedicated, external team of
experienced professionals for the coding and maintenance of our
products. We believe we have mitigated the associated risks of
managing an external team of software and engineering development
professionals by incorporating internal management and oversight,
as well as appropriate systems, protocols, controls, and procedures
and ensuring that we have access to additional qualified
professionals to provide like or complementary services.
Government Regulation
Government regulation is not of significant concern for our
business nor is government regulation expected to become an
impediment to the business in the near- or mid-term as management
is currently unaware of any planned or anticipated government
regulation that would have a material impact on our business. Our
management believes it currently possesses all requisite authority
to conduct our business as described in this Prospectus.
Employees
As of April 11, 2022, we had 167 full-time employee and no
part-time employees.
Legal Proceedings
DarkPulse, Inc. v. Twitter, Inc.
On January 24, 2022, the Company filed a petition in the Supreme
Court of the State of New York County of New York to compel a
disclosure from Twitter, Inc. The petition sought to compel
Twitter, Inc. to disclose the owner and operator of the “Investor
News” Twitter account (@newsfilterio) so the Company could commence
an action for damages arising from false, misleading, and untrue
statements made by the Investor News.
On February 23, 2022, the Court ordered Twitter to release
information concerning the owner and operator of the Investor News
account to the Company. The
Company will continue to pursue and expose the identities of those
individuals or groups and shall take any and all legal action to
pursue the violators.
Carebourn Capital, L.P. v. DarkPulse, Inc.
As disclosed in greater detail in the Company’s Form 10-Q, filed
November 15, 2021, the Company remains in active litigation with
Carebourn Capital, L.P. (“Carebourn”). The remainder of this
disclosure will address all material updates since the
aforementioned Form 10-Q.
On November 1, 2021, the Company filed a motion to compel Carebourn
to produce certain documents and supplement its responses to
certain interrogatories.
On September 27, 2021, Carebourn filed a declaratory judgment and a
motion for declaratory judgment, dismissal of the Company’s claims,
and summary judgment (the “Dispositive Motion”).
On February 15, 2022, the Court rendered its decision on the
aforesaid motions, denying the Dispositive Motion in its entirety
and granting in part, and denying in part, the Company’s motion to
compel. Pursuant to the Court’s ruling in the Company’s favor on
its motion to compel, the Court has awarded the Company attorneys’
costs and fees in connection with the successful portions of its
motion to compel.
On January 19, 2022, the Company filed a motion for enforcement of
a protective order. It is the Company’s position that Carebourn has
violated a protective order that was entered into by the parties
and seeks to protect confidential information exchanged during the
litigation. The Court has not yet rendered a decision on this
motion.
On March 24, 2022, Carebourn filed a Motion to Compel against
DarkPulse, alleging that DarkPulse failed to fulfill its discovery
obligations by not producing a privilege log. DarkPulse contends
that Carebourn’s motion is meritless and premature.
The Company remains committed to actively litigating its claims for
relief under the Exchange Act.
More Capital, LLC v. DarkPulse, Inc. et al
As disclosed in greater detail in the Company’s Form 10-Q, filed
November 15, 2021, the Company remains in active litigation with
More Capital, LLC (“More”). The remainder of this disclosure
will address all material updates since the aforementioned Form
10-Q.
On October 27, 2021, the Company served its initial discovery
requests, consisting of interrogatories, requests for admission,
and requests for production, on More.
On November 24, 2021, More served its responses to the Company’s
initial discovery requests. After reviewing More’s responses, it is
the Company’s position that More’s responses are false, misleading,
untrue, and/or evasive.
On February 28, 2022, the Company filed its motion to compel More
to produce certain documents and supplement or otherwise modify its
responses to certain interrogatories and requests for admission.
DarkPulse’s motion will be heard on April 14, 2022.
On March 9, 2022, More filed a motion for summary judgment against
the Company. The Company’s opposition was filed on or before March
23, 2022, and More’s motion will be heard on April 6, 2022.
The Company remains committed to actively litigating its claims for
relief under the Exchange Act.
Goodman et al. v. DarkPulse, Inc.
As disclosed in greater detail in the Company’s Form 10-Q, filed
November 15, 2021, the Company remains in active litigation with
Stephen Goodman (“Goodman”), Mark Banash (“Banash”),
and David Singer (“Singer”) (Goodman, Banash, and Singer
together, the “Series D Plaintiffs”). The remainder of this
disclosure will address all material updates since the
aforementioned Form 10-Q.
On August 20, 2021, the Company and the Series D Plaintiffs entered
into a stipulation, pursuant to which the Company withdrew its
motion to dismiss and the Company was provided with an extended
period of time to respond to the complaint.
On September 8, 2021, the Company filed its Answer and
Counterclaims, wherein the Company alleges counterclaims arising
from various breaches of fiduciary duties by the Series D
Plaintiffs while they were employed as officers of the Company.
On December 9, 2021, the parties participated in private mediation.
No understanding of settlement was reached at the conclusion
thereof.
The Company remains committed to actively litigating its claims and
defenses against the Series D Plaintiffs.
DarkPulse, Inc. v. FirstFire Global Opportunities Fund, LLC, and
Eli Fireman (SDNY)
On December 31, 2021, the Company commenced an action against
FirstFire Global Opportunities Fund, LLC (“FirstFire”), and
Eli Fireman (“Fireman”) (FirstFire and Fireman together, the
“FirstFire Parties”) in the United States District Court for
the Southern District of New York. The complaint alleges that
FirstFire is an unregistered dealer acting in violation of Section
15(a) of the Exchange Act of 1934 and that the Company is entitled
to rescissionary relief from certain convertible promissory notes
and securities purchase agreements entered into by the Company and
FirstFire pursuant to Section 29(b) of the Exchange Act. The
complaint also asserts claims against Fireman for control person
liability under Section 20(a) of the Exchange Act, unjust
enrichment of FirstFire, and constructive trust against
FirstFire.
On January 14, 2022, the Company moved for entry of a temporary
restraining order and award of a preliminary injunction against
FirstFire to enjoin them from selling or attempting to sell,
transfer, or otherwise dispose of the 177,275,000 common shares the
Company believed were in FirstFire’s possession pursuant to the
conversion of a certain note.
On January 14, 2022, the Court denied the Company’s order to show
cause seeking a temporary restraining order.
Following expedited briefing by the parties, on January 21, 2022,
the Court denied the Company’s motion for preliminary
injunction.
On March 14, 2022, the FirstFire Parties filed their letter request
for a motion to dismiss the Company’s complaint. The Company
responded to the FirstFire Parties’ letter on March 17, 2022. As of
the filing date, the Court has not yet issued a decision on the
FirstFire Parties letter request to file its motion to dismiss.
FirstFire Global Opportunities Fund, LLC v. DarkPulse, Inc.
(Del. Chancery Court)
On December 13, 2021, FirstFire commenced an action against the
Company in the Court of Chancery of the State of Delaware. The
complaint seeks declaratory judgment of the issuance of 177,375,000
shares of Company common stock pursuant to a certain convertible
promissory note.
On January 4, 2022, the Company filed a motion to dismiss
FirstFire’s complaint.
On February 11, 2022, the Company filed its opening memorandum of
law in support of its motion to dismiss. The Company’s memorandum
argues that the issuance of the certain convertible promissory note
to FirstFire was made under is void ab initio as it violates
New York’s criminal usury laws, and that FirstFire improperly
amended the governing law provision of the void convertible note to
evade being declared void ab initio and, instead, continue
to enforce the unlawful transaction.
On March 14, 2022, FirstFire filed a notice of voluntary dismissal
of its complaint.
As of December 31, 2021, DarkPulse views the aforesaid FirstFire
Delaware Chancery matter as fully disclosed.
DarkPulse, Inc. v. EMA Financial, LLC et al
On January 4, 2022, the Company commenced an action against EMA
Financial, LLC (“EMA”), EMA Group, Inc. (“EMA
Group”), and Felicia Preston (“Preston”) (EMA, EMA
Group, and Preston together, the “EMA Parties”) in the
United States District Court for the Southern District of New York.
The complaint alleges that EMA is an unregistered dealer acting in
violation of Section 15(a) of the Exchange Act and that the Company
is entitled to rescissionary relief from certain convertible
promissory notes and securities purchase agreements entered into by
the Company and EMA pursuant to Section 29(b) of the Exchange Act.
The complaint also asserts claims against Preston for control
person liability under Section 20(a) of the Exchange Act, unjust
enrichment of EMA, EMA Group, and Preston, and constructive trust
against the EMA Parties.
On March 28, 2022, the Company filed its first amended complaint
against the EMA Parties. The amended complaint alleges the same
causes of action asserted in the initial complaint—(1) that EMA is
an unregistered dealer acting in violation of Section 15(a) of the
Exchange Act and, pursuant to Section 29(b) of the Exchange Act,
the Company is entitled to rescissionary relief from certain
convertible promissory notes and securities purchase agreements
entered into by the Company and EMA, (2) that Preston is liable
pursuant to Section 20(a) of the Exchange Act, and (3) unjust
enrichment—along with two claims: that the EMA Parties, first,
violated and, second conspired to violate the Racketeer Influenced
and Corrupt Organizations (RICO) Act for engaging in the collection
of an unlawful debt.
The Company remains committed to actively litigating its claims for
relief under the Exchange Act.
In addition to the foregoing Legal Proceedings, the Company is also
actively investigating potential legal claims, including but not
limited to stock fraud, market manipulation, and/or defamation,
against certain Twitter accounts, websites, and social media
channels. The investigation is ongoing and should potential claims
be identified, the Company will evaluate commencing formal
litigation proceedings.
From time to time, the Company may become involved in litigation
relating to claims arising out of its operations in the normal
course of business. To the best of the Company’s knowledge, no
governmental authority is contemplating any proceeding to which the
Company is a party or to which any of the Company’s properties are
subject, which would reasonably be likely to have a material
adverse effect on the Company’s business, financial condition and
operating results.
From time to time, we may become involved in litigation relating to
claims arising out of our operations in the normal course of
business. We are not currently involved in any pending legal
proceeding or litigation and, to the best of our knowledge, no
governmental authority is contemplating any proceeding to which we
are a party or to which any of our properties is subject, which
would reasonably be likely to have a material adverse effect on our
business, financial condition and operating results.
DIRECTORS,
EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
Executive Officers and Directors
The following table sets forth the name, age, and position of each
executive officer and director of the Company:
Director's Name |
Age |
Position |
Dennis O’Leary |
58 |
Chairman of the Board, Chief
Executive Officer, President, Chief Financial Officer, Secretary
& Treasurer |
|
|
|
Dr. Anthony Brown |
48 |
Director |
|
|
|
Carl Eckel |
63 |
Director |
|
|
|
Bill Bayliss |
59 |
Chief Executive Officer of Optilan |
Dennis M. O’Leary, Chairman, CEO, President, CFO. Mr.
O’Leary was appointed as the Company’s Chief Executive Officer,
President, Chief Financial Officer and Chairman of the Board in
April 2018. Mr. O’Leary is a serial entrepreneur with significant
international experience having founded Sulu Electric Power and
Light Corp (Philippines), a firm with expertise in utility scale
power generation and solar energy. In 2010, Mr. O’Leary co-founded
DarkPulse Technologies Inc., a wholly-owned subsidiary of the
Company, which is developing specialized devices that monitor
activities along national borders and provide structural health and
safety monitoring of oil and gas pipelines. He holds extensive
start-up experience including multiple exit strategies. Mr. O’Leary
is an Ambassador for the Province of New Brunswick, Canada, and a
Research Member of the NATO Science and Technology Organization. He
served as a member of the Board at Arizona State University’s
School of Engineering, Global Resolve as Chair of the Impact
Committee. His previous employment includes the NYPD where he
worked as a member of the Manhattan North Tactical Narcotics Team,
which prosecuted establishments involved in the illegal
distribution of narcotics. He was a member of a joint taskforce
working with the DEA and USINS in the execution of warrants related
to narcotics trafficking. While at the NYPD, he was assigned to the
Department of Justice as a member of the FBI’s investigative team
with internal designation C14. He is a licensed private pilot with
turbine experience. Mr. O’Leary was appointed as a Director due to
his extensive experience in the industries in which we operate. Mr.
O’Leary is not, and has not been during the past five years, the
director of any other public companies.
Dr. Anthony Brown, Director. Dr. Brown has served as a
Director of the Company since April 2019. He is a physicist and
scientist with extensive experience in the development of Brillouin
scattering-based distributed fiber optic sensing. In 2010, Dr.
Brown co-founded DarkPulse Technologies, Inc., a wholly-owned
subsidiary of the Company. Dr. Brown has more than 25 years of
research and lecturing experience gained at the University of New
Brunswick (“UNB”), focusing primarily on the development of
Brillouin scattering-based distributed fiber optic sensor
technology. From 2001 to 2012, Dr. Brown served as an assistant
professor and research associate at UNB. During Dr. Brown’s tenure
at UNB, he was instrumental in developing numerous patents in the
field of fiber optic sensing. From 2012 to 2015, Dr. Brown served
as an Adjunct Professor at UNB. From 2013 through the present, Dr.
Brown has served as a data scientist for Xplornet Communications,
Inc. From 2018 through the present, Dr. Brown has served as a
consultant for the Company. Dr. Brown received a Bachelor of
Science degree in Physics from UNB in 1995, and a PhD in Physics
from UNB in 2001. Dr. Brown was appointed as a Director due to his
extensive experience in the development of Brillouin
scattering-based distributed fiber optic sensing. Dr. Brown is not,
and has not been during the past five years, the director of any
other public companies.
Carl Eckel, Director. Mr. Eckel has served as a Director of
the Company since April 2019. He is a U.S. military veteran with
over 35 years of defense communications system development and
support experience. Mr. Eckel’s career began in the field of
telecommunications operations and continued to evolve with the
rapid advancements in telecommunications technologies. While
serving in the United States Air Force from 1977 to 1985, Mr. Eckel
was responsible for managing leased communications accounting,
planning, user requirement changes, and system upgrades and
replacements for critical Air Force Satellite Control Network
(“AFSCN”) Programs at Onizuka AFS, until his honorable
discharge in 1985. As a private civilian, from 1985 to 1992, Mr.
Eckel served as a Database Systems Administrator and Site
Integrator for Ford Aerospace / Loral where he was responsible for
into customer communications requirements analysis and development
of training for operations and maintenance of the classified and
unclassified systems supporting all Space Shuttle and satellite
activities. In 1993 recognizing the government’s need for quality
affordable training for operations and maintenance of complex
software and hardware communications systems, Mr. Eckel started a
successful training development and delivery business that provided
training to Washington D.C. area clients such as the Pentagon 7th
CG, the White House Communications Agency. and PACAF based in
Hawaii. Mr. Eckel worked for Allied Signal/Honeywell in 1995-96 as
a Group Field Engineer maintaining critical Control Center and
Remote Tracking Communications Equipment around the world, and then
rejoining communications systems support with Lockheed from 1997 to
1998. From 1999 to 2000, Mr. Eckel resumed support on the
government side of the AFSCN serving initially in Network Security
and Systems Integration. From 2000 to 2001, Mr. Eckel served as a
Deputy Maintenance Manager for ITT where he was responsible for
maintenance of AFSCN mission control communications systems. From
2001 to 2013, Mr. Eckel served as a Site Manager, Program Manager,
and Program Director for IITC / Nortel / PEC / Avaya Government
Solutions where he held a team leadership role transitioning back
into program management. With this transition Mr. Eckel was a part
of establishing and delivering contract performance that netted
99-100% contract satisfaction award fees. Mr. Eckel advanced to
program director level managing contract team activities, including
subcontractors, at multiple locations supporting programs for the
Air Force, Army, and NOAA/NWS. In early 2014, Mr. Eckel
transitioned into the Oil and Gas Industry as a safety professional
in support of pipeline integrity work, station work, and mainline
projects for clients including Enbridge, Hess, Tesoro, MarkWest,
TransCanada, Kinder Morgan, and Shell. From 2014 through the
present, Mr. Eckel has served as a Safety Manager for Minnesota
Limited, LLC where he is responsible for safety compliance,
including field safety inspections, incident and accident
investigation, and reporting. Mr. Eckel received a diploma in
Communications Systems from the USAF Technical School in Shepherd
AFB, TX. Mr. Eckel holds numerous certifications, including OSHA
500 – Authorized OSHA 10 and 30 hour trainer, OSHA 510 HAZWOPER,
CPR/AED/First aid, DOT – CSA & HAZMAT Driver Training. Mr.
Eckel was appointed as a Director due to his extensive management
experience within the government and the private sectors in such
areas and industries where our technology systems may be
advantageously utilized. Mr. Eckel is not, and has not been during
the past five years, the director of any other public
companies.
Bill Bayliss, CEO, Optilan. Mr. Bayliss has served as the
CEO of Optilan since February 2020. Mr. Bayliss has been actively
involved in leadership positions in both the public and private
industrial/energy sector; including living and working in North
America, Middle East and Norway. Mr. Bayliss started his career in
support to the power generation and petrochemical businesses in a
wide range of roles including project management, sales and
commercial. He entered the oil and gas business with Brown and Root
(B&R) in both London and Aberdeen. He subsequently moved to
Norway with Kvaerner Engineering and returned back to UK with
Kellogg B&R (KBR) fulfilling various roles including Senior
Manager for the Hibernia Development in Canada, Business Manager
for the Conoco Southern North Sea operations, maintenance and major
project work before being promoted to KBR Global Operations and
Maintenance Director. In 2004, Mr. Bayliss moved to Petrofac to set
up an engineering, procurement, construction and commissioning
support business that grew significantly from an initial seed corn
start up investment, and within his role as Vice President,
developed the business into five divisional areas with an annual
turnover of circa $300 million and a support staff of 1,800. In
2009, he moved to Dubai as Chief Operating Officer of Topaz
Engineering and was accountable for four business units with a
circa $300 million turnover and over 4000 personnel. Mr. Bayliss
joined Viking Seatech in September 2011 as Group CEO to take the
business through financial and organizational restructuring and
professionalization. Mr. Bayliss led the sale of this HSBC private
equity backed debt leveraged business which was sold in August 2013
for £150million to USA trade buyer Actuant. At the end of 2014 Mr.
Bayliss moved to work as an independent consultant helping a number
of Private Equity houses including Bluewater Energy and Energy
Ventures in their due diligence activities for the acquisition of
various targets covering are Operational, Commercial (including
financial elements), HSEQ, the supply chain, organizational
structures and general management support. In mid-2016 Bill joined
ICR. As Group CEO, he developed and executed a comprehensive
strategy with the “end in mind” that delivered valuable change not
only in terms of EBITDA but attractiveness in terms of exit
multiples with the addition of new organic product lines and
geographies. At its peak under Bills guidance the business nearly
doubled in size. During late 2019, Mr. Bayliss decided to pursue
other activities and was appointed as the CEO of Optilan. Mr.
Bayliss has a Master of Science Degree in Engineering and Risk
Management.
Legal Proceedings
During the past ten years there have been no events under any
bankruptcy act, no criminal proceedings and no judgments,
injunctions, orders or decrees material to the evaluation of the
ability and integrity of any of our directors or executive
officers, and none of these persons has been involved in any
judicial or administrative proceedings resulting from involvement
in mail or wire fraud or fraud in connection with any business
entity, any judicial or administrative proceedings based on
violations of federal or state securities, commodities, banking or
insurance laws or regulations, or any disciplinary sanctions or
orders imposed by a stock, commodities or derivatives exchange or
other self-regulatory organization.
Family Relationships
There are no family relationships between any of our directors and
executive officers.
Audit Committee
As of December 31, 2021, we did not have a functioning Audit
Committee. Our management is currently reviewing our SEC filings
and relying on outside experts to assist with this process.
EXECUTIVE
COMPENSATION
Summary Compensation for Named Executive Officers
The following table shows the executive compensation paid to our
named executive officers for the years ended December 31, 2021 and
2020.
Name and Principal
Position |
|
Year Ended
Dec 31,
|
|
|
Salary |
|
|
All Other
Compensation |
|
|
Total |
|
Dennis O’Leary |
|
|
2021 |
|
|
$ |
60,000 |
|
|
$ |
– |
|
|
$ |
60,000 |
|
Chairman/CEO and Director |
|
|
2020 |
|
|
$ |
– |
|
|
$ |
– |
|
|
$ |
– |
|
Bill Bayliss |
|
|
2021 |
|
|
$ |
343,918 |
|
|
$ |
68,782 |
|
|
$ |
412,700 |
|
CEO, Optilan |
|
|
2020 |
|
|
$ |
321,655 |
|
|
$ |
12,866 |
|
|
$ |
334,521 |
|
Summary Compensation for Directors
The following table shows the executive compensation paid to our
directors (excluding named executive officers) for the year ended
December 31, 2021.
Name and Principal
Position |
|
Year Ended Dec
31, |
|
|
Salary |
|
|
Total |
|
Dr. Anthony Brown, Director |
|
|
2021 |
|
|
$ |
– |
|
|
$ |
– |
|
Carl Eckel, Director |
|
|
2021 |
|
|
$ |
60,000 |
|
|
$ |
60,000 |
|
Equity Awards
As of December 31, 2021, there were no outstanding equity
awards.
SECURITY OWNERSHIP
OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Principal Shareholders
The table below sets forth information as to our directors, named
executive officers, and executive officers and each person owning
of record or was known by the Company to own beneficially shares of
stock greater than 5% of the 5,379,559,651 (5,379,471,416
common plus 88,235 preferred) shares as of April 11, 2022. The
table includes preferred stock that is convertible into common
stock and information as to the ownership of the Company's Stock by
each of its directors, named executive officers, and executive
officers and by the directors and executive officers as a group.
There were no stock options outstanding as of April 11, 2022.
Except as otherwise indicated, all shares are owned directly, and
the persons named in the table have sole voting and investment
power with respect to shares shown as beneficially owned by them.
The address for each of our directors, named executive officers,
and executive officers is 1345 Avenue of the Americas,
2nd Floor, New York, NY 10105.
Name
and Position |
Shares of
Common
Stock
Owned
|
Shares of
Series D
Preferred
Stock Owned(1)
|
Amount and
Nature of
Beneficial
Ownership(2)
|
Percentage
of Beneficial Ownership Before
Offering(3) |
Percentage
of Beneficial Assuming Remaining 130,250,482 Shares are
Sold |
Dennis
O’Leary, CEO and Director |
– |
67,647 |
135,294 |
* |
* |
Dr.
Anthony Brown, Director |
– |
5,882 |
11,764 |
* |
* |
Carl
Eckel, Director |
– |
– |
– |
– |
– |
Bill
Bayliss, CEO, Optilan |
– |
– |
– |
– |
– |
Total
named executive officers, executive officers, and directors (four
persons) |
– |
73,529 |
147,058 |
* |
* |
*Less than 1%
|
(1) |
Each share of Series D Preferred
Stock is convertible, at the option of the holder, into two shares
of our Common Stock. |
|
|
|
|
(2) |
Under Rule 13d-3 of the Exchange
Act, a beneficial owner of a security includes any person who,
directly or indirectly, through any contract, arrangement,
understanding, relationship, or otherwise has or shares: (i) voting
power, which includes the power to vote, or to direct the voting of
shares; and (ii) investment power, which includes the power to
dispose or direct the disposition of shares. Certain shares may be
deemed to be beneficially owned by more than one person (if, for
example, persons share the power to vote or the power to dispose of
the shares). In addition, shares are deemed to be beneficially
owned by a person if the person has the right to acquire the shares
(for example, upon exercise of an option) within 60 days of the
date as of which the information is provided. In computing the
percentage ownership of any person, the amount of shares
outstanding is deemed to include the number of shares beneficially
owned by such person (and only such person) by reason of these
acquisition rights. As a result, the percentage of outstanding
shares of any person as shown in the above table does not
necessarily reflect the person’s actual ownership or voting power
with respect to the number of shares of common stock actually
outstanding on the date of this prospectus. |
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
Certain Relationships and Related Transactions
Except as disclosed below, for transactions with our executive
officers and directors, please see the disclosure under “EXECUTIVE COMPENSATION”
above.
Director Independence
We are not currently subject to listing requirements of any
national securities exchange or inter-dealer quotation system which
has requirements that a majority of the board of directors be
“independent” and, as a result, we are not at this time required to
have our Board of Directors comprised of a majority of “independent
directors.”
We currently have not established any committees of the Board of
Directors. Our Board of Directors may designate from among its
members an executive committee and one or more other committees in
the future. We do not have a nominating committee or a nominating
committee charter. Further, we do not have a policy with regard to
the consideration of any director candidates recommended by
security holders. To date, other than as described above, no
security holders have made any such recommendations. The entire
Board of Directors performs all functions that would otherwise be
performed by committees. Given the present size of our board it is
not practical for us to have committees. If we are able to grow our
business and increase our operations, we intend to expand the size
of our board and allocate responsibilities accordingly.
DESCRIPTION OF
SECURITIES
We have authorized capital stock consisting of the following. The
total number of shares of capital stock which the Company has the
authority to issue is: 20,002,000,000. These shares shall be
divided into two classes with 20,000,000,000 shares designated as
common stock at $0.0001 par value (the “Common Stock”) and
2,000,000 shares designated as preferred stock at $0.01 par value
(the “Preferred Stock”).The Preferred Stock of the Company
is issuable by authority of the Board of Director(s) of the Company
in one or more classes or one or more series within any class and
such classes or series shall have such voting powers, full or
limited, or no voting powers, and such designations, preferences,
limitations or restrictions as our Board of Directors may
determine, from time to time. We have 5,379,471,416 common shares
and 88,235 preferred shares outstanding as of the date of this
prospectus.
Common Stock
Our Certificate of Incorporation authorize us to issue
20,000,000,000 shares of common stock, par value $0.0001 per share.
The holders of outstanding common shares are entitled to receive
dividends out of assets or funds legally available for the payment
of dividends of such times and in such amounts as the board from
time to time may determine. Holders of common stock are entitled to
one vote for each share held on all matters submitted to a vote of
stockholders. There is no cumulative voting of the election of
directors then standing for election. The common shares are not
entitled to pre-emptive rights and are not subject to conversion or
redemption. Upon liquidation, dissolution or winding up of the
Company, the assets legally available for distribution to
stockholders are distributable ratably among the holders of the
common shares after payment of liquidation preferences, if any, on
any outstanding payment of other claims of creditors. Each
outstanding common share is duly and validly issued, fully paid and
non-assessable.
Preferred Stock
Our Certificate of Incorporation authorize us to issue 2,000,000
shares of preferred stock, par value $0.01 per share. Our Board of
Directors has the authority to issue additional shares of preferred
stock in one or more series, and fix for each series, the
designation of and number of shares to be included in each such
series. Our Board of Directors is also authorized to set the
powers, privileges, preferences, and relative participating,
optional or other rights, if any, of the shares of each such series
and the qualifications, limitations or restrictions of the shares
of each such series.
Unless our Board of Directors provides otherwise, the shares of all
series of preferred stock will rank on parity with respect to the
payment of dividends and to the distribution of assets upon
liquidation. Any issuance by us of shares of our preferred stock
may have the effect of delaying, deferring or preventing a change
of our control or an unsolicited acquisition proposal. The issuance
of preferred stock also could decrease the amount of earnings and
assets available for distribution to the holders of common stock or
could adversely affect the rights and powers, including voting
rights, of the holders of common stock.
On July 12, 2018, we filed a Certificate of Designation with the
State of Delaware amending the designation of its previously
designated “Class D Voting Preferred Stock,” designating 100,000
shares of the Company’s preferred stock as “Series D Preferred
Stock.” As of July 18, 2018, all shares of the Company’s Class A
Voting Preferred Stock, Class B Voting Preferred Stock, and Class C
Voting Preferred Stock had been returned to the Company and
cancelled. There are presently 88,235 shares of Series D Preferred
Stock outstanding.
On December 23, 2021, we amended the Certificate of Designation for
the Series D Preferred Stock. Pursuant to the amendment, Section 4
was changed to the following:
4. Conversion. Each share of
Series D Stock shall be convertible, at the sole and exclusive
election of the holder of such share of Series D Preferred Stock,
into two (2) shares of Common Stock of the Corporation.
Each share of Series D Preferred Stock entitles the holder to 6,000
votes on all matters submitted to a vote of our stockholders and is
convertible at the election of the holder into two shares of Common
Stock.
Stock Options
We currently have no outstanding stock options.
Dividend Policy
We have never declared a cash dividend on our common stock and our
Board of Directors does not anticipate that we will pay cash
dividends in the foreseeable future. Any future determination to
pay cash dividends will be at the discretion of our board of
directors and will depend upon our financial condition, operating
results, capital requirements, restrictions contained in our
agreements and other factors which our Board of Directors deems
relevant.
Transfer Agent
We have appointed Standard Registrar and Transfer
Company, 440 East 400 South,
Suite 200, Salt Lake City, UT
84111, to act as transfer agent for the common stock.
Anti-Takeover Effects of Delaware Law, Our Certificate of
Incorporation and Bylaws
Certain provisions of our charter documents and Delaware law could
have an anti-takeover effect and could delay, discourage or prevent
a tender offer or takeover attempt that a stockholder might
consider to be in its best interests, including attempts that might
otherwise result in a premium being paid over the market price of
our common stock.
Charter and Bylaws
Our Certificate of Incorporation and Bylaws contain provisions that
could have the effect of delaying or preventing changes in control
or changes in our management without the consent of our board of
directors, including, among other things:
|
· |
no cumulative voting
in the election of directors, which limits the ability of minority
stockholders to elect director candidates; |
|
· |
the ability of our
board of directors to issue shares of preferred stock and to
determine the price and other terms of those shares, including
preferences and voting rights, without stockholder approval, which
could be used to significantly dilute the ownership of a hostile
acquirer; |
|
· |
the exclusive right of
our board of directors to elect a director to fill a vacancy
created by the expansion of our board of directors or the
resignation, death or removal of a director, which prevents
stockholders from being able to fill vacancies on our board of
directors; |
|
· |
the requirement that a
special meeting of stockholders may be called only by a majority
vote of our board of directors or by stockholders holding shares of
our common stock representing in the aggregate a majority of votes
then outstanding, which could delay the ability of our stockholders
to force consideration of a proposal or to take action, including
the removal of directors; and |
|
· |
the ability of our
board of directors, by majority vote, to amend our bylaws, which
may allow our board of directors to take additional actions to
prevent a hostile acquisition and inhibit the ability of an
acquirer to amend our by-laws to facilitate a hostile
acquisition. |
Delaware Anti-Takeover Statute
Under Section 203 of the General Corporation Law of the State of
Delaware (the “DGCL”), a corporation may not, in general,
engage in a business combination with any holder of 15% or more of
its capital stock unless the holder has held the stock for three
years or (i) our board of directors approves the transaction prior
to the stockholder acquiring the 15% ownership position, (ii) upon
consummation of the transaction that resulted in the stockholder
acquiring the 15% ownership position, the stockholder owns at least
85% of the outstanding voting stock (excluding shares owned by
directors or officers and shares owned by certain employee stock
plans) or (iii) the transaction is approved by the board of
directors and by the stockholders at an annual or special meeting
by a vote of 66 2/3% of the outstanding voting stock (excluding
shares held or controlled by the interested stockholder). In
general, Section 203 defines an interested stockholder as any
entity or person beneficially owning 15% or more of the outstanding
voting stock of the corporation and any entity or person affiliated
with or controlling or controlled by any such entity or person.
A Delaware corporation may opt out of this provision by express
provision in its original certificate of incorporation or by
amendment to its certificate of incorporation or by-laws approved
by its stockholders. We have opted out of Section 203.
Authorized but Unissued Shares
Our authorized but unissued shares of Common Stock and Preferred
Stock will be available for future issuance without stockholder
approval, except as may be required under the listing rules of any
stock exchange on which our Common Stock is then listed. We may use
additional shares for a variety of corporate purposes, including
future public offerings to raise additional capital, corporate
acquisitions and employee benefit plans. The existence of
authorized but unissued shares of Common Stock and Preferred Stock
could render more difficult or discourage an attempt to obtain
control of us by means of a proxy contest, tender offer, merger or
otherwise.
Limitations on Liability and Indemnification of Officers and
Directors
Under our Certificate of Incorporation, our directors have no
personal liability to us or our stockholders for monetary damages
for breach of fiduciary duty as a director, except (i) for any
breach of the duty of loyalty to the Company or its stockholders,
(ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii) under
Section 174 of the DGCL as it may from time to time be amended or
any successor provision thereto, or (iv) for any transaction from
which a director derives an improper personal benefit.
PLAN OF
DISTRIBUTION
The common stock offered by this prospectus is being offering by
the Selling Security Holder. The common stock may be sold or
distributed from time to time by the Selling Share Holder directly
to one or more purchasers or through brokers, dealers, or
underwriters who may act solely as agents at market price
prevailing at the time of sale, at prices related to the prevailing
market prices, at negotiated prices , or at fixed prices, which may
be changed . The Selling Security Holder may use any one or more of
the following methods when selling securities:
|
· |
ordinary brokers’ transactions; |
|
· |
transactions involving cross or block
trades; |
|
· |
through brokers, dealers, or underwriters may act
solely as agents; |
|
· |
“at
the market” into an existing market for the common
stock; |
|
· |
in
other ways not involving market makers or established business
markets, including direct sales to purchasers or sales effected
through agents; |
|
· |
in
privately negotiated transactions; or |
|
· |
any
combination of the foregoing. |
In order to comply with the securities laws of certain states, if
applicable, the shares may be sold only through registered or
licensed brokers or dealers. In addition, in certain states, the
shares may not be sold unless they have been registered or
qualified for sale in the state or an exemption from the state’s
registration or qualification requirement is available and complied
with.
The Selling Security Holder is an “underwriter” within the meaning
of Section 2(a)(11) of the Securities Act.
GHS has informed us that it intends to use an unaffiliated
broker-dealer to effectuate all sales, if any, of the common stock
that it may purchase from us pursuant to the EFA. Such sales will
be made at prices and at terms then prevailing or at prices related
to the then current market price. Each such unaffiliated
broker-dealer will be an underwriter within the meaning of Section
2(a)(11) of the Securities Act. GHS has informed us that each such
broker-dealer will receive commissions from GHS that will not
exceed customary brokerage commissions.
Brokers, dealers, underwriters or agents participating in the
distribution of the shares as agents may receive compensation in
the form of commissions, discounts, or concessions from the Selling
Security Holder and/or purchasers of the common stock for whom the
broker-dealers may act as agent. The compensation paid to a
particular broker-dealer may be less than or in excess of customary
commissions. Neither we nor GHS can presently estimate the amount
of compensation that any agent will receive.
We know of no existing arrangements between GHS or any other
stockholder, broker, dealer, underwriter or agent relating to the
sale or distribution of the shares offered by this prospectus. At
the time a particular offer of shares is made, a prospectus
supplement, if required, will be distributed that will set forth
the names of any agents, underwriters or dealers and any
compensation from the Selling Security Holder, and any other
required information.
We will pay the expenses incident to the registration, offering,
and sale of the shares to GHS. We have agreed to indemnify GHS and
certain other persons against certain liabilities in connection
with the offering of shares of common stock offered hereby,
including liabilities arising under the Securities Act or, if such
indemnity is unavailable, to contribute amounts required to be paid
in respect of such liabilities. GHS has agreed to indemnify us
against liabilities under the Securities Act that may arise from
certain written information furnished to us by GHS specifically for
use in this prospectus or, if such indemnity is unavailable, to
contribute amounts required to be paid in respect of such
liabilities.
GHS has represented to us that at no time prior to the EFA has GHS
or its agents, representatives or affiliates engaged in or
effected, in any manner whatsoever, directly or indirectly, any
short sale (as such term is defined in Rule 200 of Regulation SHO
of the Exchange Act) of our common stock or any hedging transaction
, which establishes a net short position with respect to our common
stock. GHS agreed that during the term of the EFA, it, its agents,
representatives or affiliates will not enter into or effect,
directly or indirectly, any of the foregoing transactions.
We have advised GHS that it is required to comply with Regulation M
promulgated under the Exchange Act. With certain exceptions,
Regulation M precludes the selling stockholder, any affiliated
purchasers, and any broker-dealer or other person who participates
in the distribution from bidding for or purchasing, or attempting
to induce any person to bid for or purchase any security which is
the subject of the distribution until the entire distribution is
complete. Regulation M also prohibits any bids or purchases made in
order to stabilize the price of a security in connection with the
distribution of that security. All of the foregoing may affect the
marketability of the securities offered by this prospectus.
This offering will terminate on the date that all shares offered by
this prospectus have been sold by GHS or November 9, 2023,
whichever occurs sooner.
Our common stock is quoted on the OTC Markets under the symbol
“DPLS.”
The Selling Security Holder is an “underwriter” within the meaning
of Section 2(a)(11) of the Securities Act.
The Selling Security Holder and any broker-dealers or agents that
are involved in selling the securities may be deemed to be
“underwriters” within the meaning of the Securities Act in
connection with such sales. In such event, any commissions received
by such broker-dealers or agents and any profit on the resale of
the securities purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. The Selling
Security Holder has informed us that it does not have any written
or oral agreement or understanding, directly or indirectly, with
any person to distribute the securities.
Because the Selling Security Holder is deemed to be an
“underwriter” within the meaning of the Securities Act, it will be
subject to the prospectus delivery requirements of the Securities
Act, including Rule 172 thereunder. In addition, any securities
covered by this prospectus which qualify for sale pursuant to Rule
144 under the Securities Act may be sold under Rule 144 rather than
under this prospectus. The Selling Security Holder has advised us
that there is no underwriter or coordinating broker acting in
connection with the proposed sale of the resale securities by the
Selling Security Holder.
We agreed to keep this prospectus effective until the earlier of
(i) the date on which the securities may be resold by the Selling
Security Holder without registration and without regard to any
volume or manner-of-sale limitations by reason of Rule 144, without
the requirement for us to be in compliance with the current public
information requirement under Rule 144 under the Securities Act or
any other rule of similar effect or (ii) all of the securities have
been sold pursuant to this prospectus or Rule 144 under the
Securities Act or any other rule of similar effect. The resale
securities will be sold only through registered or licensed brokers
or dealers if required under applicable state securities laws. In
addition, in certain states, the resale securities covered hereby
may not be sold unless they have been registered or qualified for
sale in the applicable state or an exemption from the registration
or qualification requirement is available and is complied with.
Under applicable rules and regulations under the Exchange Act, any
person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to
the Common Stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In
addition, the Selling Security Holder will be subject to applicable
provisions of the Exchange Act and the rules and regulations
thereunder, including Regulation M, which may limit the timing of
purchases and sales of the Common Stock by the Selling Security
Holder or any other person. We will make copies of this prospectus
available to the Selling Security Holder and have informed the
Selling Security Holder of the need to deliver a copy of this
prospectus to each purchaser at or prior to the time of the sale
(including by compliance with Rule 172 under the Securities
Act).
SHARES ELIGIBLE FOR
FUTURE SALE
The sale of a substantial number of shares of our Common Stock, or
the perception that such sales could occur, could adversely affect
prevailing market prices for our Common Stock. In addition, any
such sale or perception could make it more difficult for us to sell
equity, or equity related, securities in the future at a time and
price that we deem appropriate. If and when this Registration
Statement becomes effective, we might elect to adopt a stock option
plan and file a Registration Statement under the Securities Act
registering the shares of Common Stock reserved for issuance
thereunder. Following the effectiveness of any such Registration
Statement, the shares of Common Stock issued under such plan, other
than shares held by affiliates, if any, would be immediately
eligible for resale in the public market without restriction.
The sale of shares of our Common Stock which are not registered
under the Securities Act, known as “restricted” shares, typically
are effected under Rule 144. As of April 11, 2022, we had
outstanding an aggregate of 5,379,471,416 shares of Common Stock of
which approximately 116,972,640 shares are restricted Common Stock.
All our shares of Common Stock might be sold under Rule 144 after
having been held for six months. No prediction can be made as to
the effect, if any, that future sales of “restricted” shares of our
Common Stock, or the availability of such shares for future sale,
will have on the market price of our Common Stock or our ability to
raise capital through an offering of our equity securities.
SECURITIES
AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
As of December 31, 2021, the Company had no securities authorized
for issuance under equity compensation plans either approved or not
approved by the Company’s shareholders.
CHANGES IN AND
DISAGREEMENTS WITH ACCOUNTANTS
Dismissal of Principal Independent Accountant
On January 24, 2022, we informed Boyle CPA, the Company’s
independent registered public accounting firm (“Boyle”), of
our decision (approved by the Board of Directors) to dismiss Boyle
as our independent registered public accounting firm effective as
of January 24, 2022. Boyle was not dismissed for any cause.
None of the reports of Boyle on our financial statements for the
year ended December 31, 2020 contained an adverse opinion or
disclaimer of opinion, or was qualified or modified as to
uncertainty, audit scope or accounting principles, other
than all such reports
contained statements indicating there is substantial doubt about
our ability to continue as a going concern.
There were no disagreements between the Company and Boyle, for the
fiscal year ended December 31, 2020 and any subsequent interim
period through January 24, 2022 (date of dismissal) on any matter
of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which, if not resolved
to the satisfaction of Boyle, would have caused them to make
reference to the subject matter of the disagreement in connection
with its report.
Engagement of New Principal Independent
Accountant
On January 24, 2022, we engaged Urish Popeck & Co., LLC
(“Urish”) our independent registered public accounting firm
for the year ended December 31, 2021.
During our two most recent fiscal years, and any subsequent interim
period prior to engaging Urish, neither we nor anyone on our behalf
consulted Urish regarding either:
(i) the application of accounting principles to a specified
transaction regarding the Company, either completed or proposed; or
the type of audit opinion that might be rendered on our financial
statements; or (ii) any matter regarding the Company that was
either the subject of a disagreement or a reportable event.
DISCLOSURE OF
COMMISSION POSITION ON INDEMNIFICATION OF SECURITIES ACT
LIABILITIES
We have entered into indemnification agreements with each of our
directors, executive officers and other key employees. The
indemnification agreements will require us to indemnify our
directors to the fullest extent permitted by Delaware law. We have
agreed to indemnify each of our directors and certain officers
against certain liabilities, including liabilities under the
Securities Act. Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to our directors,
officers and controlling persons pursuant to the provisions
described above, or otherwise, we have been advised that in the
opinion of the SEC such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such
liabilities (other than our payment of expenses incurred or paid by
our director, officer or controlling person in the successful
defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the
securities being registered, we will, unless in the opinion of our
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final adjudication
of such issue.
LEGAL
MATTERS
The legality of the issuance of the shares of Common Stock offered
by this Prospectus will be passed upon for us by Business Legal
Advisors, LLC, Draper, Utah.
EXPERTS
No expert or counsel named in this prospectus as having prepared or
certified any part of this prospectus or having given an opinion
upon the validity of the securities being registered or upon other
legal matters in connection with the registration or offering of
the Common Stock was employed on a contingency basis, or had, or is
to receive, in connection with the offering, a substantial
interest, direct or indirect, in the registrant or any of its
parents or subsidiaries. Nor was any such person connected with the
registrant or any of its parents or subsidiaries as a promoter,
managing or principal underwriter, voting trustee, director,
officer, or employee.
The financial statements of DarkPulse, Inc. as of December 31,
2020, which include an explanatory paragraph relating to our
ability to continue as a going concern, included in this Prospectus
have been audited by Boyle, an independent auditor, as stated in
their report appearing herein. Such financial statements have been
so included in reliance upon the reports of such firm given its
authority as experts in accounting and auditing.
The financial statements of DarkPulse, Inc. as of December 31,
2021, which include an explanatory paragraph relating to our
ability to continue as a going concern, included in this Prospectus
have been audited by Urish Popeck & Co., LLC, an independent
auditor, as stated in their report appearing herein. Such financial
statements have been so included in reliance upon the reports of
such firm given its authority as experts in accounting and
auditing.
WHERE YOU CAN FIND
MORE INFORMATION
We have filed a registration statement on Form S-1 under the
Securities Act (SEC File No. 333-261453) relating to the shares of
common stock being offered by this prospectus, and reference is
made to such registration statement. This prospectus constitutes
the prospectus of DarkPulse, Inc., filed as part of the
registration statement, and it does not contain all information in
the registration statement, as certain portions have been omitted
in accordance with the rules and regulations of the SEC.
Upon the effective date of the registration statement of which this
prospectus is a part, we will be required to file reports and other
documents with the SEC. We do not presently intend to voluntarily
furnish you with a copy of our Prospectus. You may read and copy
any materials we file with the SEC at the public reference room of
the SEC at 100 F Street, NE., Washington, DC 20549, between the
hours of 10:00 a.m. and 3:00 p.m., except federal holidays and
official closings, at the Public Reference Room. You may obtain
information on the operation of the Public Reference Room by
calling the SEC at 1-800-SEC-0330. Our SEC filings are also
available to you on the Internet website for the SEC at
http://www.sec.gov.
DARKPULSE, INC.
Index to
Financial Statements
As of December 31, 2021 and 2020
and for the Years Ended December 31, 2021 and 2020
REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
Shareholders and Board of Directors
Of DarkPulse, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheet of
DarkPulse, Inc. and its subsidiaries (the “Company”) as of December
31, 2021, the related consolidated statements of operations,
comprehensive loss, stockholders’ deficit, and cash flows for the
year ended December 31, 2021, and the related notes (collectively
referred to as the consolidated financial statements). In our
opinion, the consolidated financial statements present fairly, in
all material respects, the financial position of the Company at
December 31, 2021, and the results of its operations and its cash
flows for the year ended December 31, 2021, in conformity
with accounting principles generally accepted in the United States
of America.
Substantial Doubt about the Company’s Ability to Continue as a
Going Concern – See also Critical Audit Matters Section
Below
The accompanying consolidated financial statements have been
prepared assuming that the Company will continue as a going
concern. As discussed in Note 3 to the consolidated financial
statements, the Company has suffered recurring losses from
operations and has a net capital deficiency at December 31, 2021.
These conditions raise substantial doubt about its ability to
continue as a going concern. Management’s plans in regard to these
matters are also described in Note 3. The consolidated financial
statements do not include any adjustments that might result from
the outcome of this uncertainty.
Basis for Opinion
These consolidated financial statements are the responsibility of
the Company’s management. Our responsibility is to express an
opinion on the Company’s consolidated financial statements based on
our audits. We are a public accounting firm registered with the
Public Company Accounting Oversight Board (United States) (“PCAOB”)
and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and
the PCAOB.
We conducted our audit in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due
to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an
understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of
the Company’s internal control over financial reporting.
Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of
material misstatement of the consolidated financial statements,
whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a
test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audit also included
evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation
of the consolidated financial statements. We believe that our
audit provides a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising
from the current period audit of the consolidated financial
statements that were communicated or required to be communicated to
the audit committee and that: (1) relate) to accounts or
disclosures that are material to the consolidated financial
statements and (2) involved our especially challenging, subjective,
or complex judgments. The communication of critical audit matters
does not alter in any way our opinion on the consolidated financial
statements, taken as a whole, and we are not, by communicating the
critical audit matters below, providing separate opinions on the
critical audit matters or on the accounts or disclosures to which
they relate.
Accounting for Embedded Derivative Liabilities Related to
Convertible Debentures
As described in Note 6 to the financial statements, the Company had
convertible debentures that required accounting considerations and
significant estimates.
The Company determined that variable conversion features issued in
connection with certain convertible debentures required derivative
liability classification. These variable conversion features were
initially measured at fair value and subsequently have been
remeasured to fair value at each reporting period. The Company
determined the fair value of the embedded derivatives using the
Black-Scholes-Merton option pricing model. The value of the
embedded derivative liabilities related to the convertible
debentures was $533,753 at December 31, 2021.
We identified the accounting considerations and related valuations,
including the related fair value determinations of the embedded
derivative liabilities of such as a critical audit matter.
Our audit procedures related to the Company’s accounting
considerations and significant estimate included the following,
among others:
|
· |
We reviewed the
accounting considerations made by the Company in determining the
nature of the various features; |
|
· |
We evaluated of the
potential derivatives and potential bifurcation in the
instruments; |
|
· |
We evaluated the
determination of the fair value of the various debt and equity
instruments and the conversion features that include valuation
models and assumptions utilized by management against current
accounting guidance. |
|
· |
We tested the
mathematical accuracy of management’s calculations related to the
estimate. |
Auditing these elements is especially challenging and requires
auditor judgement due to the nature and extent of audit effort
required to address these matters, including the extent of
specialized skill or knowledge needed.
Going Concern Uncertainty – See also Going Concern
Uncertainty explanatory paragraph above
As described further in Note 3 to the consolidated financial
statements, the Company has suffered recurring losses from
operations and does not have an established source of revenues
sufficient to cover its operating costs. The ability of the Company
to continue as a going concern is dependent on executing its
business plan and ultimately to attain profitable operations.
Accordingly, the Company has determined that these factors raise
substantial doubt as to the Company’s ability to continue as a
going concern for a period of one year from the issuance of these
financial statements. Management intends to continue to fund its
business by way of public or private offerings of the Company’s
stock or through loans from private investors, in order satisfy the
Company’s obligations as they come due for at least one year from
the financial statement issuance date. However, the Company has not
concluded that these plans alleviate the substantial doubt related
to its ability to continue as a going concern.
We determined the Company’s ability to continue as a going concern
is a critical audit matter due to the estimation and uncertainty
regarding the Company’s available capital and the risk of bias in
management’s judgments and assumptions in their determination. Our
audit procedures related to the Company’s assertion on its ability
to continue as a going concern included the following, among
others:
|
· |
We performed testing
procedures such as analytical procedures to identify
conditions and events that indicate that there could be substantial
doubt about the Company’s ability to continue as a going
concern for a reasonable period of time. |
|
· |
We reviewed and
evaluated management's plans for dealing with adverse effects of
these conditions and events. |
|
· |
We inquired of Company
management and reviewed company records to assess whether there are
additional factors that contribute to the uncertainties
disclosed. |
|
· |
We assessed whether
the Company’s determination that there is substantial doubt about
its ability to continue as a going concern was adequately
disclosed. |
Revenue Recognition
The Company recognizes revenue upon transfer of control of promised
services to customers in an amount that reflects the consideration
the Company expects to receive in exchange for those services.
Significant judgment is exercised by the Company in determining
revenue recognition for customer agreements, and include the
pattern of delivery (i.e., timing of when revenue is recognized)
for each distinct performance obligation.
The related audit effort in evaluating management’s judgments in
determining revenue recognition for customer agreements required a
high degree of auditor judgment.
Our principal audit procedures related to the Company’s revenue
recognition for customer agreements included the following:
|
· |
We gained an
understanding of internal controls related to revenue
recognition. |
|
· |
We evaluated
management’s significant accounting policies for
reasonableness. |
|
· |
We selected a sample
of revenues recognized and performed the following
procedures: |
|
o |
Obtained and read contract source
documents for each selection and other documents that were part of
the agreement, if applicable. |
|
o |
Assessed the terms in the customer
agreement and evaluated the appropriateness of management’s
application of their accounting policies, along with their use of
estimates, in the determination of revenue recognition
conclusions. |
|
o |
We
tested the mathematical accuracy of management’s calculations of
revenue and the associated timing of revenue recognized in the
financial statements. |
Business Combinations – Valuation of Intangible
Assets
As described in note 4 of the Consolidated Financial Statements,
the Company completed the acquisitions of 100% of Optilan Guernsey
Limited and Optilan Holdco 2 Limited (Optilan) and TJM Electronics
West for $694,527 and $450,000, respectively and 60% of Wildlife
Specialists LLC, Remote Intelligence, LLC and TerraData Unmanned,
PLLC for $1,478,000 and $1,478,000, and $600,000 respectively
(collectively referred to as the “Acquisitions”) and accounted for
as business combinations. The acquired intangible assets included
Optilan Holdco 3, Limited tradename for valued at $4,033,638. The
Company recorded the acquired intangible assets at fair value on
the date of acquisition considering a discounted cash flow
methodology. The methods used to estimate the fair value of
acquired intangible assets involve assumptions. The assumptions
applied by management in estimating the fair value of acquired
intangible assets included income projections and discount
rates.
The principal considerations for our determination that performing
procedures relating to the valuation of intangible assets in the
Acquisitions is a critical audit matter are (1) there was a degree
in significant auditor judgement and subjectivity in applying
procedures to the fair value of the intangible assets acquired due
to the judgment by management when developing estimates and (2)
audit effort was required relating to the estimates, projections,
discount rates, and weighted average cost of capital utilized by
the Company. In addition, the audit effort involved the use of
professionals with specialized skill and knowledge to assist in
performing these procedures and evaluating the conclusions.
Our principal audit procedures to evaluate the valuation of
intangible assets included the following:
|
· |
We read the purchase
agreements used in the underlying acquisitions and utilized by the
Company to allocate the purchase price. |
|
· |
We obtained the
valuation reports prepared by management’s third-party
expert. |
|
· |
Utilized professionals
with specialized skill and knowledge to evaluate the reasonableness
of the methodology, assumptions, including the discount rate and
weighted average cost of capital, as compared to their experience
and publically available market data. |
|
· |
Considered the
reasonableness of the overall allocation of the total purchase
price. |
/s/
Urish Popeck & Co., LLC
We have served as the Company's auditor since 2021.
Pittsburgh, PA
April 15, 2022

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
DarkPulse, Inc.
Opinion on the Financial
Statements
We have audited the accompanying consolidated balance sheets of
DarkPulse, Inc. (the “Company”) as of December 31, 2020, the
related consolidated statements of operations, stockholders’
deficit, and cash flows for the year then ended, and the related
notes (collectively referred to as the “financial statements”). In
our opinion, the financial statements present fairly, in all
material respects, the financial position of the Company as of
December 31, 2020, and the results of its operations and its cash
flows for the year then ended, in conformity with accounting
principles generally accepted in the United States of America.
Substantial Doubt About the Company’s
Ability to Continue as a Going Concern
As discussed in Note 3 to the
consolidated financial statements, the Company’s net losses, lack
of revenues, and working capital deficiency raise substantial doubt
about its ability to continue as a going concern for one year from
the issuance of these financial statements. Management’s plans are
also described in Note 3. The financial statements do not include
adjustments that might result from the outcome of this
uncertainty.
Basis of
Opinion
These financial statements are the responsibility of the Company’s
management. Our responsibility is to express an opinion on the
Company’s financial statements based on our audit. We are a public
accounting firm registered with the Public Company Accounting
Oversight Board (United States) (“PCAOB”) and are required to be
independent with respect to the Company in accordance with U.S.
federal securities laws and the applicable rules and regulations of
the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with standards of the Public
Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of
material misstatement, whether due to fraud or error. The Company
is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our
audit we are required to obtain an understanding of internal
control over financial reporting but not for the purpose of
expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express
no such opinion.
Our audit included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial
statements. We believe that our audit provides a reasonable basis
for our opinion.
/s/
Boyle CPA, LLC
We have served as the Company’s auditor from 2019 through 2022
Bayville, NJ
April 15, 2021
DARKPULSE, INC.
Consolidated
Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
3,658,846 |
|
|
$ |
337 |
|
Accounts
receivable, net |
|
|
4,223,990 |
|
|
|
– |
|
Inventory |
|
|
865,019 |
|
|
|
– |
|
Unbilled
revenue |
|
|
497,773 |
|
|
|
– |
|
Other
current assets |
|
|
181,000 |
|
|
|
– |
|
TOTAL CURRENT
ASSETS |
|
|
9,426,628 |
|
|
|
337 |
|
|
|
|
|
|
|
|
|
|
NON-CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Property and
equipment, net |
|
|
2,370,711 |
|
|
|
– |
|
Operating lease
right-of-use assets |
|
|
2,038,106 |
|
|
|
– |
|
Patents, net |
|
|
342,962 |
|
|
|
393,990 |
|
Intangible
assets |
|
|
3,886,588 |
|
|
|
– |
|
Goodwill |
|
|
17,088,501 |
|
|
|
– |
|
Other
assets, net |
|
|
282,884 |
|
|
|
91,464 |
|
TOTAL NON-CURRENT
ASSETS |
|
|
26,009,752 |
|
|
|
485,454 |
|
|
|
|
|
|
|
|
|
|
TOTAL
ASSETS |
|
$ |
35,436,380 |
|
|
$ |
485,791 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' DEFICIT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Accounts payable
and accrued liabilities |
|
$ |
7,844,271 |
|
|
$ |
1,089,869 |
|
Convertible notes,
net of discount $0 and $35,525 respectively |
|
|
378,263 |
|
|
|
931,158 |
|
Notes payable |
|
|
2,000,000 |
|
|
|
– |
|
Customer
deposits |
|
|
2,802,809 |
|
|
|
– |
|
Derivative
liability |
|
|
533,753 |
|
|
|
1,220,877 |
|
Contract
liabilities |
|
|
3,216,562 |
|
|
|
– |
|
Operating lease
liabilities - current |
|
|
747,422 |
|
|
|
– |
|
Other
current liabilities |
|
|
2,024,433 |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
TOTAL
CURRENT LIABILITIES |
|
|
19,547,513 |
|
|
|
3,241,904 |
|
|
|
|
|
|
|
|
|
|
NON-CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Secured
debenture |
|
|
1,172,364 |
|
|
|
1,176,092 |
|
Operating lease
liabilities – non-current |
|
|
2,474,530 |
|
|
|
– |
|
Other
liabilities – non-current |
|
|
676,331 |
|
|
|
– |
|
TOTAL
NON-CURRENT LIABILITIES |
|
|
4,323,225 |
|
|
|
1,176,092 |
|
|
|
|
|
|
|
|
|
|
TOTAL
LIABILITIES |
|
|
23,870,738 |
|
|
|
4,417,996 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
– |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS’ DEFICIT: |
|
|
|
|
|
|
|
|
Convertible preferred stock - Class D (par value $0.01;
100,000
shares authorized; 88,235
issued and outstanding at December 31, 2021 and, 2020,
respectively) |
|
|
883 |
|
|
|
883 |
|
Common
stock (par value $0.0001), 20,000,000,000
shares authorized, 5,197,821,885 and
4,088,762,151
shares issued and outstanding at December 31, 2021 and, 2020,
respectively |
|
|
519,782 |
|
|
|
408,876 |
|
Treasury stock, 100,000 shares at
December 31, 2021 and 2020 |
|
|
(1,000 |
) |
|
|
(1,000 |
) |
Paid-in capital in excess of par
value |
|
|
20,248,703 |
|
|
|
1,805,813 |
) |
Non-controlling
interest in variable interest entity and subsidiary |
|
|
2,358,227 |
|
|
|
(12,439 |
) |
Accumulated other
comprehensive income |
|
|
(284,463 |
) |
|
|
315,832 |
|
Accumulated deficit |
|
|
(11,276,490 |
) |
|
|
(6,450,170 |
) |
|
|
|
|
|
|
|
|
|
TOTAL
STOCKHOLDERS’ DEFICIT |
|
|
11,565,642 |
|
|
|
(3,932,205 |
) |
|
|
|
|
|
|
|
|
|
TOTAL
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
$ |
35,436,380 |
|
|
$ |
485,791 |
|
See accompanying notes to consolidated financial statements.
DARKPULSE, INC.
Consolidated
Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
For
the Year Ended |
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
REVENUES |
|
$ |
7,783,340 |
|
|
$ |
– |
|
COST OF GOODS
SOLD |
|
|
6,685,210 |
|
|
|
– |
|
GROSS PROFIT |
|
|
1,098,130 |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
Selling, general
and administrative |
|
|
3,918,967 |
|
|
|
149,259 |
|
Salaries, wages
and payroll taxes |
|
|
2,653,683 |
|
|
|
187 |
|
Professional
fees |
|
|
2,930,245 |
|
|
|
50,415 |
|
Depreciation and
amortization |
|
|
258,306 |
|
|
|
51,028 |
|
Debt
transaction expenses |
|
|
184,950 |
|
|
|
7,850 |
|
TOTAL
OPERATING EXPENSES |
|
|
9,946,150 |
|
|
|
258,739 |
|
|
|
|
|
|
|
|
|
|
OPERATING
LOSS |
|
|
(8,848,020 |
) |
|
|
(258,739 |
) |
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSE): |
|
|
|
|
|
|
|
|
Interest
expense |
|
|
(130,359 |
) |
|
|
(135,064 |
) |
Gain (Loss) on
change in fair market value of derivative liabilities |
|
|
687,124 |
|
|
|
54,623 |
|
Gain (Loss) on
convertible notes |
|
|
(35,525 |
) |
|
|
(3,889 |
) |
Gain on
forgiveness of debt |
|
|
3,488,860 |
|
|
|
67,227 |
|
Foreign
currency exchange rate variance |
|
|
11,600 |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
TOTAL
OTHER INCOME (EXPENSE) |
|
|
4,021,700 |
|
|
|
(17,103 |
) |
|
|
|
|
|
|
|
|
|
NET LOSS |
|
|
(4,826,320 |
) |
|
|
(275,842 |
) |
Net loss
attributable to non-controlling interests in variable interest
entity and subsidiary |
|
|
133,702 |
|
|
|
– |
|
Net loss
attributable to Company stockholders |
|
$ |
(4,692,618 |
) |
|
$ |
(275,842 |
) |
LOSS PER SHARE |
|
|
|
|
|
|
|
|
Basic
and Diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
WEIGHTED AVERAGE SHARES OUTSTANDING: |
|
|
|
|
|
|
|
|
Basic
and Diluted |
|
|
4,775,929,690 |
|
|
|
2,323,180,245 |
|
See accompanying notes to consolidated financial statements.
DARKPULSE, INC.
Consolidated
Statements of Comprehensive Loss
|
|
|
|
|
|
|
|
|
For
the Year Ended |
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
|
|
|
|
|
|
|
NET LOSS |
|
$ |
(4,692,618 |
) |
|
$ |
(275,842 |
) |
|
|
|
|
|
|
|
|
|
OTHER COMPREHENSIVE LOSS |
|
|
|
|
|
|
|
|
Unrecognized Gain (Loss) on Foreign Exchange |
|
|
26,539 |
|
|
|
(20,943 |
) |
COMPREHENSIVE
LOSS |
|
$ |
(4,666,079 |
) |
|
$ |
(296,785 |
) |
See accompanying notes to consolidated financial statements.
DARKPULSE, INC.
Consolidated
Statement of Stockholders' Deficit
For the Years Ended December 31, 2021 and 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred
Stock |
|
|
Common
Stock |
|
|
Treasury |
|
|
Paid in
Capital in
Excess
of Par |
|
|
Non-
Controlling Interest in |
|
|
Accumulated Other
Comprehensive |
|
|
Accumulated |
|
|
Total Stockholders’ |
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Stock |
|
|
Value |
|
|
Subsidiary |
|
|
Income |
|
|
Deficit |
|
|
Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2019 |
|
|
88,235 |
|
|
$ |
883 |
|
|
|
1,392,042,112 |
|
|
$ |
13,920,421 |
|
|
$ |
(1,000 |
) |
|
$ |
(11,877,864 |
) |
|
$ |
(12,439 |
) |
|
$ |
336,775 |
|
|
$ |
(6,174,328 |
) |
|
$ |
(3,807,552 |
) |
Conversion of convertible notes |
|
|
– |
|
|
|
– |
|
|
|
2,696,720,039 |
|
|
|
26,967,200 |
|
|
|
– |
|
|
|
(26,794,968 |
) |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
172,232 |
|
Change
to Par Value |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(40,478,745 |
) |
|
|
|
|
|
|
40,478,745 |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
Closing
of DarkPulse East LLC |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(100 |
) |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(100 |
) |
Foreign
currency adjustment |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(20,943 |
) |
|
|
– |
|
|
|
(20,943 |
) |
Net
loss |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(275,842 |
) |
|
|
(275,842 |
) |
Balance, December 31, 2020 |
|
|
88,235 |
|
|
$ |
883 |
|
|
|
4,088,762,151 |
|
|
$ |
408,876 |
|
|
$ |
(1,000 |
) |
|
$ |
1,805,813 |
|
|
$ |
(12,439 |
) |
|
$ |
315,832 |
|
|
$ |
(6,450,170 |
) |
|
$ |
(3,932,205 |
) |
Conversion of convertible notes |
|
|
– |
|
|
|
– |
|
|
|
908,659,678 |
|
|
|
90,866 |
|
|
|
– |
|
|
|
1,610,853 |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
1,701,719 |
|
Common
stock issued for cash |
|
|
– |
|
|
|
– |
|
|
|
179,974,598 |
|
|
|
17,997 |
|
|
|
|
|
|
|
14,575,330 |
|
|
|
|
|
|
|
– |
|
|
|
– |
|
|
|
14,593,327 |
|
Common
stock issued for acquisitions |
|
|
– |
|
|
|
– |
|
|
|
15,000,000 |
|
|
|
1,500 |
|
|
|
|
|
|
|
1,654,500 |
|
|
|
2,370,666 |
|
|
|
– |
|
|
|
– |
|
|
|
4,026,666 |
|
Stock
based compensation |
|
|
– |
|
|
|
– |
|
|
|
5,425,453 |
|
|
|
543 |
|
|
|
|
|
|
|
602,207 |
|
|
|
|
|
|
|
– |
|
|
|
– |
|
|
|
602,750 |
|
Foreign
currency adjustment |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
|
|
|
|
– |
|
|
|
– |
|
|
|
(600,295 |
) |
|
|
– |
|
|
|
(600,295 |
) |
Net
loss |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
|
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(4,826,320 |
) |
|
|
(4,826,320 |
) |
Balance, December 31, 2021 |
|
|
88,235 |
|
|
$ |
883 |
|
|
|
5,197,821,885 |
|
|
$ |
519,782 |
|
|
$ |
(1,000 |
) |
|
$ |
20,248,703 |
|
|
$ |
2,358,227 |
|
|
$ |
(284,463 |
) |
|
$ |
(11,276,490 |
) |
|
$ |
11,565,642 |
|
See accompanying notes to consolidated financial statements.
DARKPULSE, INC.
Consolidated
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended
December 31,
|
|
|
|
2021 |
|
|
2020 |
|
CASH FLOWS FROM OPERATING
ACTIVITIES: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(4,826,320 |
) |
|
$ |
(275,842 |
) |
Adjustments to reconcile net loss to
net cash used by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and
amortization |
|
|
129,493 |
|
|
|
86,607 |
|
Loan acquisition
costs |
|
|
(480,450 |
) |
|
|
7,850 |
|
Stock based
compensation |
|
|
602,750 |
|
|
|
– |
|
Gain on reduction
of loan default penalty |
|
|
– |
|
|
|
(9,900 |
) |
Gain on
extinguishment of debt |
|
|
(3,488,860 |
) |
|
|
(67,227 |
) |
Operating lease
expense |
|
|
(1,346,808 |
) |
|
|
– |
|
Amortization of
debt discount |
|
|
515,975 |
|
|
|
51,739 |
|
Derivative
liability |
|
|
(687,124 |
) |
|
|
(54,624 |
) |
Changes in operating assets and
liabilities: |
|
|
|
|
|
|
|
|
Accounts
receivable |
|
|
771,432 |
|
|
|
– |
|
Inventory |
|
|
1,175,869 |
|
|
|
– |
|
Unbilled
revenue |
|
|
822,031 |
|
|
|
– |
|
Contract
liability |
|
|
(922,631 |
) |
|
|
– |
|
Customer
deposits |
|
|
(365,684 |
) |
|
|
– |
|
Accounts payable
and accrued expenses |
|
|
(2,041,131 |
) |
|
|
269,589 |
|
Operating lease
liabilities |
|
|
2,451,692 |
|
|
|
– |
|
Other
current liabilities |
|
|
(3,672,703 |
) |
|
|
– |
|
Net
cash used by operating activities |
|
|
(11,363,470 |
) |
|
|
8,192 |
|
CASH FLOWS FROM INVESTING
ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchases of
property and equipment |
|
|
(754,961 |
) |
|
|
– |
|
Business
acquisitions, net of cash received |
|
|
(583,319 |
) |
|
|
– |
|
Capitalized
patents |
|
|
(191,420 |
) |
|
|
(4,969 |
) |
Deposits |
|
|
(159,453 |
) |
|
|
– |
|
Net
cash used by investing activities |
|
|
(1,689,153 |
) |
|
|
(4,969 |
) |
CASH FLOWS FROM FINANCING
ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from sale
of common stock |
|
|
14,593,327 |
|
|
|
– |
|
Proceeds from
convertible debentures |
|
|
1,102,700 |
|
|
|
40,000 |
|
Repayments of
convertible debentures |
|
|
(384,600 |
) |
|
|
– |
|
Proceeds from
related party notes payable |
|
|
– |
|
|
|
(44,096 |
) |
Proceeds from notes payable |
|
|
2,000,000 |
|
|
|
– |
|
Net
cash provided by financing activities |
|
|
17,311,427 |
|
|
|
(4,096 |
) |
NET INCREASE (DECREASE) IN CASH |
|
|
4,258,804 |
|
|
|
(873 |
) |
Effect of exchange rate on cash |
|
|
(600,295 |
) |
|
|
– |
|
CASH, beginning
of year |
|
|
337 |
|
|
|
1,210 |
|
CASH, end of
year |
|
$ |
3,658,846 |
|
|
$ |
337 |
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION: |
|
|
|
|
|
|
|
|
Cash paid during
the year ended December 31: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
– |
|
|
$ |
– |
|
Income taxes |
|
$ |
– |
|
|
$ |
– |
|
Non-cash finance and investing
activities during the year ended December 31: |
|
|
|
|
|
|
|
|
Issuance of common
stock for convertible notes payable and interest |
|
|
181,560 |
|
|
|
– |
|
Issuance of common
stock for Wildlife Specialists and Remote Intelligence |
|
|
1,654,500 |
|
|
|
– |
|
Non-controlling
interest for Wildlife Specialists and Remote Intelligence |
|
|
2,370,666 |
|
|
|
– |
|
See accompanying notes to consolidated financial statements.
DARKPULSE, INC.
Notes to the
Consolidated Financial Statements
For the Years ended December 31, 2021 and 2020
NOTE 1 – BASIS OF FINANCIAL
STATEMENT PRESENTATION
Organization and Description of Business
DarkPulse, Inc. (“DPI” or “Company”) is a technology-security
company incorporated in 1989 as Klever Marketing, Inc. (“Klever”).
Its’ wholly-owned subsidiary, DarkPulse Technologies Inc. (“DPTI”),
originally started as a technology spinout from the University of
New Brunswick, Fredericton, Canada. The Company’s security and
monitoring systems will initially be delivered in applications for
border security, pipelines, the oil and gas industry and mine
safety. Current uses of fiber optic distributed sensor technology
have been limited to quasi-static, long-term structural health
monitoring due to the time required to obtain the data and its poor
precision. The Company’s patented BOTDA dark-pulse sensor
technology allows for the monitoring of highly dynamic environments
due to its greater resolution and accuracy.
On April 27, 2018, Klever entered into an Agreement and Plan of
Merger (the “Merger Agreement” or the “Merger”) involving Klever as
the surviving parent corporation and acquiring a privately held New
Brunswick corporation known as DarkPulse Technologies Inc. as its
wholly owned subsidiary. On July 18, 2018, the parties closed the
Merger Agreement, as amended on July 7, 2018, and the name of the
Company was subsequently changed to DarkPulse, Inc. With the change
of control of the Company, the Merger is being be accounted for as
a recapitalization in a manner similar to a reverse
acquisition.
On July 20, 2018, the Company filed a Certificate of Amendment to
its Certificate of Incorporation with the State of Delaware,
changing the name of the Company to DarkPulse, Inc. The Company
filed a corporate action notification with the Financial Industry
Regulatory Authority (FINRA), and the Company's ticker symbol was
changed to DPLS.
NOTE 2 – SIGNIFICANT ACCOUNTING
POLICIES
A summary of the significant accounting policies consistently
applied in the preparation of the accompanying financial statements
are as follows:
Basis of
Presentation and Principles of Consolidation
The Company’s consolidated financial statements are prepared in
accordance with accounting principles generally accepted in the
United States (“US GAAP”). The consolidated financial statements of
the Company include the Company and its wholly-owned subsidiaries.
All material intercompany balances and transactions have been
eliminated in consolidation.
Our consolidated financial statements as of December 31, 2021 and
2020 include the accounts of DarkPulse Inc. and its
subsidiaries:
DarkPulse Technologies Inc. (“DPTI”), a New Brunswick, Canada
corporation, a wholly owned subsidiary, incorporated December 16,
2010.
DPTI owns 100% of DarkPulse Technology Holdings Inc., a New York
corporation, incorporated July 6, 2017.
DPTI indirectly owns 37.572% of DarkPulse Technologies
International Inc., ("DPTINY") a New York corporation, incorporated
on September 7, 2017. On or about September 18, 2017, DPTI entered
into a shareholder agreement with three investors, whereby DPTI
would own 50.2% of DPTINY and the investors would own 49.8%. On or
about October 3, 2017, another investor entered into an agreement
with DPTINY to fund it $37,500 for a 0.5% equity interest in
DPTINY. On December 26, 2017, DPTI’s CEO incorporated another
corporation named DarkPulse Technologies International Inc.,
("DPTIDel") in the State of Delaware. On or about April 16, 2018,
seven investors and DPTI entered into a new agreement whereby it
was agreed that the investors would own 62.428% of DPTIDel, and the
September 18, 2017 agreement with respect to DPTINY was considered
null and void. Accordingly, the funding of $37,500 to DPTINY in
October 2017 has been converted to an equity interest in DPTIDel as
of April 2018. As of April 16, 2018, DPTI owns approximately
37.572% of the shares of common stock of DPTIDel and 100% of the
issued shares of Series A Preferred Stock of DPTIDel, pursuant to
which the Company controls both DPTIDel and DPTINY.
On August 9, 2021, the Company entered into a Share Purchase
Agreement with Optilan Guernsey Limited and Optilan Holdco 2
Limited (the “Sellers”), pursuant to which the Company purchased
from the Sellers all of the issued and outstanding equity interests
of Optilan HoldCo 3 Limited, a private company incorporated in
England and Wales (“Optilan”) for £1.00 and also a commitment to
enter into the Subscription (as defined below). As of August 9,
2021, the Company owns all of the equity interests of Optilan.
On August 30, 2021, the Company closed two separate Membership
Interest Purchase Agreements with Remote Intelligence, Limited
Liability Company, a Pennsylvania limited liability company
(“RI”) and Wildlife Specialists, LLC, a Pennsylvania limited
liability company (“WS”) pursuant to which the Company
agreed to pay to the majority shareholder of each of RI and WS an
aggregate of
15,000,000 shares of the Company’s Common Stock and
$1,000,000
in exchange for
60% ownership of each of RI and WS.
On September 8, 2021, the Company entered into and closed the Stock
Purchase Agreement with TJM Electronics West, Inc., an Arizona
corporation (“TJM”), and TJM’s shareholders, pursuant to
which we agreed to purchase all of the equity interests in TJM in
exchange for $450,000.
Effective October 1, 2021 the Company entered into and closed the
Membership Purchase Agreement with TerraData Unmanned, PLLC, a
Florida limited liability company (“TerraData”), and Justin
Dee, the sole shareholder of TerraData, pursuant to which the
Company agreed to purchase
60% of the equity interests in TerraData in exchange for
3,725,386 shares of the Company’s Common Stock and
$400,000.
Use of
Estimates
In preparing the consolidated financial statements, management is
required to make estimates and assumptions that affect the reported
amounts of assets and liabilities as of the date of the statements
of financial condition, and revenues and expenses for the years
then ended. Actual results may differ significantly from those
estimates. Significant estimates made by management include, but
are not limited to, the assumptions used to calculate stock-based
compensation, derivative liabilities, preferred deemed dividend and
common stock issued for services.
Cash and
Cash Equivalents
The Company considers all highly liquid investments with a maturity
of three months or less when acquired to be cash equivalents. The
Company places its cash with high credit quality financial
institutions. The Company’s account at this institution is insured
by the Federal Deposit Insurance Corporation (“FDIC”) up to
$250,000. To reduce its risk associated with the failure of such
financial institution, the Company evaluates at least annually the
rating of the financial institution in which it holds deposits.
Foreign
Currency Translation
The Company’s reporting currency is US Dollars. The accounts of one
of the Company’s subsidiaries is maintained using the appropriate
local currency, British Pound (“GBP”) as the functional currency.
The accounts of one of the Company’s subsidiaries is maintained
using the appropriate local currency, Canadian Dollar (“CAD”) as
the functional currency. All assets and liabilities are translated
into U.S. Dollars at balance sheet date, shareholders' equity is
translated at historical rates and revenue and expense accounts are
translated at the average exchange rate for the year or the
reporting period. The translation adjustments are reported as a
separate component of stockholders’ equity, captioned as
accumulated other comprehensive (loss) gain. Transaction gains and
losses arising from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency are
included in the statements of operations.
The relevant translation rates are as follows: for the year ended
December 31, 2021 closing rate at
1.353583 US$: GBP, average rate at 1.375671
US$:GBP and for the Optilan acquisition closing rate at
1.38138 US$: GBP.
The relevant translation rates are as follows: for the year ended
December 31, 2021 closing rate at 1.2794 US$: CAD,
average rate at 1.2534
US$:CAD and for the year ended December 31, 2020 closing rate at
1.2754 US$: CAD,
average rate at 1.3388
US$:CAD.
Long-Lived Assets and
Goodwill
The Company accounts for long-lived assets in accordance with the
provisions of ASC 360-10-35, Property, Plant and Equipment,
Impairment or Disposal of Long-lived Assets. This accounting
standard requires that long-lived assets be reviewed for impairment
whenever events or changes in circumstances indicate that the
carrying amount may not be recoverable. Recoverability of assets to
be held and used is measured by a comparison of the carrying amount
of an asset to future undiscounted net cash flows expected to be
generated by the asset. If the carrying amount of an asset exceeds
its estimated future cash flows, an impairment charge is recognized
by the amount by which the carrying amount of the asset exceeds the
fair value of the asset.
The Company accounts for goodwill and intangible assets in
accordance with ASC 350, Intangibles – Goodwill and Other. Goodwill
represents the excess of the purchase price of an entity over the
estimated fair value of the assets acquired and liabilities
assumed. ASC 350 requires that goodwill and other intangibles with
indefinite lives be tested for impairment annually or on an interim
basis if events or circumstances indicate that the fair value of an
asset has decreased below its carrying value. During the fourth
quarter of 2020, the Company adopted ASU No. 2017-04, Intangibles –
Goodwill and Other (Topic 350): Simplifying the Test for Goodwill
Impairment. This guidance simplifies the accounting for goodwill
impairment by removing Step 2 of the goodwill impairment test,
which requires a hypothetical purchase price allocation. Goodwill
impairment will now be the amount by which a reporting unit’s
carrying value exceeds its fair value, not to exceed the carrying
amount of goodwill. The adoption of this standard had no material
impact on the Consolidated Financial Statements. During fiscal 2021
and 2020, the Company recorded no impairments.
Intangible
Assets - Intrusion Detection Intellectual Property
The Company relies on patent laws and restrictions on disclosure to
protect its intellectual property rights. As of December 31, 2021,
the Company held three U.S. and foreign patents on its intrusion
detection technology, which expire in calendar years 2025 through
2034 (depending on the payment of maintenance fees).
The DPTI issued patents cover a System and Method for Brillouin
Analysis, a System and Method for Resolution Enhancement of a
Distributed Sensor, and a Flexible Fiber Optic Deformation System
Sensor and Method. Maintenance of intellectual property rights and
the protection thereof is important to our business. Any patents
that may be issued may not sufficiently protect the Company's
intellectual property and third parties may challenge any issued
patents. Other parties may independently develop similar or
competing technology or design around any patents that may be
issued to the Company. The Company cannot be certain that the steps
it has taken will prevent the misappropriation of its intellectual
property, particularly in foreign countries where the laws may not
protect proprietary rights as fully as in the United States.
Further, the Company may be required to enforce its intellectual
property or other proprietary rights through litigation, which,
regardless of success, could result in substantial costs and
diversion of management's attention. Additionally, there may be
existing patents of which the Company is unaware that could be
pertinent to its business, and it is not possible to know whether
there are patent applications pending that the Company's products
might infringe upon, since these applications are often not
publicly available until a patent is issued or published.
For the year ended December 31, 2021, the Company had patent
amortization costs on its intrusion detection technology totaling
$51,028. Patents costs
are being amortized over the remaining life of each patent, which
is from 7 to 16 years.
The DPTI issued patents cover a System and Method for Brillouin
Analysis, a System and Method for Resolution Enhancement of a
Distributed Sensor, and a Flexible Fiber Optic Deformation System
Sensor and Method. Maintenance of intellectual property rights and
the protection thereof is important to our business. Any patents
that may be issued may not sufficiently protect the Company's
intellectual property and third parties may challenge any issued
patents. Other parties may independently develop similar or
competing technology or design around any patents that may be
issued to the Company. The Company cannot be certain that the steps
it has taken will prevent the misappropriation of its intellectual
property, particularly in foreign countries where the laws may not
protect proprietary rights as fully as in the United States.
Further, the Company may be required to enforce its intellectual
property or other proprietary rights through litigation, which,
regardless of success, could result in substantial costs and
diversion of management's attention. Additionally, there may be
existing patents of which the Company is unaware that could be
pertinent to its business, and it is not possible to know whether
there are patent applications pending that the Company's products
might infringe upon, since these applications are often not
publicly available until a patent is issued or published.
The following is a summary of activity related to the DPTI patents
for the year ended December 31, 2021:
Intangible Assets |
|
|
|
|
Balance at January 1, 2021 |
|
$ |
393,990 |
|
Additions |
|
|
– |
|
Amortization |
|
|
(51,028 |
) |
Balance at December 31, 2021 |
|
$ |
342,962 |
|
The following is a summary of the DPTI patents as of December 31,
2021:
|
|
2021 |
|
Historical cost |
|
$ |
904,269 |
|
Accumulated
amortization |
|
|
(561,307 |
) |
Carrying
Value |
|
$ |
342,962 |
|
Future expected amortization of intangible assets is as
follows:
Future expected amortization of intangible
assets |
|
|
|
|
Year Ending December 31, |
|
|
|
2022 |
|
$ |
51,028 |
|
2023 |
|
|
51,028 |
|
2024 |
|
|
51,028 |
|
2025 |
|
|
51,028 |
|
2026 |
|
|
51,028 |
|
Thereafter |
|
|
87,822 |
|
Total |
|
$ |
342,962 |
|
Property
and Equipment
Property and equipment are carried at historical cost less
accumulated depreciation. Depreciation is based on the estimated
service lives of the depreciable assets and is calculated using the
straight-line method. Expenditures that increase the value or
productive capacity of assets are capitalized. Fully depreciated
assets are retained in the property and equipment, and accumulated
depreciation accounts until they are removed from service. When
property and equipment are retired, sold or otherwise disposed of,
the asset’s carrying amount and related accumulated depreciation
are removed from the accounts and any gain or loss is included in
operations. Repairs and maintenance are expensed as incurred.
The estimated useful lives of property and equipment are generally
as follows:
Schedule of estimated useful lives |
|
|
|
|
|
|
Years |
|
Office furniture and
fixtures |
|
|
4 |
|
Plant and equipment |
|
|
4-8 |
|
Leasehold Improvements |
|
|
10 |
|
Motor Vehicles |
|
|
3 |
|
Revenue
Recognition
The Company’s revenues are generated primarily from the sale of our
products, which consist primarily of advanced technology solutions
for integrated communications and security systems. At contract
inception, we assess the goods and services promised in the
contract with customers and identify a performance obligation for
each. To determine the performance obligation, we consider all
products and services promised in the contract regardless of
whether they are explicitly stated or implied by customary business
practices. The timing of satisfaction of the performance obligation
is not subject to significant judgment. We measure revenue as the
amount of consideration expected to be received in exchange for
transferring goods and services. We generally recognize product
revenues at the time of shipment, provided that all other revenue
recognition criteria have been met.
The Company recognizes revenue when its customer obtains control of
promised goods or services, in an amount that reflects the
consideration which we expect to receive in exchange for those
goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of
ASC 606, we perform the following five steps: (i) identify the
contract(s) with a customer; (ii) identify the performance
obligations in the contract; (iii) determine the transaction price;
(iv) allocate the transaction price to the performance obligations
in the contract; and (v) recognize revenue when (or as) we satisfy
a performance obligation. The five-step model is applied to
contracts when it is probable that we will collect the
consideration we are entitled to in exchange for the goods or
services transferred to the customer. At contract inception, once
the contract is determined to be within the scope of ASC 606, we
assess the goods or services promised within each contract and
determine those that are performance obligations and assess whether
each promised good or service is distinct. We then recognize
revenue in the amount of the transaction price that is allocated to
the respective performance obligation when (or as) the performance
obligation is satisfied.
In accordance with ASU No. 2016-12, Revenue from Contracts with
Customers (Topic 606): Narrow-Scope Improvements and Practical
Expedient, which is to (1) clarify the objective of the
collectability criterion for applying paragraph 606-10-25-7; (2)
permit an entity to exclude amounts collected from customers for
all sales (and other similar) taxes from the transaction price; (3)
specify that the measurement date for noncash consideration is
contract inception; (4) provide a practical expedient that permits
an entity to reflect the aggregate effect of all modifications that
occur before the beginning of the earliest period presented when
identifying the satisfied and unsatisfied performance obligations,
determining the transaction price, and allocating the transaction
price to the satisfied and unsatisfied performance obligations; (5)
clarify that a completed contract for purposes of transition is a
contract for which all (or substantially all) of the revenue was
recognized under legacy GAAP before the date of initial
application, and (6) clarify that an entity that retrospectively
applies the guidance in Topic 606 to each prior reporting period is
not required to disclose the effect of the accounting change for
the period of adoption. The amendments of this ASU are effective
for fiscal years beginning after December 15, 2017, and interim
periods within those fiscal years. There was no impact as a result
of adopting this ASU on the financial statements and related
disclosures. Based on the terms and conditions of the product
arrangements, the Company believes that its products and services
can be accounted for separately as its products and services have
value to the Company’s customers on a stand-alone basis. When a
transaction involves more than one product or service, revenue is
allocated to each deliverable based on its relative fair value;
otherwise, revenue is recognized as products are delivered or as
services are provided over the term of the customer contract.
Contract liabilities is shown separately in the unaudited
consolidated balance sheets as current liabilities. At December 31,
2021 and December 31, 2020, we had contract liabilities of
$3,216,562 and $0, respectively.
Cost of
Product Sales and Services
Cost of sales consists primarily of materials, airtime and overhead
costs incurred internally and amounts incurred to contract
manufacturers to produce our products, airtime and other
implementation costs incurred to install our products and train
customer personnel, and customer service and third-party original
equipment manufacturer costs to provide continuing support to our
customers. There are certain costs which are deferred and recorded
as prepaids, until such revenue is recognized. Refer to revenue
recognition above as to what constitutes deferred revenue.
Concentration of Credit
Risk
The Company has no significant concentrations of credit risk.
Related
Parties
The Company accounts for related party transactions in accordance
with ASC 850 (“Related Party Disclosures”). A party is considered
to be related to the Company if the party directly or indirectly or
through one or more intermediaries, controls, is controlled by, or
is under common control with the Company. Related parties also
include principal owners of the Company, its management, members of
the immediate families of principal owners of the Company and its
management and other parties with which the Company may deal if one
party controls or can significantly influence the management or
operating policies of the other to an extent that one of the
transacting parties might be prevented from fully pursuing its own
separate interests. A party which can significantly influence the
management or operating policies of the transacting parties or if
it has an ownership interest in one of the transacting parties and
can significantly influence the other to an extent that one or more
of the transacting parties might be prevented from fully pursuing
its own separate interests is also a related party.
Leases
Effective January 1, 2019, the Company accounts for its leases
under ASC 842, Leases. Under this guidance, arrangements
meeting the definition of a lease are classified as operating or
financing leases, and are recorded on the consolidated balance
sheet as both a right of use asset and lease liability, calculated
by discounting fixed lease payments over the lease term at the rate
implicit in the lease or the Company’s incremental borrowing rate.
Lease liabilities are increased by interest and reduced by payments
each period, and the right of use asset is amortized over the lease
term. For operating leases, interest on the lease liability and the
amortization of the right of use asset result in straight-line rent
expense over the lease term. For finance leases, interest on the
lease liability and the amortization of the right of use asset
results in front-loaded expense over the lease term. Variable lease
expenses are recorded when incurred.
In calculating the right of use asset and lease liability, the
Company has elected to combine lease and non-lease components. The
Company excludes short-term leases having initial terms of 12
months or less from the new guidance as an accounting policy
election, and recognizes rent expense on a straight-line basis over
the lease term.
Derivative Financial
Instruments
The Company evaluates the embedded conversion feature within its
convertible debt instruments under ASC 815-15 and ASC 815-40 to
determine if the conversion feature meets the definition of a
liability and, if so, whether to bifurcate the conversion feature
and account for it as a separate derivative liability. For
derivative financial instruments that are accounted for as
liabilities, the derivative instrument is initially recorded at its
fair value and is then re-valued at each reporting date, with
changes in the fair value reported in the statements of operations.
For stock-based derivative financial instruments, the Company uses
a lattice model, in accordance with ASC 815-15 “Derivative and
Hedging” to value the derivative instruments at inception and on
subsequent valuation dates. The classification of derivative
instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each
reporting period. Derivative instrument liabilities are classified
in the balance sheet as current or non-current based on whether
net-cash settlement of the derivative instrument could be required
within 12 months after the balance sheet date.
Beneficial Conversion
Features
The Company evaluates the conversion feature for whether it was
beneficial as described in ASC 470-30. The intrinsic value of a
beneficial conversion feature inherent to a convertible note
payable, which is not bifurcated and accounted for separately from
the convertible note payable and may not be settled in cash upon
conversion, is treated as a discount to the convertible note
payable. This discount is amortized over the period from the date
of issuance to the date the note is due using the effective
interest method. If the note payable is retired prior to the end of
its contractual term, the unamortized discount is expensed in the
period of retirement to interest expense. In general, the
beneficial conversion feature is measured by comparing the
effective conversion price, after considering the relative fair
value of detachable instruments included in the financing
transaction, if any, to the fair value of the shares of common
stock at the commitment date to be received upon conversion.
Fair
Value of Financial Instruments
The Company measures its financial assets and liabilities in
accordance with the requirements of FASB ASC 820, “Fair Value
Measurements and Disclosures”. As defined in FASB ASC 820, the fair
value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market
participants at the measurement date (exit price). The Company
utilized the market data of similar entities in its industry or
assumptions that market participants would use in pricing the asset
or liability, including assumptions about risk and the risks
inherent in the inputs to the valuation technique. These inputs can
be readily observable, market corroborated, or generally
unobservable. The Company classifies fair value balances based on
the observability of those inputs. FASB ASC 820 established a fair
value hierarchy that prioritizes the inputs used to measure fair
value. The hierarchy gives the highest priority to unadjusted
quoted prices in active markets for identical assets or liabilities
(level 1 measurement) and the lowest priority to unobservable
inputs (level 3 measurement) as follows:
Level 1 – Quoted prices are available in active markets for
identical assets or liabilities as of the reporting date. Active
markets are those in which transactions for the asset or liability
occur in sufficient frequency and volume to provide pricing
information on an ongoing basis. Level 1 primarily consists of
financial instruments such as exchange-traded derivatives,
marketable securities and listed equities.
Level 2 – Pricing inputs are other than quoted prices in active
markets included in level 1, which are either directly or
indirectly observable as of the reported date and includes those
financial instruments that are valued using models or other
valuation methodologies. These models are primarily
industry-standard models that consider various assumptions,
including quoted forward prices for commodities, time value,
volatility factors, and current market and contractual prices for
the underlying instruments, as well as other relevant economic
measures. Substantially all of these assumptions are observable in
the marketplace throughout the full term of the instrument, can be
derived from observable data or are supported by observable levels
at which transactions are executed in the marketplace. Instruments
in this category generally include non-exchange-traded derivatives
such as commodity swaps, interest rate swaps, options and
collars.
Level 3 – Pricing inputs include significant inputs that are
generally less observable from objective sources. These inputs may
be used with internally developed methodologies that result in
management’s best estimate of fair value.
Income
Taxes
The Company accounts for income taxes pursuant to the provision of
ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”) which
requires, among other things, an asset and liability approach to
calculating deferred income taxes. The asset and liability approach
requires the recognition of deferred tax assets and liabilities for
the expected future tax consequences of temporary differences
between the carrying amounts and the tax bases of assets and
liabilities. A valuation allowance is provided to offset any net
deferred tax assets for which management believes it is more likely
than not that the net deferred asset will not be realized.
The Company follows the provision of ASC 740-10 related to
Accounting for Uncertain Income Tax Positions. When tax returns are
filed, there may be uncertainty about the merits of positions taken
or the amount of the position that would be ultimately sustained.
In accordance with the guidance of ASC 740-10, the benefit of a tax
position is recognized in the financial statements in the period
during which, based on all available evidence, management believes
it is more likely than not that the position will be sustained upon
examination, including the resolution of appeals or litigation
processes, if any. Tax positions taken are not offset or aggregated
with other positions.
Tax positions that meet the more likely than not recognition
threshold are measured at the largest amount of tax benefit that is
more than 50 percent likely of being realized upon settlement with
the applicable taxing authority. The portion of the benefit
associated with tax positions taken that exceed the amount measured
as described above should be reflected as a liability for uncertain
tax benefits in the accompanying balance sheet along with any
associated interest and penalties that would be payable to the
taxing authorities upon examination.
The Company believes its tax positions are all more likely than not
to be upheld upon examination. As such, the Company has not
recorded a liability for uncertain tax benefits.
The Company has adopted ASC 740-10-25, “Definition of Settlement”,
which provides guidance on how an entity should determine whether a
tax position is effectively settled for the purpose of recognizing
previously unrecognized tax benefits and provides that a tax
position can be effectively settled upon the completion and
examination by a taxing authority without being legally
extinguished. For tax positions considered effectively settled, an
entity would recognize the full amount of tax benefit, even if the
tax position is not considered more likely than not to be sustained
based solely on the basis of its technical merits and the statute
of limitations remains open. The federal and state
income tax returns of the Company are subject to examination by the
IRS and state taxing authorities, generally for three years after
they are filed.
The Company's U.S. subsidiaries were incorporated in 2017, and tax
returns have not yet been filed. The Company does not anticipate a
tax liability for the years 2021 and 2020. The Company has filed
tax returns in Canada for the year ended December 31, 2018, and
they are still subject to audit.
Stock-based
Compensation
Stock-based compensation is accounted for based on the requirements
of the Share-Based Payment Topic of ASC 718 which requires
recognition in the consolidated financial statements of the cost of
employee and director services received in exchange for an award of
equity instruments over the period the employee or director is
required to perform the services in exchange for the award
(presumptively, the vesting period). The ASC also requires
measurement of the cost of employee and director services received
in exchange for an award based on the grant-date fair value of the
award.
Pursuant to ASC Topic 718, for share-based payments to consultants
and other third-parties, compensation expense is determined at the
“measurement date.” The expense is recognized over the vesting
period of the award. Until the measurement date is reached, the
total amount of compensation expense remains uncertain. The Company
initially records compensation expense based on the fair value of
the award at the reporting date. Further, ASC Topic 718, provides
guidance about which changes to the terms or conditions of a
share-based payment award require an entity to apply modification
accounting in Topic 718, such as the repricing of share options,
which would revalue those options and the accounting for the
cancellation of an equity award whether a replacement award or
other valuable consideration is issued in conjunction with the
cancellation. If not, the cancellation is viewed as a replacement
and not a modification, with a repurchase price of $0.
Income
(Loss) Per Common Share
The Company accounts for earnings per share pursuant to ASC 260,
Earnings per Share, which requires disclosure on the financial
statements of "basic" and "diluted" earnings (loss) per share.
Basic earnings (loss) per share are computed by dividing net income
(loss) by the weighted average number of common shares outstanding
for the year. Diluted earnings (loss) per share is computed by
dividing net income (loss) by the weighted average number of common
shares outstanding plus common stock equivalents (if dilutive)
related to stock options and warrants for each year. In periods
where the Company has a net loss, all dilutive securities are
excluded.
Schedule of antidilutive shares |
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
December 31, 2020 |
|
Convertible preferred
stock |
|
|
– |
|
|
|
– |
|
Stock Options |
|
|
– |
|
|
|
– |
|
Stock
Warrants |
|
|
– |
|
|
|
– |
|
Recently
Issued Accounting Pronouncements
In October 2016, the FASB issued ASU 2016-16, “Income Taxes
(Topic 740): Intra-Entity Transfers of Assets Other than
Inventory”, which eliminates the exception that prohibits the
recognition of current and deferred income tax effects for
intra-entity transfers of assets other than inventory until the
asset has been sold to an outside party. The updated guidance is
effective for annual periods beginning after December 15, 2019,
including interim periods within those fiscal years. Early adoption
of the update is permitted. The adoption of ASU 2016-16 did not
have a material impact on the consolidated financial
statements.
In January 2017, the FASB issued ASU 2017-04
Intangibles-Goodwill and Other (“ASC 350”): Simplifying the
Accounting for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04
simplifies the subsequent measurement of goodwill by eliminating
Step 2 from the goodwill impairment test. In computing the implied
fair value of goodwill under Step 2, an entity had to perform
procedures to determine the fair value at the impairment testing
date of its assets and liabilities (including unrecognized assets
and liabilities) following the procedure that would be required in
determining the fair value of assets acquired and liabilities
assumed in a business combination. Instead, under ASU 2017-04, an
entity should perform its annual or interim goodwill impairment
test by comparing the fair value of a reporting unit with its
carrying amount. An entity should recognize an impairment charge
for the amount by which the carrying amount exceeds the reporting
unit’s fair value; however, the loss recognized should not exceed
the total amount of goodwill allocated to that reporting unit.
Additionally, an entity should consider income tax effects from any
tax-deductible goodwill on the carrying amount of the reporting
unit when measuring the goodwill impairment loss, if applicable.
ASU 2017-04 is effective for annual or any interim goodwill
impairment tests for fiscal years beginning after December 15,
2019. The adoption of ASU 2017-04 did not have a material impact on
the consolidated financial statements.
In July 2021, the FASB issued ASU No. 2021-05, Lessors—Certain
Leases with Variable Lease Payments (Topic 842), Which requires
a lessor to classify a lease with variable lease payments that do
not depend on an index or rate (hereafter referred to as “variable
payments”) as an operating lease on the commencement date of the
lease if specified criteria are met. ASU 2021-05 is effective for
the fiscal year beginning after December 15, 2022, including
interim periods within that fiscal year. The Company expects that
there would be no material impact on the Company’s condensed
consolidated financial statements upon the adoption of this
ASU.
In November 2021, the FASB issued ASU No. 2021-08, Business
Combinations (Topic 805): Accounting for Contract Assets and
Contract Liabilities from Contracts with Customers, issued by
the Financial Accounting Standards Board. This ASU requires
entities to recognize and measure contract assets and contract
liabilities acquired in a business combination in accordance with
ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The
update will generally result in the recognition of contract assets
and contract liabilities at amounts consistent with those recorded
by the acquiree immediately before the acquisition date rather than
at fair value. The Company expects that there would be no material
impact on the Company’s condensed consolidated financial statements
upon the adoption of this ASU.
Although there are several other new accounting pronouncements
issued or proposed by the FASB, which the Company has adopted or
will adopt, as applicable, the Company does not believe any of
these accounting pronouncements has had or will have a material
impact on its financial position or results of operations.
NOTE 3 – GOING
CONCERN
As shown in the accompanying financial statements, the Company
generated net losses of $4,826,320
and $275,842
during the years ended December 31, 2021 and 2020, respectively. As
of December 31, 2021, the Company’s current liabilities exceeded
its current assets by $10,120,885. As of December 31, 2021,
the Company had $3,658,846 of cash.
The Company will require additional funding during the next twelve
months to finance the growth of its current operations and achieve
its strategic objectives. These factors, as well as the uncertain
conditions that the Company faces relative to capital raising
activities, create substantial doubt as to the Company’s ability to
continue as a going concern. The Company is seeking to raise
additional capital principally through private placement offerings
and is targeting strategic partners in an effort to finalize the
development of its products and begin generating revenues. The
ability of the Company to continue as a going concern is dependent
upon the success of future capital offerings or alternative
financing arrangements or expansion of its operations. The
accompanying financial statements do not include any adjustments
that might be necessary should the Company be unable to continue as
a going concern. Management is actively pursuing additional sources
of financing sufficient to generate enough cash flow to fund its
operations through calendar year 2022. However, management cannot
make any assurances that such financing will be secured.
NOTE 4 – BUSINESS
ACQUISITIONS
Optilan Holdco 3 Limited
On August 9, 2021, the Company entered into a Share Purchase
Agreement with Optilan Guernsey Limited and Optilan Holdco 2
Limited (the “Sellers”), pursuant to which the Company purchased
from the Sellers all of the issued and outstanding equity interests
of Optilan HoldCo 3 Limited, a private company incorporated in
England and Wales (“Optilan”) for £1.00 and also a commitment to
enter into the Subscription (as defined below). As of August 9,
2021, the Company owns all of the equity interests of Optilan.
The Company has accounted for the purchase using the acquisition
method of accounting for business combinations under ASC 805.
Accordingly, the purchase price has been allocated to the
underlying assets and liabilities in proportion to their respective
fair values. The excess of the consideration transferred over the
estimated fair values of the net assets acquired was recorded as
goodwill. The following table summarizes the acquired assets and
assumed liabilities for the fair value of the assets and
liabilities recognized in the Condensed Consolidated Balance Sheet
at December 31, 2021:
Schedule of fair value of assets and liabilities in
acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in US$’s) |
|
|
Amounts Recognized as of Acquisition Date |
|
|
|
Measurement Period Adjustments (1) |
|
|
Fair Value |
|
Cash |
|
$ |
736,177 |
|
|
$ |
(6,000 |
) |
|
$ |
730,177 |
|
Accounts receivable |
|
|
4,619,381 |
|
|
|
– |
|
|
|
4,619,381 |
|
Inventory |
|
|
2,040,887 |
|
|
|
– |
|
|
|
2,040,887 |
|
Property & equipment |
|
|
1,393,274 |
|
|
|
– |
|
|
|
1,393,274 |
|
Right-of-use assets |
|
|
1,385,825 |
|
|
|
(694,527 |
) |
|
|
691,298 |
|
Unbilled revenue |
|
|
540,321 |
|
|
|
779,483 |
|
|
|
1,319,804 |
|
Intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Trade name |
|
|
– |
|
|
|
4,033,638 |
|
|
|
4,033,638 |
|
Goodwill |
|
|
12,181,350 |
|
|
|
(1,830,489 |
) |
|
|
10,350,861 |
|
Total assets |
|
|
22,891,215 |
|
|
|
2,288,105 |
|
|
|
25,179,320 |
|
Accounts payable |
|
|
11,622,018 |
|
|
|
(174,846 |
) |
|
|
11,447,172 |
|
Contract deposits |
|
|
3,168,493 |
|
|
|
– |
|
|
|
3,168,493 |
|
Contract liabilities, current |
|
|
4,139,193 |
|
|
|
– |
|
|
|
4,139,193 |
|
Lease liabilities, current |
|
|
141,730 |
|
|
|
– |
|
|
|
141,730 |
|
Other current liabilities |
|
|
2,496,725 |
|
|
|
3,157,478 |
|
|
|
5,654,203 |
|
Lease
liabilities, noncurrent |
|
|
628,529 |
|
|
|
– |
|
|
|
628,529 |
|
Total purchase
consideration |
|
$ |
694,527 |
|
|
$ |
(694,527 |
) |
|
$ |
– |
|
Wildlife Specialists, LLC and Remote Intelligence,
LLC
On August 30, 2021, the Company closed two separate Membership
Interest Purchase Agreements (the “MPAs”) with Remote
Intelligence, Limited Liability Company, a Pennsylvania limited
liability company (“RI”) and Wildlife Specialists, LLC, a
Pennsylvania limited liability company (“WS”) pursuant to
which the Company agreed to pay to the majority shareholder of each
of RI and WS an aggregate of
15,000,000 shares of the Company’s Common Stock, $500,000 to
be paid on the closing date, and an additional $500,000 to be paid
12 weeks from closing date in exchange for
60% ownership of each of RI and WS. RI and WS are now
subsidiaries of the Company.
The Company has accounted for the purchase using the acquisition
method of accounting for business combinations under ASC 805.
Accordingly, the purchase price has been allocated to the
underlying assets and liabilities in proportion to their respective
fair values. The excess of the consideration transferred over the
estimated fair values of the net assets acquired was recorded as
goodwill. The following table summarizes the acquired assets and
assumed liabilities for the fair value of the assets and
liabilities recognized in the Condensed Consolidated Balance Sheet
at December 31, 2021:
Schedule of Condensed Consolidated Balance
Sheet |
|
|
|
|
WILDLIFE SPECIALISTS |
|
|
|
|
|
Consideration |
|
Cash |
|
$ |
500,000 |
|
Common
stock |
|
|
978,000 |
|
Purchase
price |
|
$ |
1,478,000 |
|
The allocation of the total purchase price to the tangible and
intangible assets acquired and liabilities assumed by DarkPulse
based on the estimated fair values as of August 29, 2021 was as
follows:
Schedule of fair value of assets and liabilities in
acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
WILDLIFE SPECIALISTS |
|
|
Amounts |
|
|
|
Measurement |
|
|
|
|
(Amounts in US$’s) |
|
|
Recognized as
of
Acquisition
Date
|
|
|
|
Period
Adjustments
(1)
|
|
|
Fair Value |
|
Cash |
|
$ |
33,910 |
|
|
$ |
(6,098 |
) |
|
$ |
27,812 |
|
Accounts receivable |
|
|
161,866 |
|
|
|
170,486 |
|
|
|
332,352 |
|
Other current assets |
|
|
600 |
|
|
|
20,947 |
|
|
|
21,547 |
|
Property & equipment |
|
|
99,490 |
|
|
|
(77,945 |
) |
|
|
21,545 |
|
Goodwill |
|
|
1,191,085 |
|
|
|
1,597,593 |
|
|
|
2,788,678 |
|
Total assets |
|
|
1,486,951 |
|
|
|
1,704,983 |
|
|
|
3,191,934 |
|
Assumed liabilities |
|
|
393,651 |
|
|
|
334,950 |
|
|
|
728,601 |
|
Non-controlling interest |
|
|
– |
|
|
|
985,333 |
|
|
|
985,333 |
|
Total
Consideration for 60% of equity interests |
|
$ |
1,478,000 |
|
|
$ |
– |
|
|
$ |
1,478,000 |
|
Schedule of Condensed Consolidated Balance
Sheet |
|
|
|
|
REMOTE INTELLIGENCE |
|
|
|
|
|
Consideration |
|
Cash |
|
$ |
500,000 |
|
Common
stock |
|
|
978,000 |
|
Purchase
price |
|
$ |
1,478,000 |
|
The allocation of the total purchase price to the tangible and
intangible assets acquired and liabilities assumed by the Company
based on the estimated fair values as of August 29, 2021 was as
follows:
Schedule of fair value of assets and liabilities in
acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
REMOTE INTELLIGENCE |
|
|
Amounts |
|
|
|
|
|
|
|
|
(Amounts in US$’s) |
|
|
Recognized
as of
Acquisition
Date
|
|
|
|
Measurement
Period
Adjustments
(1)
|
|
|
Fair Value |
|
Cash |
|
$ |
6,158 |
|
|
$ |
(5,800 |
) |
|
$ |
358 |
|
Accounts receivable |
|
|
24,036 |
|
|
|
16,024 |
|
|
|
40,060 |
|
Property & equipment |
|
|
111,636 |
|
|
|
76,710 |
|
|
|
188,346 |
|
Goodwill |
|
|
1,729,800 |
|
|
|
1,080,103 |
|
|
|
2,809,903 |
|
Total assets |
|
|
1,871,630 |
|
|
|
1,167,037 |
|
|
|
3,038,667 |
|
Assumed liabilities |
|
|
393,630 |
|
|
|
181,704 |
|
|
|
575,334 |
|
Non-controlling
interest |
|
|
– |
|
|
|
985,333 |
|
|
|
985,333 |
|
Total
Consideration for 60% of equity interests |
|
$ |
1,478,000 |
|
|
$ |
– |
|
|
$ |
1,478,000 |
|
TJM Electronics West, Inc.
On September 8, 2021, the Company entered into and closed the Stock
Purchase Agreement with TJM Electronics West, Inc., an Arizona
corporation (“TJM”), and TJM’s shareholders, pursuant to
which we agreed to purchase all of the equity interests in TJM in
exchange for $450,000.
TJM is now a wholly-owned subsidiary of the Company.
The Company has accounted for the purchase using the acquisition
method of accounting for business combinations under ASC 805.
Accordingly, the purchase price has been allocated to the
underlying assets and liabilities in proportion to their respective
fair values. The excess of the consideration transferred over the
estimated fair values of the net assets acquired was recorded as
goodwill. The following table summarizes the acquired assets and
assumed liabilities for the fair value of the assets and
liabilities recognized in the Condensed Consolidated Balance Sheet
at December 31, 2021:
Schedule of fair value of assets and liabilities in
acquisition |
|
|
|
|
|
|
Fair Value |
|
Accounts receivable |
|
$ |
3,400 |
|
Property & equipment |
|
|
91,051 |
|
Goodwill |
|
|
355,549 |
|
Total assets |
|
|
450,000 |
|
Total
Consideration |
|
$ |
450,000 |
|
TerraData Unmanned, PLLC.
Effective October 1, 2021 the Company entered into and closed the
Membership Purchase Agreement (the “TerraData MPA”) with
TerraData Unmanned, PLLC, a Florida limited liability company
(“TerraData”), and Justin Dee, the sole shareholder of
TerraData, pursuant to which the Company agreed to purchase
60% of the equity interests in TerraData in exchange for
3,725,386 shares of the Company’s Common Stock and
$400,000,
subject to adjustments as defined in the TerraData MPA, to be paid
within 12 weeks of closing. TerraData is now a subsidiary of the
Company.
The Company has accounted for the purchase using the acquisition
method of accounting for business combinations under ASC 805.
Accordingly, the purchase price has been allocated to the
underlying assets and liabilities in proportion to their respective
fair values. The excess of the consideration transferred over the
estimated fair values of the net assets acquired was recorded as
goodwill. The following table summarizes the acquired assets and
assumed liabilities for the fair value of the assets and
liabilities recognized in the Condensed Consolidated Balance Sheet
at December 31, 2021:
Schedule of Condensed Consolidated Balance
Sheet |
|
|
|
|
|
|
|
|
|
|
|
Consideration |
|
Cash |
|
$ |
400,000 |
|
Common
stock |
|
|
200,000 |
|
Purchase
price |
|
$ |
600,000 |
|
The allocation of the total purchase price to the tangible and
intangible assets acquired and liabilities assumed by the Company
based on the estimated fair values as of October 1, 2021 was as
follows:
Schedule of fair value of assets and liabilities in
acquisition |
|
|
|
|
(Amounts in US$'s) |
|
Fair Value |
|
Cash |
|
$ |
8,691 |
|
Goodwill |
|
|
992,049 |
|
Total assets |
|
|
1,000,740 |
|
Assumed liabilities |
|
|
740 |
|
Non-controlling
interest |
|
|
400,000 |
|
Total
Consideration for 60% of equity interests |
|
$ |
600,000 |
|
Unaudited Supplemental Pro Forma Data
Unaudited pro forma results of operations for the nine months ended
December 31, 2021 and 2020 as though the Company acquired Optilan,
Wildlife Specialists, Remote Intelligence, TJM Electronic West and
TerraData Unmanned (the “Acquired Companies”) on the first day of
each fiscal year are set forth below.
Proforma results of operations
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2021 |
|
|
2020 |
|
Pro forma revenues |
|
$ |
23,329,213 |
|
|
$ |
45,344,847 |
|
Pro forma operating income
(loss) |
|
$ |
11,477,923 |
|
|
$ |
(16,627,266 |
) |
Pro forma net income (loss) |
|
$ |
11,264,238 |
|
|
$ |
(11,308,866 |
) |
Pro forma net income (loss)
attributable to DarkPulse |
|
$ |
11,912,054 |
|
|
$ |
(11,367,321 |
) |
NOTE 5 – REVENUE
The following table is a summary of the Company’s timing of revenue
recognition for the years ended December 31, 2021 and 2020:
Schedule of timing of revenue
recognition |
|
|
|
|
|
|
|
|
|
|
Years
Ended |
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
Timing of revenue recognition: |
|
|
|
|
|
|
Services and products
transferred at a point in time |
|
$ |
7,783,340 |
|
|
$ |
– |
|
Services and
products transferred over time |
|
|
– |
|
|
|
– |
|
Total
revenue |
|
$ |
7,783,340 |
|
|
$ |
– |
|
The Company disaggregates revenue by source and geographic
destination to depict how the nature, amount, timing and
uncertainty of revenue and cash flows are affected by economic
factors.
Revenue by source consisted of the following for the years ended
December 31, 2021 and 2020:
Schedule of revenue by source consisted |
|
|
|
|
|
|
|
|
|
|
Years
Ended |
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
Revenue by products and services: |
|
|
|
|
|
|
|
|
Products |
|
$ |
1,533,378 |
|
|
$ |
– |
|
Services |
|
|
6,249,962 |
|
|
|
– |
|
Total
revenue |
|
$ |
7,783,340 |
|
|
$ |
– |
|
Revenue by geographic destination consisted of the following for
the for the years ended December 31, 2021 and 2020:
Schedule of revenue by geographic
destination |
|
|
|
|
|
|
|
|
|
|
Years
Ended |
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
Revenue by geography: |
|
|
|
|
|
|
|
|
North America |
|
$ |
535,407 |
|
|
$ |
– |
|
International |
|
|
7,247,933 |
|
|
|
– |
|
Total
revenue |
|
$ |
7,783,340 |
|
|
$ |
– |
|
Contract Balances
The Company records contract assets when it has a right to
consideration and records accounts receivable when it has an
unconditional right to consideration. Contract liabilities consist
of cash payments received (or unconditional rights to receive cash)
in advance of fulfilling performance obligations. As of December
31, 2021, the Company did not have a contract assets balance.
The following table is a summary of the Company’s opening and
closing balances of contract liabilities related to contracts with
customers.
Schedule of contract liabilities related to
contracts with customers |
|
|
|
|
|
|
Total |
|
Balance at December 31, 2020 |
|
$ |
– |
|
Additions through advance billings to
or payments from vendors |
|
|
– |
|
Additions through business
acquisition |
|
|
4,139,193 |
|
Revenue recognized from current period
advance billings to or payments from vendors |
|
|
– |
|
Revenue
recognized from amounts acquired through business acquisition |
|
|
(922,631 |
) |
Balance at December 31, 2021 |
|
$ |
3,216,562 |
|
NOTE 6 – CONVERTIBLE DEBT
SECURITIES
The Company uses the Black-Scholes Model to calculate the
derivative value of its convertible debt. The valuation result
generated by this pricing model is necessarily driven by the value
of the underlying common stock incorporated into the model. The
values of the common stock used were based on the price at the date
of issue of the debt security as of December 31, 2021. Management
determined the expected volatility between 475.55-624.25%, a risk
free rate of interest between 0.10-0.13%, and contractual lives of
the debt varying from zero months to eight months. Management made
the determination to use an expected life rather than contractual
life for the calculations for the matured debt as of December 31,
2021. The expected life is equal to the contractual life extended
by one year which vary from two to seven months. The table below
details the Company's outstanding convertible notes, with totals
for the face amount, amortization of discount, initial loss, change
in the fair market value, and the derivative liability.
Schedule of convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Face |
|
|
Debt |
|
|
Initial |
|
|
Change |
|
|
Derivative
Balance |
|
|
|
Amount |
|
|
Discount |
|
|
Loss |
|
|
in FMV |
|
|
12/31/2021 |
|
|
|
$ |
90,228 |
|
|
$ |
– |
|
|
$ |
58,959 |
|
|
$ |
19,840 |
|
|
$ |
128,370 |
|
|
|
|
162,150 |
|
|
|
– |
|
|
|
74,429 |
|
|
|
35,654 |
|
|
|
230,692 |
|
|
|
|
72,488 |
|
|
|
– |
|
|
|
11,381 |
|
|
|
15,938 |
|
|
|
103,130 |
|
|
|
|
53,397 |
|
|
|
– |
|
|
|
7,850 |
|
|
|
(16,767 |
) |
|
|
71,561 |
|
Subtotal |
|
|
378,263 |
|
|
|
– |
|
|
|
152,619 |
|
|
|
54,665 |
|
|
|
533,753 |
|
Transaction
expense |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
$ |
378,263 |
|
|
$ |
– |
|
|
$ |
152,619 |
|
|
$ |
54,665 |
|
|
$ |
533,753 |
|
Financings
On October 7, 2020, the Company entered into a securities purchase
agreement with Geneva Roth Remark Holdings, Inc. (“Geneva”) issuing
to Geneva a convertible promissory note in the aggregate principal
amount of $47,850 with a $4,350 original issue
discount and $3,500 in transactional expenses
due to Geneva and its counsel. The note bears interest at 9% per annum and may be
converted into common shares of the Company's common stock at a
conversion price equal to 70% of the lowest trading price of the
Company's common stock during the 20 prior trading days. The
Company received $40,000 net cash. On
April 16, 2021, Geneva converted $47,850
of principal and $2,153 into
8,065,040 shares of common stock.
On January 4, 2021, the Company entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $42,350 with a $3,850 original issue
discount and $3,500 in transactional expenses
due to Geneva and its counsel. The note bears interest at 8% per annum and may be
converted into common shares of the Company's common stock at a
conversion price equal to 70% of the lowest trading price of the
Company's common stock during the 20 prior trading days. The
Company received $35,000 net cash. On
July 12, 2021, Geneva converted $42,350
of principal and $1,540 into
1,784,146 shares of common stock.
On February 3, 2021, the Company entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $94,200
with a $15,700
original issue discount and $3,500
in transactional expenses due to Geneva and its counsel. The note
bears interest at
4.5% per annum and may be converted into common shares of
the Company's common stock at a conversion price equal to 81% of
the lowest two trading prices of the Company's common stock during
the 10 prior trading days. The Company received $75,000
net cash. On July 14, 2021, the Company repaid $94,200
of principal.
On February 18, 2021, the Company entered into a securities
purchase agreement with Geneva issuing to Geneva a convertible
promissory note in the aggregate principal amount of $76,200 with a $12,700 original issue
discount and $3,500 in transactional expenses
due to Geneva and its counsel. The note bears interest at 4.5% per annum and may be
converted into common shares of the Company's common stock at a
conversion price equal to 81% of the lowest two trading prices of
the Company's common stock during the 10 prior trading days. The
Company received $60,000 net cash. On
July 14, 2021, the Company repaid $76,200
of principal.
On April 5, 2021, the Company entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $64,200 with a $10,700 original issue
discount and $3,500 in transactional expenses
due to Geneva and its counsel. The note bears interest at 4.5% per annum and may be
converted into common shares of the Company's common stock at a
conversion price equal to 81% of the lowest two trading prices of
the Company's common stock during the 10 prior trading days. The
Company received $50,000 net cash. On
July 14, 2021, the Company repaid $64,200 of principal.
On April 26, 2021, the Company entered a Securities Purchase
Agreement and Registration Rights with FIRSTFIRE GLOBAL
OPPORTUNITIES FUND, LLC, a Delaware limited liability company (the
“FirstFire”), pursuant to which the Company issued to
FirstFire a Convertible Promissory Note in the principal amount of
$825,000
(the “FirstFire Note”). The purchase price of the FirstFire
Note is $750,000.
The FirstFire Note matures on
January 26, 2022 upon which time all accrued and unpaid
interest will be due and payable. Interest accrues on the FirstFire
Note at
10% per annum guaranteed until the FirstFire Note becomes
due and payable, whether at maturity or upon acceleration or by
prepayment or otherwise. The FirstFire Note is convertible at any
time after 180 days from issuance, upon the election of the
FirstFire, into shares of the Company’s Common Stock at $0.015
per share. The FirstFire Note is subject to various “Events of
Default,” which are disclosed in the FirstFire Note. Upon the
occurrence of an “Event of Default,” the conversion price would
become $0.005.
On November 17, 2021, FirstFire converted $825,000 of principal and
$61,875 of interest into 177,375,000 shares of common stock.
On December 31, 2021, the Company commenced an action against
FirstFire Global Opportunities Fund, LLC, and Eli Fireman
(“Fireman”) in the United States District Court for the Southern
District of New York. The complaint alleges that FirstFire is an
unregistered dealer acting in violation of Section 15(a) of the
Securities Exchange Act of 1934 (the “Act”), and that the Company
is entitled to rescissionary relief from certain convertible
promissory notes and securities purchase agreements entered into by
the Company and FirstFire pursuant to Section 29(b) of the Act. The
complaint also asserts claims against Fireman for control person
liability under Section 20(a) of the Act, unjust enrichment of
FirstFire, and constructive trust against FirstFire.
On May 19, 2021, the Company entered into a Stipulation of
Settlement with four note holders pursuant to which the Company
agreed to pay $173,000 to the note holders.
On June 3, 2021, the Company entered into a Settlement and Mutual
Release Agreement with Auctus Fund, LLC. Pursuant to the Agreement,
the Auctus agreed to convert the Promissory Note issued on
September 25, 2018 by the Company to the Lender in the principal
amount of $100,000
(the “Auctus Note”) into 12,500,000 shares of the Company’s
Common stock (the “Auctus Shares”) as consideration for full
and complete satisfaction of and settlement of the Auctus Note,
which also terminates all obligations owing under both the Auctus
Note and the corresponding Securities Purchase Agreement dated
September 25, 2018 between the Company and Auctus. Auctus also
agreed to limit the resales of the Auctus Shares in the public
market to no more than
2,500,000 shares per calendar week until all of the Auctus
Shares have been sold.
On July 14, 2021, the Company entered a Securities Purchase
Agreement (the “GS SPA”) with GS Capital Partners, LLC
pursuant to which the Company issued to the Lender a 6% Redeemable
Note in the principal amount of $2,000,000
(the “GS Note”). The purchase price of the GS Note is
$1,980,000.
The GS Note matures on
July 14, 2022 upon which time all accrued and unpaid
interest will be due and payable. Interest accrues on the GS Note
at
6% per annum until the GS Note becomes due and payable. The
GS Note is subject to various “Events of Default,” which are
disclosed in the GS Note. Upon the occurrence of an “Event of
Default,” the interest rate on the GS Note will be 18%. The GS Note
is not convertible into shares of the Company’s Common Stock and is
not dilutive to existing or future shareholders and the Company
used a portion of the proceeds of the GS Note to retire convertible
debt. As of December 31, 2021, $2,000,000 remains outstanding.
As of December 31, 2021 and 2020 respectively, there was $378,263 and $931,158 of convertible
debt outstanding, net of debt discount of $0, and $35,525. As of December 31,
2021 and 2020 respectively, there was derivative liability of
$533,753 and $1,220,880 related to
convertible debt securities.
NOTE 7 - DEBENTURE
DPTI issued a convertible Debenture to the University (see Note 1)
in exchange for the Patents assigned to the Company, in the amount
of Canadian $1,500,000, or US $1,491,923 on December 16, 2010, the
date of the Debenture. On April 24, 2017 DPTI issued a replacement
secured term Debenture in the same C$1,500,000 amount as the
original Debenture. The interest rate is the Bank of Canada Prime
overnight rate plus 1% per annum. The Debenture had an initial
required payment of Canadian $42,000 (US$33,385) due on April 24,
2018 for reimbursement to the University of its research and
development costs, and this has been paid. Interest-only
maintenance payments are due annually starting after April 24,
2018. Payment of the principal begins on the earlier of (a) three
years following two consecutive quarters of positive earnings
before interest, taxes, depreciation and amortization, (b) six
years from April 24, 2017, or (c) in the event DPTI fails to raise
defined capital amounts or secure defined contract amounts by April
24 in the years 2018, 2019, and 2020. The Company has raised funds
in excess of the amount required for 2020, 2019 and 2018. The
principal repayment amounts will be due quarterly over a six year
period in the amount of Canadian Dollars $62,500. Based on the
exchange rate between the Canadian Dollar and the U.S. Dollar on
December 31, 2018, the quarterly principal repayment amounts will
be US$48,447. The Debenture is secured by the Patents assigned by
the University to DPTI by an Assignment Agreement on December 16,
2010. DPTI has pledged the Patents, and granted a lien on them
pursuant to an Escrow Agreement dated April 24, 2017, between DPTI
and the University.
The Debenture was initially recorded at the $1,491,923 equivalent
US Dollar amount of Canadian $1,500,000 as of December 16, 2010,
the date of the original Debenture. The liability is being adjusted
quarterly based on the current exchange value of the Canadian
dollar to the US dollar at the end of each quarter. The adjustment
is recorded as unrealized gain or loss in the change of the value
of the two currencies during the quarter. The amounts recorded as
an unrealized gain (loss) for the years ended December 31, 2021 and
2020, were $20,941 and $20,941 respectively.
These amounts are included in Accumulated Other Comprehensive Loss
in the Equity section of the consolidated balance sheet, and as
Unrealized Loss on Foreign Exchange on the consolidated statement
of comprehensive loss. The Debenture also includes a provision
requiring DPTI to pay the University a 2% royalty on sales of any
and all products or services which incorporate the Patents for a
period of five years from April 24, 2018.
For the years ended December 31, 2021 and 2020, the Company
recorded interest expense of $52,538 and $52,538, respectively.
As of December 31, 2021, the debenture liability totaled $1,172,364, all of which was long
term.
Future minimum required payments over the next 5 years and
thereafter are as follows:
Future minimum required payments |
|
|
|
|
Period ending December 31, |
|
|
|
2022 |
|
$ |
– |
|
2023 |
|
|
– |
|
2024 |
|
|
– |
|
2025 |
|
|
– |
|
2026 and after |
|
|
1,172,364 |
|
Total |
|
$ |
1,172,364 |
|
NOTE 8 – LEASES
The Company adopted ASC 842 “Leases” using the modified
retrospective approach, electing the practical expedient that
allows the Company not to restate its comparative periods prior to
the adoption of the standard on January 1, 2019. As such, the
disclosures required under ASC 842 are not presented for periods
before the date of adoption.
The following was included in our balance sheet as of December 31,
2021 and 2020:
Schedule of operating leases |
|
|
|
|
|
|
|
|
|
|
December 31, |
|
Operating leases |
|
2021 |
|
|
2020 |
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
ROU operating lease
assets |
|
$ |
2,038,106 |
|
|
$ |
– |
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Current portion of operating
lease |
|
$ |
747,422 |
|
|
$ |
– |
|
Operating lease,
net of current portion |
|
$ |
2,474,530 |
|
|
$ |
– |
|
Total operating
lease liabilities |
|
$ |
3,221,952 |
|
|
$ |
– |
|
The weighted average remaining lease term and weighted average
discount rate at December 31, 2021 were as follows:
Schedule of weighted average remaining lease term
and weighted average discount rate |
|
|
|
|
Weighted average remaining lease
term (years) |
|
December 31,
2021
|
|
Operating leases |
|
|
8.25 |
|
Weighted average discount rate |
|
|
|
|
Operating leases |
|
|
6.00% |
|
Operating
Leases
On January 12, 2021, the Company’s newly acquired subsidiary
entered into an operating lease agreement to rent office space in
Mumbai, India. This three-year agreement commenced January 12, 2021
with an annual rent of approximately $50,000.
On May 27, 2021, the Company’s newly acquired subsidiary entered
into an operating lease agreement to rent office space in Warwick,
United Kingdom. This ten-year agreement commenced May 27, 2021 with
an annual rent of approximately $85,000 with the first six months rent
free.
On August 31, 2021, the Company’s newly acquired subsidiary entered
into an operating lease agreement to rent office space in Tempe,
Arizona. This five-year agreement commenced August 31, 2021 with an
annual rent of approximately $192,000.
On October 20, 2021, the Company’s newly acquired subsidiary
entered into an operating lease agreement to rent office space in
Warwick, United Kingdom. This ten-year agreement commenced October
20, 2021 with an annual rent of approximately $200,000 with the first six months rent
free.
The following table reconciles future minimum operating lease
payments to the discounted lease liability as of December 31,
2021:
Schedule of future minimum operating lease
payments |
|
|
|
|
2022 |
|
$ |
405,924 |
|
2023 |
|
|
498,401 |
|
2024 |
|
|
463,402 |
|
2025 |
|
|
472,343 |
|
2026 and
later |
|
|
1,751,345 |
|
Total lease payments |
|
|
3,591,415 |
|
Less imputed
interest |
|
|
(369,463 |
) |
Total lease obligations |
|
|
3,221,952 |
|
Less current
lease obligations |
|
|
(747,422 |
) |
Long-term lease
obligations |
|
$ |
2,474,530 |
|
NOTE 9 – ACCOUNTS PAYABLE AND
ACCRUED LIABILITIES
Accrued liabilities consist of the following as of December 31:
Schedule of accounts payable and accrued
liabilities |
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
Accounts payable |
|
$ |
7,227,129 |
|
|
$ |
519,899 |
|
Accrued
liabilities |
|
|
617,142 |
|
|
|
569,970 |
|
|
|
$ |
7,844,271 |
|
|
$ |
1,089,869 |
|
NOTE 10 – INCOME
TAXES
The domestic and foreign components of loss before (benefit)
provision for income taxes were as follows:
Schedule of income components
|
|
2021 |
|
|
2020 |
|
Domestic: |
|
$ |
(4,285,237 |
) |
|
$ |
(169,282 |
) |
Foreign: |
|
|
(541,083 |
) |
|
|
(106,560 |
) |
Total income (loss) before income
taxes |
|
$ |
(4,826,320 |
) |
|
$ |
(275,842 |
) |
The provision (benefit) for income taxes for the years ended
December 31, 2021 and 2020 differs from the amount which would be
expected as a result of applying the statutory tax rates to the
losses before income taxes due primarily to the valuation allowance
to fully reserve net deferred tax assets.
The following table summarizes the significant differences between
statutory rates for the years ended December 31, 2021 and 2020:
Statutory tax rate |
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
Statutory tax rate: |
|
|
|
|
|
|
|
|
U.S. |
|
|
21.00% |
|
|
|
21.00% |
|
State taxes |
|
|
2.19% |
|
|
|
3.63% |
|
Foreign rate differential |
|
|
0.46% |
|
|
|
0.00% |
|
Other |
|
|
(1.81)% |
|
|
|
0.00% |
|
Change in
valuation allowance: |
|
|
(21.84)% |
|
|
|
(24.63)% |
|
|
|
|
–% |
|
|
|
–% |
|
The Company’s deferred tax assets and liabilities as of December
31, 2021 and 2020 are as follows:
Deferred Tax assets and liabilities |
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
Deferred Tax (Liabilities): |
|
|
|
|
|
|
|
|
Net operating losses |
|
$ |
2,356,871 |
|
|
$ |
1,351,897 |
|
Intangible assets |
|
|
(170,119 |
) |
|
|
– |
|
Right of use asset |
|
|
(319,752 |
) |
|
|
– |
|
Stock based compensation |
|
|
498,571 |
|
|
|
– |
|
Less: Valuation
allowance |
|
|
(2,365,571 |
) |
|
|
(1,351,897 |
) |
Deferred
tax assets (liabilities) |
|
$ |
– |
|
|
$ |
– |
|
The Company has approximately $7,448,199
of federal and state net operating loss carryforwards as of
December 31, 2021, which will not expire but will be limited to 80%
utilization. The company also has net operating losses in the
United Kingdom of $1,414,454
which will not expire and $636,852
of net operating loss carryforwards in Canada which will begin to
expire in 2038.
The Company records a tax valuation allowance when it is more
likely than not that it will not be able to recover the value of
its deferred tax assets. For the years ended December 31, 2021 and
2020, the Company calculated its estimated annualized effective tax
rate at 0% and 0%, respectively, for both the
United States, Canada and the United Kingdom. The Company had
no income tax expense
on its losses for the years ended December 31, 2021 and 2020,
respectively.
The Company recognizes the financial statement benefit of a tax
position only after determining that the relevant tax authority
would more likely than not sustain the position following an audit.
For tax positions meeting the more-likely-than-not threshold, the
amount recognized in the financial statements is the largest
benefit that has a greater than 50% likelihood of being realized
upon ultimate settlement with the relevant tax authority. The
Company recognizes interest accrued on uncertain tax positions as
well as interest received from favorable tax settlements within
interest expense. The Company recognizes penalties accrued on
unrecognized tax benefits within selling, general and
administrative expenses. As of December 31, 2021 and 2020, the
Company had no uncertain tax positions.
The Company does not anticipate any significant changes to the
total amounts of unrecognized tax benefits in the next twelve
months. The Company files income tax returns in New Brunswick,
Canada, and the U.S. federal, New York, and Delaware jurisdictions
and the United Kingdom jurisdictions. Tax years 2011 to current
remain open to examination by Canadian authorities; the tax year
2018 remains open to examination by U.S. authorities.
NOTE 11 – PREFERRED
STOCK
In accordance with the Company’s bylaws, the Company has authorized
a total of 2,000,000
shares of preferred stock, par value $0.01
per share, for all classes. As of December 31, 2021 and 2020
respectively, there were 88,235
and 88,235
total preferred shares issued and outstanding for all classes.
On December 23, 2021, pursuant to the approval of the Board of
Directors and a majority vote of the holders of Series D Preferred
Stock, the Company amended the Certificate of Designation for the
Series D Preferred Stock so that each share of Series D Stock is
convertible, at the sole and exclusive election of the holder, into
two shares of Common Stock of the Company.
NOTE 12 – COMMON
STOCK
In accordance with the Company’s bylaws, the Company has authorized
a total of 20,000,000,000
shares of common stock, par value $0.0001
per share. As of December 31, 2021 and 2020, there were 5,197,821,885 and
4,088,762,156 common shares issued and outstanding.
On February 18, 2020, the majority stockholders holding a majority
of the issued and outstanding voting shares of the Company amended
the Company’s Certificate of Incorporation to amend the par value
of the Company’s common stock from $0.01 to $0.0001.
On January 14, 2021, the Company issued an aggregate of 100,000,000 shares of
common stock upon the conversion of convertible debt, as issued on
September 24, 2018, in the amount of $28,000.
On January 25, 2021, the Company issued an aggregate of 150,000,000 shares of
common stock upon the conversion of convertible debt, as issued on
September 24, 2018, in the amount of $42,000.
On February 1, 2021, the Company issued an aggregate of 30,999,995 shares of
common stock upon the conversion of convertible debt, as issued on
February 12, 2019, in the amount of $8,116.
On February 11, 2021, the Company issued an aggregate of 100,000,000 shares of
common stock upon the conversion of convertible debt, as issued on
September 24, 2018, in the amount of $56,000.
On February 18, 2021, the Company issued an aggregate of 220,000,000 shares of
common stock upon the conversion of convertible debt, as issued on
September 24, 2018, in the amount of $75,436 for
principal and $39,638 for
interest.
On April 15, 2021, the Company issued an aggregate of 8,065,040 shares of
common stock upon the conversion of convertible debt, as issued on
October 7, 2020, in the amount of $47,850 and interest
of $2,153.25.
On April 30, 2021, the Company issued
60,000,000 shares of common stock as compensation for loan
acquisition costs associated with the note issued on the same date
for the amount of $825,000.
On June 4, 2021, the Company issued an aggregate of 12,500,000 shares of
common stock upon the conversion of convertible debt, as issued on
September 25, 2018, in the amount of $76,656.83 and
interest of $260.61.
On July 12, 2021, the Company issued an aggregate of 1,784,146 shares of
common stock upon the conversion of convertible debt, as issued on
January 12, 2021, in the amount of $42,350.
On July 14, 2021, the Company issued an aggregate of 45,037,115 shares of
common stock upon the conversion of convertible debt, as issued on
October 7, 2020, in the amount of $93,864 and interest
of $26,246.
On July 19, 2021, the Company issued an aggregate of 2,898,382 shares of
common stock upon the conversion of convertible debt, as issued on
October 7, 2020, in the amount of $10,497 and interest
of $6,748.
On August 25, 2021, the Company issued
31,799,260 shares of common stock for $3,000,000.
On August 31, 2021, the Company issued
27,297,995 shares of common stock for $3,000,000.
On September 22, 2021, the Company issued
25,630,272 shares of common stock for $2,000,000.
On September 30, 2021, the Company issued
15,000,000 shares of common stock pursuant to two separate
Membership Interest Purchase Agreements with Remote Intelligence,
and Wildlife Specialists, LLC.
On September 30, 2021, the Company issued
3,194,081 shares of common stock as compensation valued at
$250,000
for loan acquisition costs associated with proceeds raised.
On October 1, 2021, the Company issued
37,187,289 shares of common stock for $3,000,000.
On October 15, 2021, the Company issued
14,282,304 shares of common stock for $1,055,000.
On October 22, 2021, the Company issued
1,596,594 shares of common stock as compensation valued at
$250,000
for loan acquisition costs associated with proceeds raised.
On October 25, 2021, the Company issued 634,778 shares of common
stock as compensation valued at $250,000
for loan acquisition costs associated with proceeds raised.
On November 17, 2021, the Company issued an aggregate of 177,375,000 shares of
common stock upon the conversion of convertible debt, as issued on
April 30, 2021, in the amount of $825,000 and
interest of $61,875.
On December 21, 2021, the Company issued an aggregate of 43,777,478 shares of common
stock for $2,538,327.
At December 31, 2021, the Company had 1,589,257,888 in common
shares reserved for issuance for convertible debt securities.
NOTE 13 – STOCK
OPTIONS
As of December 31, 2021 and 2020, the Company had no outstanding stock
options.
NOTE 14 – COMMITMENTS AND
CONTINGENCIES
Potential Royalty Payments
The Company, in consideration of the terms of the debenture to the
University of New Brunswick, shall pay to the University a two
percent royalty on sales of any and all products or services, which
incorporate the Company's patents for a period of five years from
April 24, 2018.
Legal Matters
DarkPulse, Inc. v. Twitter, Inc.
On January 24, 2022, the Company filed a petition in the Supreme
Court of the State of New York County of New York to compel a
disclosure from Twitter, Inc. The petition sought to compel
Twitter, Inc. to disclose the owner and operator of the “Investor
News” Twitter account (@newsfilterio) so the Company could commence
an action for damages arising from false, misleading, and untrue
statements made by the Investor News.
On February 23, 2022, the Court ordered Twitter to release
information concerning the owner and operator of the Investor News
account to the Company. The
Company will continue to pursue and expose the identities of those
individuals or groups and shall take any and all legal action to
pursue the violators.
Carebourn Capital, L.P. v. DarkPulse, Inc.
As disclosed in greater detail in the Company’s Form 10-Q, filed
November 15, 2021, the Company remains in active litigation with
Carebourn Capital, L.P. (“Carebourn”). The remainder of this
disclosure will address all material updates since the
aforementioned Form 10-Q.
On November 1, 2021, the Company filed a motion to compel Carebourn
to produce certain documents and supplement its responses to
certain interrogatories.
On September 27, 2021, Carebourn filed a declaratory judgment and a
motion for declaratory judgment, dismissal of the Company’s claims,
and summary judgment (“Dispositive Motion”).
On February 15, 2022, the Court rendered its decision on the
aforesaid motions, denying the Dispositive Motion in its entirety
and granting in part, and denying in part, the Company’s motion to
compel. Pursuant to the Court’s ruling in the Company’s favor on
its motion to compel, the Court has awarded the Company attorneys’
costs and fees in connection with the successful portions of its
motion to compel.
On January 19, 2022, the Company filed a motion for enforcement of
a protective order. It is the Company’s position that Carebourn has
violated a protective order that was entered into by the parties
and seeks to protect confidential information exchanged during the
litigation. The Court has not yet rendered a decision on this
motion.
On March 24, 2022, Carebourn filed a Motion to Compel against
DarkPulse, alleging that DarkPulse failed to fulfill its discovery
obligations by not producing a privilege log. DarkPulse contends
that Carebourn’s motion is meritless and premature.
The Company remains committed to actively litigating its claims for
relief under the Securities Exchange Act of 1934.
More Capital, LLC v. DarkPulse, Inc. et al
As disclosed in greater detail in the Company’s Form 10-Q, filed
November 15, 2021, the Company remains in active litigation with
More Capital, LLC (“More”). The remainder of this disclosure will
address all material updates since the aforementioned Form
10-Q.
On October 27, 2021, the Company served its initial discovery
requests, consisting of interrogatories, requests for admission,
and requests for production, on More.
On November 24, 2021, More served its responses to the Company’s
initial discovery requests. After reviewing More’s responses, it is
the Company’s position that More’s responses are false, misleading,
untrue, and/or evasive.
On February 28, 2022, the Company filed its motion to compel More
to produce certain documents and supplement or otherwise modify its
responses to certain interrogatories and requests for admission.
DarkPulse’s motion will be heard on April 14, 2022.
On March 9, 2022, More filed a motion for summary judgment against
the Company. The Company’s opposition is being filed on or before
March 23, 2022, and More’s motion will be heard on April 6,
2022.
The Company remains committed to actively litigating its claims for
relief under the Securities Exchange Act of 1934.
Goodman et al. v. DarkPulse, Inc.
As disclosed in greater detail in the Company’s Form 10-Q, filed
November 15, 2021, the Company remains in active litigation with
Stephen Goodman (“Goodman”), Mark Banash (“Banash”), and David
Singer (“Singer”) (Goodman, Banash, and Singer together, the
“Series D Plaintiffs”). The remainder of this disclosure will
address all material updates since the aforementioned Form
10-Q.
On August 20, 2021, the Company and the Series D Plaintiffs entered
into a stipulation, pursuant to which the Company withdrew its
motion to dismiss and the Company was provided with an extended
period of time to respond to the complaint.
On September 8, 2021, the Company filed its Answer and
Counterclaims, wherein the Company alleges counterclaims arising
from various breaches of fiduciary duties by the Series D
Plaintiffs while they were employed as officers of the Company.
On December 9, 2021, the parties participated in private mediation.
No understanding of settlement was reached at the conclusion
thereof.
The Company remains committed to actively litigating its claims and
defenses against the Series D Plaintiffs.
DarkPulse, Inc. v. FirstFire Global Opportunities Fund, LLC, and
Eli Fireman (SDNY)
On December 31, 2021, the Company commenced an action against
FirstFire Global Opportunities Fund, LLC (“FirstFire”), and Eli
Fireman (“Fireman”) (FirstFire and Fireman together, the “FirstFire
Parties”) in the United States District Court for the Southern
District of New York. The complaint alleges that FirstFire is an
unregistered dealer acting in violation of Section 15(a) of the
Securities Exchange Act of 1934 (the “Act”), and that the Company
is entitled to rescissionary relief from certain convertible
promissory notes and securities purchase agreements entered into by
the Company and FirstFire pursuant to Section 29(b) of the Act. The
complaint also asserts claims against Fireman for control person
liability under Section 20(a) of the Act, unjust enrichment of
FirstFire, and constructive trust against FirstFire.
On January 14, 2022, the Company moved for entry of a temporary
restraining order and award of a preliminary injunction against
FirstFire to enjoin them from selling or attempting to sell,
transfer, or otherwise dispose of the 177,275,000 common shares the
Company believed were in FirstFire’s possession pursuant to a
certain note.
On January 14, 2022, the Court denied the Company’s order to show
cause seeking a temporary restraining order.
Following expedited briefing by the parties, on January 21, 2022,
the Court denied the Company’s motion for preliminary
injunction.
On March 14, 2022, the FirstFire Parties filed their letter request
for a motion to dismiss the Company’s complaint. The Company
responded to the FirstFire Parties’ letter on March 17, 2022. As of
the filing date, the Court has not yet issued a decision on the
FirstFire Parties letter request to file its motion to dismiss.
FirstFire Global Opportunities Fund, LLC v. DarkPulse, Inc.
(Del. Chancery Court)
On December 13, 2021, FirstFire Global Opportunities Fund, LLC
(“FirstFire”) commenced an action against the Company in the Court
of Chancery of the State of Delaware. The complaint seeks
declaratory judgment of the issuance of
177,375,000 shares of Company common stock pursuant to a
certain convertible promissory note.
On January 4, 2022, the Company filed a motion to dismiss
FirstFire’s complaint.
On February 11, 2022, the Company filed its opening memorandum of
law in support of its motion to dismiss. The Company’s memorandum
argues that FirstFire the certain convertible promissory note that
the issuance was made under is void ab initio as it violates New
York’s criminal usury laws, and that FirstFire improperly amended
the governing law provision of the void convertible note to evade
being declared void ab initio and, instead, continue to enforce the
unlawful transaction.
On March 14, 2022, FirstFire filed a notice of voluntary dismissal
of its complaint.
As of December 31, 2021, DarkPulse views the aforesaid FirstFire
Delaware Chancery matter as fully closed.
DarkPulse, Inc. v. EMA Financial, LLC et al
On January 4, 2022, the Company commenced an action against EMA
Financial, LLC (“EMA”), EMA Group, Inc. (“EMA Group”), and Felicia
Preston (“Preston”) (EMA, EMA Group, and Preston together, the “EMA
Parties”) in the United States District Court for the Southern
District of New York. The complaint alleges that EMA is an
unregistered dealer acting in violation of Section 15(a) of the
Securities Exchange Act of 1934 (the “Act”), and that the Company
is entitled to rescissionary relief from certain convertible
promissory notes and securities purchase agreements entered into by
the Company and EMA pursuant to Section 29(b) of the Act. The
complaint also asserts claims against Preston for control person
liability under Section 20(a) of the Act, unjust enrichment of EMA,
EMA Group, and Preston, and constructive trust against the EMA
Parties.
On March 28, 2022, the Company filed its first amended complaint
against the EMA Parties. The amended complaint alleges the same
causes of action asserted in the initial complaint—(1) that EMA is
an unregistered dealer acting in violation of Section 15(a) of the
Act and, pursuant to Section 29(b) of the Act, the Company is
entitled to rescissionary relief from certain convertible
promissory notes and securities purchase agreements entered into by
the Company and EMA, (2) that Preston is liable pursuant to Section
20(a) of the Act, and (3) unjust enrichment—along with two claims:
that the EMA Parties, first, violated and, second conspired to
violate the Racketeer Influenced and Corrupt Organizations (RICO)
Act for engaging in the collection of an unlawful debt.
The Company remains committed to actively litigating its claims for
relief under the Securities Exchange Act of 1934.
From time to time, we may become involved in litigation relating to
claims arising out of our operations in the normal course of
business. We are not currently involved in any pending legal
proceeding or litigation and, to the best of our knowledge, no
governmental authority is contemplating any proceeding to which we
are a party or to which any of our properties is subject, which
would reasonably be likely to have a material adverse effect on our
business, financial condition and operating results.
COVID-19
On March 11, 2020, the World Health Organization announced that
infections of the novel Coronavirus (COVID-19) had become pandemic,
and on March 13, the U.S. President announced a National Emergency
relating to the disease. There is a possibility of continued
widespread infection in the United States and abroad, with the
potential for catastrophic impact. National, state and local
authorities have required or recommended social distancing and
imposed or are considering quarantine and isolation measures on
large portions of the population, including mandatory business
closures. These measures, while intended to protect human life, are
expected to have serious adverse impacts on domestic and foreign
economies of uncertain severity and duration. Some economists are
predicting the United States will soon enter a recession. The
sweeping nature of the coronavirus pandemic makes it extremely
difficult to predict how the Company’s business and operations will
be affected in the longer run, but we expect that it may materially
affect our business, financial condition and results of operations.
The extent to which the coronavirus impacts our results will depend
on future developments, which are highly uncertain and cannot be
predicted, including new information which may emerge concerning
the severity of the coronavirus and the actions to contain the
coronavirus or treat its impact, among others. Moreover, the
coronavirus outbreak has begun to have indeterminable adverse
effects on general commercial activity and the world economy, and
our business and results of operations could be adversely affected
to the extent that this coronavirus or any other epidemic harms the
global economy generally and/or the markets in which we operate
specifically. Any of the foregoing factors, or other cascading
effects of the coronavirus pandemic that are not currently
foreseeable, could materially increase our costs, negatively impact
our revenues and damage the Company’s results of operations and its
liquidity position, possibly to a significant degree. The duration
of any such impacts cannot be predicted.
NOTE 15 – RELATED PARTY
TRANSACTIONS
The Company follows subtopic 850-10 of the FASB Accounting
Standards Codification for the identification of related parties
and disclosure of related party transactions. Pursuant to
Section 850-10-20 the related parties include a) affiliates of the
Company; b) Entities for which investments in their equity
securities would be required, absent the election of the fair value
option under the Fair Value Option Subsection of Section 825-10-15,
to be accounted for by the equity method by the investing entity;
c) trusts for the benefit of employees, such as pension and
profit-sharing trusts that are managed by or under the trusteeship
of management; d) principal owners of the Company; e) management of
the Company; f) other parties with which the Company may deal if
one party controls or can significantly influence the management or
operating policies of the other to an extent that one of the
transacting parties might be prevented from fully pursuing its own
separate interests; and g) Other parties that can significantly
influence the management or operating policies of the transacting
parties or that have an ownership interest in one of the
transacting parties and can significantly influence the other to an
extent that one or more of the transacting parties might be
prevented from fully pursuing its own separate interests. The
financial statements shall include disclosures of material related
party transactions, other than compensation arrangements, expense
allowances, and other similar items in the ordinary course of
business. However, disclosure of transactions that are eliminated
in the preparation of consolidated or combined financial statements
is not required in those statements. The disclosures shall include:
a) the nature of the relationship(s) involved; b) a description of
the transactions, including transactions to which no amounts or
nominal amounts were ascribed, for each of the periods for which
income statements are presented, and such other information deemed
necessary to an understanding of the effects of the transactions on
the financial statements; c) the dollar amounts of transactions for
each of the periods for which income statements are presented and
the effects of any change in the method of establishing the terms
from that used in the preceding period; and d) amounts due from or
to related parties as of the date of each balance sheet presented
and, if not otherwise apparent, the terms and manner of
settlement.
During the years ended December 31, 2021 and 2020, the Company’s
Chief Executive Officer advanced personal funds in the amount of
$593 and $68,254 for Company
expenses.
NOTE 16 – SUBSEQUENT
EVENTS
On January 12, 2022, the Company issued 23,372,430 shares of common
stock for $1,150,000.
On January 21, 2022, the Company issued 33,454,988 shares of common
stock for $1,150,000.
On February 7, 2022, the Company issued 16,040,411 shares of common
stock for $500,000.
On March 7, 2022, the Company issued 75,798,921 shares of common
stock for $2,500,000.
On March 23, 2022, the Company issued 29,257,395 shares of common
stock for $1,500,000.
On April 11, 2022, the Company issued 23,746,816 shares of common
stock for $1,000,000.
PART II - INFORMATION NOT REQUIRED IN PROSPECTUS
Item 13 - Other Expenses of Issuance and Distribution
We estimate that expenses in connection with the distribution
described in this Registration Statement (other than brokerage
commissions, discounts or other expenses relating to the sale of
the shares by the Selling Security Holder) will be as set forth
below. We will pay all of the expenses with respect to the
distribution, and such amounts, with the exception of the SEC
registration fee, are estimates.
|
|
|
Amount
to Be Paid
|
|
SEC registration
fee |
|
$ |
2,823.00 |
|
State filing fees |
|
$ |
500.00 |
|
Edgarizing costs |
|
$ |
500.00 |
|
Accounting fees and expenses |
|
$ |
1,000.00 |
|
Legal fees and
expenses |
|
$ |
15,000.00 |
|
Total |
|
$ |
19,823.00 |
|
Item 14 - Indemnification of Directors and Officers
Under our Certificate of Incorporation, our directors have no
personal liability to us or our stockholders for monetary damages
for breach of fiduciary duty as a director, except (i) for any
breach of the duty of loyalty to the Company or its stockholders,
(ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii) under
Section 174 of the DGCL as it may from time to time be amended or
any successor provision thereto, or (iv) for any transaction from
which a director derives an improper personal benefit.
We do not maintain any policy of directors’ and officers’ liability
insurance that insures our directors and officers against the cost
of defense, settlement or payment of a judgment under any
circumstances.
Item 15 - Recent Sales of Unregistered Securities
Convertible Notes
On January 10, 2019, we entered into a Securities Purchase
Agreement with GS Capital Partners, LLC, (“GS Capital”) issuing
a convertible redeemable note in the principal amount of
$65,000. The note may be
converted into common shares of our common stock at a conversion
price equal to the lower of $0.25, or 70% of the lowest trading
price of our common stock during the 20 prior trading
days.
On February 12, 2019, we entered into a securities purchase
agreement with Crown Bridge Partners, LLC (“Crown”) issuing a
convertible promissory note in the aggregate principal amount of up
to $35,000. The note may be converted into common shares of our
common stock at a conversion price equal 70% of the lowest trading
price of our common stock during the 20 prior trading days.
On April 23, 2019, we entered into a securities purchase agreement
with GS Capital issuing to GS Capital a convertible promissory note
in the aggregate principal amount of $40,000. The note bears
interest at 8% per annum and may be converted into common shares of
our common stock at a conversion price equal to 70% of the average
of the three lowest trading prices of our common stock during the
20 prior trading days.
On May 3, 2019, we entered into a securities purchase agreement
with Geneva Roth Remark Holdings, Inc. (“Geneva”) issuing to
Geneva a convertible promissory note in the aggregate principal
amount of $64,000. The note bears interest at 9% per annum and may
be converted into common shares of our common stock at a conversion
price equal to 70% of the lowest trading price of our common stock
during the 20 prior trading days.
On January 10, 2019, we entered into a Securities Purchase
Agreement with GS Capital issuing a convertible
redeemable note in the principal amount of
$65,000. The note may be
converted into common shares of our common stock at a conversion
price equal to the lower of $0.25, or 70% of the lowest trading
price of our common stock during the 20 prior trading
days.
On February 12, 2019, we entered into a securities purchase
agreement with Crown issuing a convertible promissory note in the
aggregate principal amount of up to $35,000. The note may be
converted into common shares of our common stock at a conversion
price equal 70% of the lowest trading price of our common stock
during the 20 prior trading days.
On April 23, 2019, we entered into a securities purchase agreement
with GS Capital issuing to GS Capital a convertible promissory note
in the aggregate principal amount of $40,000. The note bears
interest at 8% per annum and may be converted into common shares of
our common stock at a conversion price equal to 70% of the average
of the three lowest trading prices of our common stock during the
20 prior trading days.
On May 3, 2019, we entered into a securities purchase agreement
with Geneva issuing to Geneva a convertible promissory note in the
aggregate principal amount of $64,000. The note bears interest at
9% per annum and may be converted into common shares of our common
stock at a conversion price equal to 70% of the lowest trading
price of our common stock during the 20 prior trading days.
On October 7, 2020, we entered into a securities purchase agreement
with Geneva issuing to Geneva a convertible promissory note in the
aggregate principal amount of $47,850. The note bears interest at
9% per annum and may be converted into common shares of our common
stock at a conversion price equal to 70% of the lowest trading
price of our common stock during the 20 prior trading days.
On September 2, 2020, we entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $47,850. The note bears
interest at 9% per annum and may be converted into common shares of
our common stock at a conversion price equal to 70% of the lowest
trading price of our common stock during the 20 prior trading
days.
On January 4, 2021, we entered into a securities purchase agreement
with Geneva issuing to Geneva a convertible promissory note in the
aggregate principal amount of $42,350. The note bears interest at
8% per annum and may be converted into common shares of our common
stock at a conversion price equal to 70% of the lowest trading
price of our common stock during the 20 prior trading days.
On February 3, 2021, we entered into a securities purchase
agreement with Geneva issuing to Geneva a convertible promissory
note in the aggregate principal amount of $94,200. The note bears
interest at 4.5% per annum and ma